Sayfa ile ilgili istek ve şikayetleriniz için aşağıdaki formu kullanabilirsiniz.
"03.12.2016 11:00:51" [{"text":"afib", "indices":[5, 10]}, {"text":"stroke", "indices":[38, 45]}, {"text":"ASH16", "indices":[120, 126]}] Boehringer 9/10 #afib patients are worried about #stroke - learn why it's so important to protect yourself https://t.co/g4Cp77Sn0N #ASH16 9/10 #afib patients are worried about #stroke - learn why it's so important to protect yourself https://t.co/g4Cp77Sn0N #ASH16 "02.12.2016 16:01:24" [{"text":"ASH16", "indices":[40, 46]}, {"text":"afib", "indices":[130, 135]}] Boehringer Who else is travelling to San Diego for #ASH16? It's going to be a busy weekend - find out what's on here https://t.co/pJvrW7iS76 #afib https://t.co/uJGJR0tdZR Who else is travelling to San Diego for #ASH16? It's going to be a busy weekend - find out what's on here https://t.co/pJvrW7iS76 #afib https://t.co/uJGJR0tdZR "02.12.2016 13:05:17" [{"text":"WCLC2016", "indices":[16, 25]}, {"text":"LungCancer", "indices":[69, 80]}, {"text":"LCAM", "indices":[115, 120]}] Boehringer Who's attending #WCLC2016 by @IASLC? We're excited to launch our new #LungCancer survey of physicians. Stay tuned! #LCAM Who's attending #WCLC2016 by @IASLC? We're excited to launch our new #LungCancer survey of physicians. Stay tuned! #LCAM "02.12.2016 11:00:55" [{"text":"DYK", "indices":[0, 4]}, {"text":"afib", "indices":[16, 21]}, {"text":"stroke", "indices":[49, 56]}, {"text":"ASH16", "indices":[138, 144]}] Boehringer #DYK >1/2 of #afib patients have little to no #stroke knowledge? Head to https://t.co/elckSgRyu6] for info on strokes & prevention #ASH16 https://t.co/alJ7nbkDcd #DYK >1/2 of #afib patients have little to no #stroke knowledge? Head to https://t.co/elckSgRyu6] for info on strokes & prevention #ASH16 https://t.co/alJ7nbkDcd "30.11.2016 13:45:26" [{"text":"NSCLC", "indices":[26, 32]}, {"text":"LungCancer", "indices":[33, 44]}, {"text":"patients", "indices":[45, 54]}, {"text":"LCAM", "indices":[111, 116]}] Boehringer 2015 top reasons why some #NSCLC #LungCancer #patients did not receive mutation tests. Has it changed in 2016? #LCAM https://t.co/FZPWlawI8G 2015 top reasons why some #NSCLC #LungCancer #patients did not receive mutation tests. Has it changed in 2016? #LCAM https://t.co/FZPWlawI8G "29.11.2016 16:05:15" [{"text":"EGFR", "indices":[74, 79]}, {"text":"LungCancer", "indices":[91, 102]}] Boehringer Hope you enjoyed the @boehringerus TweetChat! We'll be talking more about #EGFR testing in #LungCancer later so stay tuned! Hope you enjoyed the @boehringerus TweetChat! We'll be talking more about #EGFR testing in #LungCancer later so stay tuned! "29.11.2016 14:50:18" [{"text":"LCAM", "indices":[7, 12]}, {"text":"EGFR", "indices":[27, 32]}, {"text":"LungCancer", "indices":[44, 55]}] Boehringer During #LCAM we're talking #EGFR testing in #LungCancer. Join @BoehringerUS TweetChat in 10 minutes! 10:00 EDT / 16:00 CET https://t.co/pIiJXT23Cu During #LCAM we're talking #EGFR testing in #LungCancer. Join @BoehringerUS TweetChat in 10 minutes! 10:00 EDT / 16:00 CET https://t.co/pIiJXT23Cu "29.11.2016 14:05:23" [{"text":"patients", "indices":[99, 108]}] Boehringer Collab. w/ China Southeast University underscores our commitment to bring medical breakthroughs to #patients in need https://t.co/d4EoqWzwGP Collab. w/ China Southeast University underscores our commitment to bring medical breakthroughs to #patients in need https://t.co/d4EoqWzwGP "29.11.2016 13:30:30" [{"text":"LungCancer", "indices":[38, 49]}, {"text":"LCAM", "indices":[122, 127]}, {"text":"WCLC2016", "indices":[128, 137]}] Boehringer We're excited to soon reveal our 2016 #LungCancer international survey results! How has the landscape changed since 2015? #LCAM #WCLC2016 https://t.co/pYmFeP9cT1 We're excited to soon reveal our 2016 #LungCancer international survey results! How has the landscape changed since 2015? #LCAM #WCLC2016 https://t.co/pYmFeP9cT1 "29.11.2016 11:19:24" [{"text":"LCAM", "indices":[7, 12]}, {"text":"EGFR", "indices":[43, 48]}, {"text":"LungCancer", "indices":[60, 71]}] Boehringer During #LCAM @boehringerus will be talking #EGFR testing in #LungCancer. Join the TweetChat today! 10:00 EDT / 16:00 CET https://t.co/UqRsnc2k93 During #LCAM @boehringerus will be talking #EGFR testing in #LungCancer. Join the TweetChat today! 10:00 EDT / 16:00 CET https://t.co/UqRsnc2k93 "29.11.2016 10:25:08" [{"text":"HearingLoss", "indices":[0, 12]}, {"text":"Research", "indices":[60, 69]}] Boehringer #HearingLoss & regenerative medicine are focus areas of #Research Beyond Borders (RBB) https://t.co/d4EoqWzwGP #HearingLoss & regenerative medicine are focus areas of #Research Beyond Borders (RBB) https://t.co/d4EoqWzwGP "28.11.2016 14:45:11" [{"text":"Research", "indices":[50, 59]}, {"text":"science", "indices":[106, 114]}] Boehringer Collab. w/ China Southeast University, project of #Research Beyond Borders (RBB), which explores emerging #science https://t.co/d4EoqWhVif Collab. w/ China Southeast University, project of #Research Beyond Borders (RBB), which explores emerging #science https://t.co/d4EoqWhVif "28.11.2016 13:54:36" [] Boehringer @fatmike182 We have no reports of missing or injured employees. We're shocked by this cruel act of inhumanity & feel w/ family & friends. @fatmike182 We have no reports of missing or injured employees. We're shocked by this cruel act of inhumanity & feel w/ family & friends. "28.11.2016 13:53:05" [] Boehringer @UitgeverArie We have no reports of missing or injured employees. We're shocked by this cruel act of inhumanity & feel w/ family & friends. @UitgeverArie We have no reports of missing or injured employees. We're shocked by this cruel act of inhumanity & feel w/ family & friends. "28.11.2016 13:12:56" [{"text":"NEWS", "indices":[0, 5]}, {"text":"HearingLoss", "indices":[97, 109]}] Boehringer #NEWS: We're collaborating w/ China Southeast University to develop new treatment approaches for #HearingLoss https://t.co/d4EoqWhVif #NEWS: We're collaborating w/ China Southeast University to develop new treatment approaches for #HearingLoss https://t.co/d4EoqWhVif "28.11.2016 09:05:24" [{"text":"MotivationMonday", "indices":[33, 50]}, {"text":"T2D", "indices":[51, 55]}, {"text":"diabetes", "indices":[56, 65]}] Boehringer Always see the beauty in others! #MotivationMonday #T2D #diabetes https://t.co/FHGkMAZFK1 Always see the beauty in others! #MotivationMonday #T2D #diabetes https://t.co/FHGkMAZFK1 "26.11.2016 14:10:19" [{"text":"AFAwareWeek", "indices":[34, 46]}, {"text":"afib", "indices":[100, 105]}] Boehringer Thanks to all those who supported #AFAwareWeek. Check out our YouTube channel CVTV for more info on #afib https://t.co/g4Cp77Sn0N Thanks to all those who supported #AFAwareWeek. Check out our YouTube channel CVTV for more info on #afib https://t.co/g4Cp77Sn0N "26.11.2016 11:20:14" [{"text":"Afib", "indices":[21, 26]}, {"text":"Afib", "indices":[99, 104]}, {"text":"AFAwareWeek", "indices":[110, 122]}] Boehringer Who knew the answer? #Afib can cause your ❤ to beat too quickly & irregularly. Learn to detect #Afib this #AFAwareWeek https://t.co/ceRo1INnto Who knew the answer? #Afib can cause your ❤ to beat too quickly & irregularly. Learn to detect #Afib this #AFAwareWeek https://t.co/ceRo1INnto "25.11.2016 09:30:38" [{"text":"lungcancer", "indices":[18, 29]}, {"text":"patients", "indices":[30, 39]}, {"text":"EGFR", "indices":[72, 77]}, {"text":"LCAM", "indices":[129, 134]}] Boehringer Are almost 25% of #lungcancer #patients still starting treatment before #EGFR mutation test results available? To be revealed... #LCAM https://t.co/2SPuhgUr58 Are almost 25% of #lungcancer #patients still starting treatment before #EGFR mutation test results available? To be revealed... #LCAM https://t.co/2SPuhgUr58 "25.11.2016 09:04:07" [{"text":"AFAwareWeek", "indices":[19, 31]}, {"text":"Afib", "indices":[68, 73]}, {"text":"heart", "indices":[89, 95]}] Boehringer To mark the end of #AFAwareWeek we have another quick quiz for you. #Afib can cause your #heart to beat… To mark the end of #AFAwareWeek we have another quick quiz for you. #Afib can cause your #heart to beat… "24.11.2016 15:25:15" [{"text":"Afib", "indices":[0, 5]}, {"text":"people", "indices":[28, 35]}, {"text":"heart", "indices":[99, 105]}, {"text":"AFAwareWeek", "indices":[123, 135]}] Boehringer #Afib affects over 33 mill. #people worldwide - RT to raise awareness of the most common sustained #heart rhythm condition #AFAwareWeek https://t.co/PxduSZWa5a #Afib affects over 33 mill. #people worldwide - RT to raise awareness of the most common sustained #heart rhythm condition #AFAwareWeek https://t.co/PxduSZWa5a "24.11.2016 14:01:58" [{"text":"Afib", "indices":[0, 5]}, {"text":"strokes", "indices":[22, 30]}, {"text":"AFAwareWeek", "indices":[86, 98]}] Boehringer #Afib leads to 3mill. #strokes per year worldwide, detect & protect yourself this #AFAwareWeek. More info here https://t.co/g4Cp77Sn0N https://t.co/AxVsdOcBrE #Afib leads to 3mill. #strokes per year worldwide, detect & protect yourself this #AFAwareWeek. More info here https://t.co/g4Cp77Sn0N https://t.co/AxVsdOcBrE "23.11.2016 15:00:51" [{"text":"afib", "indices":[20, 25]}, {"text":"AFAwareWeek", "indices":[31, 43]}, {"text":"stroke", "indices":[85, 92]}] Boehringer Find out more about #afib this #AFAwareWeek and the importance of protecting against #stroke https://t.co/0n05g2YP1v https://t.co/G3M8Z9lbNT Find out more about #afib this #AFAwareWeek and the importance of protecting against #stroke https://t.co/0n05g2YP1v https://t.co/G3M8Z9lbNT "23.11.2016 14:30:56" [{"text":"lungcancer", "indices":[69, 80]}, {"text":"LCAM", "indices":[81, 86]}, {"text":"WCLC2016", "indices":[87, 96]}] Boehringer Who is ahead, the Americans or the Brits? All will be revealed soon… #lungcancer #LCAM #WCLC2016 Stay tuned! https://t.co/bSmvREHMz2 Who is ahead, the Americans or the Brits? All will be revealed soon… #lungcancer #LCAM #WCLC2016 Stay tuned! https://t.co/bSmvREHMz2 "23.11.2016 11:00:24" [{"text":"Afib", "indices":[0, 5]}, {"text":"stroke", "indices":[28, 35]}, {"text":"AFAwareWeek", "indices":[76, 88]}] Boehringer #Afib increases the risk of #stroke x5 - learn how to protect yourself this #AFAwareWeek by following this link: https://t.co/6n4eYzESgq https://t.co/SwS18xEI1Y #Afib increases the risk of #stroke x5 - learn how to protect yourself this #AFAwareWeek by following this link: https://t.co/6n4eYzESgq https://t.co/SwS18xEI1Y "22.11.2016 14:09:53" [{"text":"EGFR", "indices":[26, 31]}, {"text":"lungcancer", "indices":[125, 136]}] Boehringer @brandingscience improved #EGFR mutation testing rates can help make a choice of 1st-line treatment for patients w/ advanced #lungcancer @brandingscience improved #EGFR mutation testing rates can help make a choice of 1st-line treatment for patients w/ advanced #lungcancer "22.11.2016 12:25:14" [{"text":"EGFR", "indices":[39, 44]}, {"text":"lungcancer", "indices":[75, 86]}, {"text":"LCAM", "indices":[128, 133]}] Boehringer Keep following to find out if rates of #EGFR mutation testing for advanced #lungcancer have improved worldwide in the last year #LCAM https://t.co/u7uJpCgnLh Keep following to find out if rates of #EGFR mutation testing for advanced #lungcancer have improved worldwide in the last year #LCAM https://t.co/u7uJpCgnLh "21.11.2016 13:16:42" [] Boehringer Thank you so much @russwinn66 for sharing your story and for inspiring us today! https://t.co/SV40UqOALZ Thank you so much @russwinn66 for sharing your story and for inspiring us today! https://t.co/SV40UqOALZ "21.11.2016 13:13:50" [{"text":"lungcancer", "indices":[29, 40]}, {"text":"LCAM15", "indices":[59, 66]}, {"text":"LCAM", "indices":[105, 110]}] Boehringer We launched an international #lungcancer insights report @ #LCAM15. Stay tuned for this year's activity! #LCAM https://t.co/nP1kF69sW6 https://t.co/iK8Jd9YbNp We launched an international #lungcancer insights report @ #LCAM15. Stay tuned for this year's activity! #LCAM https://t.co/nP1kF69sW6 https://t.co/iK8Jd9YbNp "21.11.2016 10:38:21" [] Boehringer @lungoxfordahsn @russwinn66 @CohnWolfeUK we wish you a productive and inspiring day. Big thank you for all your support! PA @lungoxfordahsn @russwinn66 @CohnWolfeUK we wish you a productive and inspiring day. Big thank you for all your support! PA "21.11.2016 09:05:24" [{"text":"MotivationMonday", "indices":[59, 76]}, {"text":"T2D", "indices":[77, 81]}, {"text":"diabetes", "indices":[82, 91]}] Boehringer A reminder to appreciate every day & the simple things #MotivationMonday #T2D #diabetes https://t.co/GbiiKTrFVx A reminder to appreciate every day & the simple things #MotivationMonday #T2D #diabetes https://t.co/GbiiKTrFVx "20.11.2016 15:01:26" [{"text":"kidneydisease", "indices":[51, 65]}, {"text":"T2D", "indices":[69, 73]}] Boehringer Last day of @ASNKidney! We hope you've enjoyed our #kidneydisease in #T2D facts Last day of @ASNKidney! We hope you've enjoyed our #kidneydisease in #T2D facts "20.11.2016 14:01:18" [{"text":"DidYouKnow", "indices":[0, 11]}, {"text":"kidneyfailure", "indices":[13, 27]}, {"text":"T2D", "indices":[73, 77]}] Boehringer #DidYouKnow: #kidneyfailure usually requires dialysis or even transplant #T2D https://t.co/6sf1LTKVcO #DidYouKnow: #kidneyfailure usually requires dialysis or even transplant #T2D https://t.co/6sf1LTKVcO "19.11.2016 15:15:27" [{"text":"DidYouKnow", "indices":[0, 11]}, {"text":"T2D", "indices":[25, 29]}, {"text":"doctor", "indices":[52, 59]}, {"text":"kidneydisease", "indices":[66, 80]}] Boehringer #DidYouKnow: people with #T2D should speak to their #doctor about #kidneydisease and manage their risk https://t.co/XFdEAPXbEe #DidYouKnow: people with #T2D should speak to their #doctor about #kidneydisease and manage their risk https://t.co/XFdEAPXbEe "19.11.2016 13:05:17" [{"text":"LCAM", "indices":[68, 73]}, {"text":"lungcancer", "indices":[101, 112]}] Boehringer "We have numbers, we have stigma, and we have hope.” Check out this #LCAM post from @TheseAreMyScars #lungcancer https://t.co/RmFpRnH9c1 "We have numbers, we have stigma, and we have hope.” Check out this #LCAM post from @TheseAreMyScars #lungcancer https://t.co/RmFpRnH9c1 "19.11.2016 08:10:18" [{"text":"socent", "indices":[8, 15]}, {"text":"MMH", "indices":[16, 20]}] Boehringer Our new #socent #MMH website is online: https://t.co/hH1z7rjsOH Our new #socent #MMH website is online: https://t.co/hH1z7rjsOH "18.11.2016 15:10:30" [{"text":"T2D", "indices":[33, 37]}, {"text":"kidneydisease", "indices":[48, 62]}] Boehringer Do you know how many people with #T2D also have #kidneydisease ? https://t.co/YfYGxx7ifN Do you know how many people with #T2D also have #kidneydisease ? https://t.co/YfYGxx7ifN "18.11.2016 13:01:42" [{"text":"LungCancer", "indices":[37, 48]}, {"text":"LCAM", "indices":[103, 108]}] Boehringer Powerful by a person with advanced #LungCancer. View the full story here now https://t.co/iz9CEK9T5k #LCAM https://t.co/gGC9o86fll Powerful by a person with advanced #LungCancer. View the full story here now https://t.co/iz9CEK9T5k #LCAM https://t.co/gGC9o86fll "17.11.2016 16:10:21" [{"text":"PRESS", "indices":[0, 6]}, {"text":"DYK", "indices":[7, 11]}, {"text":"EGFR", "indices":[67, 72]}, {"text":"NSCLC", "indices":[76, 82]}, {"text":"lungcancer", "indices":[124, 135]}] Boehringer #PRESS #DYK afatinib is now approved in more than 70 countries for #EGFR M+ #NSCLC? Learn more here https://t.co/hloxeoVBth #lungcancer #PRESS #DYK afatinib is now approved in more than 70 countries for #EGFR M+ #NSCLC? Learn more here https://t.co/hloxeoVBth #lungcancer "17.11.2016 15:02:40" [{"text":"DidYouKnow", "indices":[0, 11]}, {"text":"diabetes", "indices":[25, 34]}, {"text":"kidneydisease", "indices":[71, 85]}] Boehringer #DidYouKnow: people with #diabetes are at a greater risk of developing #kidneydisease https://t.co/Z5wzH7JqXU #DidYouKnow: people with #diabetes are at a greater risk of developing #kidneydisease https://t.co/Z5wzH7JqXU "17.11.2016 13:30:51" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[94, 105]}, {"text":"EGFR", "indices":[106, 111]}] Boehringer #PRESS LUX-Lung 7 data provides HCPs with foundations for informed 1st-line treatment choices #lungcancer #EGFR https://t.co/ojedDeyH5k #PRESS LUX-Lung 7 data provides HCPs with foundations for informed 1st-line treatment choices #lungcancer #EGFR https://t.co/ojedDeyH5k "17.11.2016 13:27:14" [{"text":"COPD", "indices":[108, 113]}] Boehringer Prof. Claus Vogelmeier, GOLD Science Committee Director, summarises key updates to GOLD recommendations for #COPD https://t.co/HYjuvGrxqx Prof. Claus Vogelmeier, GOLD Science Committee Director, summarises key updates to GOLD recommendations for #COPD https://t.co/HYjuvGrxqx "17.11.2016 11:00:53" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[107, 118]}] Boehringer #PRESS check out our infographic to learn more about the afatinib LUX-Lung 7 trial https://t.co/DCic4bVmCN #lungcancer #PRESS check out our infographic to learn more about the afatinib LUX-Lung 7 trial https://t.co/DCic4bVmCN #lungcancer "17.11.2016 08:40:13" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[127, 138]}] Boehringer #PRESS we're pleased to report EU label of afatinib will be updated to include results from LUX-Lung 7 https://t.co/ojedDeh6dM #lungcancer #PRESS we're pleased to report EU label of afatinib will be updated to include results from LUX-Lung 7 https://t.co/ojedDeh6dM #lungcancer "16.11.2016 17:05:40" [{"text":"AHA16", "indices":[20, 26]}, {"text":"congress", "indices":[87, 96]}, {"text":"T2D", "indices":[98, 102]}] Boehringer We hope you enjoyed #AHA16 as much as we did! What was your highlight from this year's #congress? #T2D We hope you enjoyed #AHA16 as much as we did! What was your highlight from this year's #congress? #T2D "16.11.2016 15:37:53" [{"text":"biosimilar", "indices":[35, 46]}] Boehringer Today we announced new data on our #biosimilar candidate to Avastin. Learn more here https://t.co/NaTofnz3jg Today we announced new data on our #biosimilar candidate to Avastin. Learn more here https://t.co/NaTofnz3jg "16.11.2016 15:17:16" [{"text":"Breathing", "indices":[0, 10]}, {"text":"COPD", "indices":[37, 42]}, {"text":"WorldCOPDday", "indices":[105, 118]}] Boehringer #Breathing exercises can help manage #COPD. Let the @WiganWarblers show you how: https://t.co/pDBRjaHA1I #WorldCOPDday. https://t.co/TkeabVdFXj #Breathing exercises can help manage #COPD. Let the @WiganWarblers show you how: https://t.co/pDBRjaHA1I #WorldCOPDday. https://t.co/TkeabVdFXj "16.11.2016 14:14:07" [{"text":"COPD", "indices":[94, 99]}] Boehringer Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within 2017 GOLD Strategy for #COPD https://t.co/Ts5QITfXRT Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within 2017 GOLD Strategy for #COPD https://t.co/Ts5QITfXRT "16.11.2016 14:05:35" [{"text":"CVDinT2D", "indices":[0, 9]}, {"text":"diabetes", "indices":[28, 37]}, {"text":"CVD", "indices":[75, 79]}] Boehringer #CVDinT2D fact: people with #diabetes have an increased risk of dying from #CVD https://t.co/Gn8nWKTHTY #CVDinT2D fact: people with #diabetes have an increased risk of dying from #CVD https://t.co/Gn8nWKTHTY "16.11.2016 12:30:53" [{"text":"Expert", "indices":[0, 7]}, {"text":"LungCancer", "indices":[38, 49]}, {"text":"LCAM", "indices":[93, 98]}] Boehringer #Expert Dr Balazs Halmos' view on the #LungCancer treatment landscape over the last 10 years #LCAM https://t.co/RlxCSIetJ0 #Expert Dr Balazs Halmos' view on the #LungCancer treatment landscape over the last 10 years #LCAM https://t.co/RlxCSIetJ0 "16.11.2016 11:00:50" [{"text":"AHA16", "indices":[54, 60]}, {"text":"cardiovascular", "indices":[102, 117]}, {"text":"afib", "indices":[118, 123]}] Boehringer Did you miss the latest RE-VERSE AD data presented at #AHA16? Full info here: https://t.co/fjL0Xxai0B #cardiovascular #afib Did you miss the latest RE-VERSE AD data presented at #AHA16? Full info here: https://t.co/fjL0Xxai0B #cardiovascular #afib "16.11.2016 10:41:16" [{"text":"COPD", "indices":[74, 79]}, {"text":"WorldCOPDDay", "indices":[114, 127]}] Boehringer 2017 GOLD Global Strategy for the Diagnosis, Management and Prevention of #COPD published https://t.co/m7AkNXVqFC #WorldCOPDDay 2017 GOLD Global Strategy for the Diagnosis, Management and Prevention of #COPD published https://t.co/m7AkNXVqFC #WorldCOPDDay "16.11.2016 09:34:50" [{"text":"COPD", "indices":[34, 39]}, {"text":"COPDathlete", "indices":[47, 59]}, {"text":"WorldCOPDday", "indices":[84, 97]}] Boehringer Who said you can’t be active with #COPD? Watch #COPDathlete @russwinn66 message for #WorldCOPDday.See more videos at https://t.co/pDBRjapYD8 https://t.co/1JN45VKA8S Who said you can’t be active with #COPD? Watch #COPDathlete @russwinn66 message for #WorldCOPDday.See more videos at https://t.co/pDBRjapYD8 https://t.co/1JN45VKA8S "16.11.2016 08:56:10" [{"text":"idarucizumab", "indices":[48, 61]}, {"text":"AHA16", "indices":[72, 78]}, {"text":"dabigatran", "indices":[79, 90]}] Boehringer Updated PhIII results on safety and efficacy of #idarucizumab presented #AHA16 #dabigatran https://t.co/MCrv9ouA3o Updated PhIII results on safety and efficacy of #idarucizumab presented #AHA16 #dabigatran https://t.co/MCrv9ouA3o "15.11.2016 17:15:38" [{"text":"afib", "indices":[75, 80]}, {"text":"anticoagulation", "indices":[81, 97]}, {"text":"AHA16", "indices":[108, 114]}] Boehringer Latest data from RE-VERSE AD to be presented in 15' - head to room 260-262 #afib #anticoagulation reversal #AHA16 Latest data from RE-VERSE AD to be presented in 15' - head to room 260-262 #afib #anticoagulation reversal #AHA16 "15.11.2016 16:05:29" [{"text":"CVDinT2D", "indices":[50, 59]}, {"text":"T2D", "indices":[83, 87]}] Boehringer "You wouldn’t think it would affect your heart" #CVDinT2D Watch Monda's story of #T2D https://t.co/gb0xjrBx4K "You wouldn’t think it would affect your heart" #CVDinT2D Watch Monda's story of #T2D https://t.co/gb0xjrBx4K "15.11.2016 15:02:08" [{"text":"ff", "indices":[5, 8]}, {"text":"diabetes", "indices":[77, 86]}, {"text":"T2D", "indices":[98, 102]}] Boehringer It's #ff Follow @AHAMeetings & @ASNKidney for up-to-date news on these #diabetes congresses #T2D It's #ff Follow @AHAMeetings & @ASNKidney for up-to-date news on these #diabetes congresses #T2D "15.11.2016 14:02:13" [{"text":"Chicago", "indices":[67, 75]}, {"text":"kidneydisease", "indices":[117, 131]}, {"text":"T2D", "indices":[135, 139]}] Boehringer Are you looking after your kidneys? Throughout the ASN congress in #Chicago we'll be sharing interesting facts about #kidneydisease in #T2D https://t.co/VMM6wREdoc Are you looking after your kidneys? Throughout the ASN congress in #Chicago we'll be sharing interesting facts about #kidneydisease in #T2D https://t.co/VMM6wREdoc "15.11.2016 09:15:01" [{"text":"Strokes", "indices":[0, 8]}, {"text":"afib", "indices":[19, 24]}, {"text":"protect", "indices":[113, 121]}, {"text":"AHA16", "indices":[131, 137]}] Boehringer #Strokes caused by #afib can be either ischaemic or haemorrhagic - visit https://t.co/g4Cp77Sn0N to learn how to #protect yourself #AHA16 https://t.co/Uju5SxaYaM #Strokes caused by #afib can be either ischaemic or haemorrhagic - visit https://t.co/g4Cp77Sn0N to learn how to #protect yourself #AHA16 https://t.co/Uju5SxaYaM "15.11.2016 08:00:57" [{"text":"LungCancer", "indices":[29, 40]}, {"text":"LCAM", "indices":[119, 124]}] Boehringer Have you seen this inspiring #LungCancer story yet? View it here now and share your thoughts https://t.co/iz9CEK9T5k #LCAM https://t.co/gZxvXzpu08 Have you seen this inspiring #LungCancer story yet? View it here now and share your thoughts https://t.co/iz9CEK9T5k #LCAM https://t.co/gZxvXzpu08 "14.11.2016 13:01:48" [{"text":"diabetes", "indices":[26, 35]}, {"text":"video", "indices":[36, 42]}, {"text":"conversation", "indices":[84, 97]}] Boehringer Check out our interactive #diabetes #video to choose the ending in a patient-doctor #conversation https://t.co/N05EEHSXfW Check out our interactive #diabetes #video to choose the ending in a patient-doctor #conversation https://t.co/N05EEHSXfW "14.11.2016 11:29:46" [{"text":"T2D", "indices":[31, 35]}, {"text":"diagnosis", "indices":[36, 46]}, {"text":"IntroDia", "indices":[63, 72]}] Boehringer How do patients get told their #T2D #diagnosis? New stats from #IntroDia reveal what happens in different countries https://t.co/6pKfhprKYB How do patients get told their #T2D #diagnosis? New stats from #IntroDia reveal what happens in different countries https://t.co/6pKfhprKYB "14.11.2016 09:15:21" [{"text":"MotivationMonday", "indices":[60, 77]}, {"text":"T2D", "indices":[78, 82]}, {"text":"diabetes", "indices":[83, 92]}] Boehringer Remember to always believe in yourself & stay positive! #MotivationMonday #T2D #diabetes https://t.co/yRDqVtxPFv Remember to always believe in yourself & stay positive! #MotivationMonday #T2D #diabetes https://t.co/yRDqVtxPFv "14.11.2016 08:47:53" [{"text":"complications", "indices":[26, 40]}, {"text":"T2D", "indices":[57, 61]}, {"text":"WorldDiabetesDay", "indices":[76, 93]}] Boehringer 63% of you think that all #complications associated with #T2D are important #WorldDiabetesDay 63% of you think that all #complications associated with #T2D are important #WorldDiabetesDay "14.11.2016 08:03:06" [{"text":"NEWS", "indices":[0, 5]}, {"text":"T2D", "indices":[56, 60]}, {"text":"CVD", "indices":[61, 65]}, {"text":"AHA16", "indices":[74, 80]}] Boehringer #NEWS @Boehringer & @LillyDiabetes announce further #T2D #CVD data at #AHA16 https://t.co/WUkX39dpgz #NEWS @Boehringer & @LillyDiabetes announce further #T2D #CVD data at #AHA16 https://t.co/WUkX39dpgz "14.11.2016 08:01:13" [{"text":"conversations", "indices":[22, 36]}, {"text":"diabetes", "indices":[56, 65]}, {"text":"video", "indices":[106, 112]}] Boehringer How do patient-doctor #conversations impact a patient's #diabetes management? Find out in our interactive #video https://t.co/N05EEHSXfW How do patient-doctor #conversations impact a patient's #diabetes management? Find out in our interactive #video https://t.co/N05EEHSXfW "13.11.2016 17:01:21" [{"text":"stroke", "indices":[40, 47]}, {"text":"afib", "indices":[62, 67]}, {"text":"AHA16", "indices":[104, 110]}] Boehringer Want to hear the latest advancements in #stroke prevention in #afib? Stop by booth 3238 & find out! #AHA16 https://t.co/5IkSOOyiGr Want to hear the latest advancements in #stroke prevention in #afib? Stop by booth 3238 & find out! #AHA16 https://t.co/5IkSOOyiGr "12.11.2016 15:01:41" [{"text":"cardiovasculardisease", "indices":[18, 40]}, {"text":"CVDinT2D", "indices":[48, 57]}] Boehringer What do you think #cardiovasculardisease means? #CVDinT2D https://t.co/DQx2SO8wG2 What do you think #cardiovasculardisease means? #CVDinT2D https://t.co/DQx2SO8wG2 "12.11.2016 14:01:40" [{"text":"AHA16", "indices":[47, 53]}, {"text":"NewOrleans", "indices":[54, 65]}, {"text":"CVDinT2D", "indices":[87, 96]}, {"text":"T2D", "indices":[97, 101]}] Boehringer Are you looking after your heart ❤? Throughout #AHA16 #NewOrleans we'll be focusing on #CVDinT2D #T2D https://t.co/9OVV2Bs2y0 Are you looking after your heart ❤? Throughout #AHA16 #NewOrleans we'll be focusing on #CVDinT2D #T2D https://t.co/9OVV2Bs2y0 "11.11.2016 15:25:14" [{"text":"lungcancer", "indices":[42, 53]}] Boehringer Experts discuss results from our advanced #lungcancer physician survey and patient roundtable … https://t.co/ajGZ7bLFgN Experts discuss results from our advanced #lungcancer physician survey and patient roundtable … https://t.co/ajGZ7bLFgN "11.11.2016 14:30:20" [{"text":"WorldCOPDday", "indices":[0, 13]}] Boehringer #WorldCOPDday is in 5 days! Tune into our Facebook page to hear tips from patients, experts and more… https://t.co/hta6aoceyJ #WorldCOPDday is in 5 days! Tune into our Facebook page to hear tips from patients, experts and more… https://t.co/hta6aoceyJ "11.11.2016 12:56:41" [{"text":"complication", "indices":[50, 63]}, {"text":"T2D", "indices":[80, 84]}, {"text":"WorldDiabetesDay", "indices":[86, 103]}] Boehringer In your opinion, what do you think is the biggest #complication associated with #T2D? #WorldDiabetesDay In your opinion, what do you think is the biggest #complication associated with #T2D? #WorldDiabetesDay "11.11.2016 11:51:34" [{"text":"dabigatran", "indices":[61, 72]}, {"text":"Afib", "indices":[76, 81]}] Boehringer Patient enrolment completed for RE-DUAL PCI™ study assessing #dabigatran in #Afib patients after PCI with stenting https://t.co/tqr2byJHMJ Patient enrolment completed for RE-DUAL PCI™ study assessing #dabigatran in #Afib patients after PCI with stenting https://t.co/tqr2byJHMJ "11.11.2016 11:15:18" [{"text":"AHA16", "indices":[54, 60]}, {"text":"cardiovascular", "indices":[82, 97]}, {"text":"afib", "indices":[98, 103]}] Boehringer Who else is travelling to New Orleans for this year's #AHA16 Scientific Sessions? #cardiovascular #afib https://t.co/AUxTU7ZYo6 Who else is travelling to New Orleans for this year's #AHA16 Scientific Sessions? #cardiovascular #afib https://t.co/AUxTU7ZYo6 "11.11.2016 10:05:47" [{"text":"lungcancer", "indices":[66, 77]}] Boehringer Physician and patient insights compiled in new report on advanced #lungcancer prescribing behaviour… https://t.co/rgz4NshxI6 Physician and patient insights compiled in new report on advanced #lungcancer prescribing behaviour… https://t.co/rgz4NshxI6 "10.11.2016 13:00:42" [{"text":"lungcancer", "indices":[69, 80]}, {"text":"LCAM", "indices":[98, 103]}] Boehringer Patient insights have been vital in understanding the drivers behind #lungcancer treatment choice #LCAM… https://t.co/MTAYS7HFJ8 Patient insights have been vital in understanding the drivers behind #lungcancer treatment choice #LCAM… https://t.co/MTAYS7HFJ8 "10.11.2016 10:54:19" [{"text":"lungcancer", "indices":[3, 14]}] Boehringer As #lungcancer therapies progress we’ve been talking to patients & physicians about therapy goals… https://t.co/BDCgCjJHxZ As #lungcancer therapies progress we’ve been talking to patients & physicians about therapy goals… https://t.co/BDCgCjJHxZ "10.11.2016 10:00:12" [] Boehringer @DaPatatch Bonjour, contactez-nous au centre d’information qui vous pourra vous répondre: centre.information@boehringer-ingelheim.com. -NR @DaPatatch Bonjour, contactez-nous au centre d’information qui vous pourra vous répondre: centre.information@boehringer-ingelheim.com. -NR "10.11.2016 09:57:19" [] Boehringer @samuelabbou Hi Samuel Abbou, please contact the information centre of Boehringer Ingelheim centre.information@boehringer-ingelheim.com. -NR @samuelabbou Hi Samuel Abbou, please contact the information centre of Boehringer Ingelheim centre.information@boehringer-ingelheim.com. -NR "09.11.2016 16:00:43" [{"text":"lungcancer", "indices":[45, 56]}, {"text":"NSCLC", "indices":[88, 94]}] Boehringer What does @IrishCancerSoc say about the role #lungcancer patients need to play in their #NSCLC treatment decisions?… https://t.co/nxyPXFnwen What does @IrishCancerSoc say about the role #lungcancer patients need to play in their #NSCLC treatment decisions?… https://t.co/nxyPXFnwen "09.11.2016 15:06:16" [] Boehringer @0800OpoSitora Gracias por contactar a nosotros. Le escribimos un mensaje privado a su inbox. Saludos cordiales, -NR @0800OpoSitora Gracias por contactar a nosotros. Le escribimos un mensaje privado a su inbox. Saludos cordiales, -NR "09.11.2016 15:01:16" [{"text":"DYK", "indices":[0, 4]}, {"text":"lungcancer", "indices":[23, 34]}] Boehringer #DYK less than half of #lungcancer physicians surveyed prioritised extension of life as their primary therapy goal… https://t.co/EfbM4sf0Je #DYK less than half of #lungcancer physicians surveyed prioritised extension of life as their primary therapy goal… https://t.co/EfbM4sf0Je "08.11.2016 14:01:23" [{"text":"lungcancer", "indices":[3, 14]}, {"text":"LCAM", "indices":[88, 93]}] Boehringer As #lungcancer treatments evolve we’re taking steps to understand prescribing behaviour #LCAM … https://t.co/f41siJEEI9 As #lungcancer treatments evolve we’re taking steps to understand prescribing behaviour #LCAM … https://t.co/f41siJEEI9 "08.11.2016 10:00:29" [{"text":"HCP", "indices":[18, 22]}, {"text":"NSCLC", "indices":[58, 64]}, {"text":"LCAM", "indices":[99, 104]}] Boehringer Survey results of #HCP prescribing behaviour for advanced #NSCLC published on Clinical Lung Cancer #LCAM… https://t.co/wxx6qLJTMt Survey results of #HCP prescribing behaviour for advanced #NSCLC published on Clinical Lung Cancer #LCAM… https://t.co/wxx6qLJTMt "08.11.2016 08:41:46" [{"text":"PRESS", "indices":[0, 6]}, {"text":"NSCLC", "indices":[88, 94]}, {"text":"LCAM", "indices":[111, 116]}] Boehringer #PRESS: New research evaluating therapy goals of 500Europ. physicians treating advanced #NSCLC published today #LCAM https://t.co/MTAtkVwcuF #PRESS: New research evaluating therapy goals of 500Europ. physicians treating advanced #NSCLC published today #LCAM https://t.co/MTAtkVwcuF "07.11.2016 14:27:25" [] Boehringer @pkerchner Wir haben Ihnen eine Nachricht gesendet, die jetzt in Ihrer Inbox sein müsste! Viele Grüße -NR @pkerchner Wir haben Ihnen eine Nachricht gesendet, die jetzt in Ihrer Inbox sein müsste! Viele Grüße -NR "07.11.2016 14:09:10" [] Boehringer @pkerchner Hallo Pierre, Sie können uns Ihre Frage gerne per DM schicken. Wir bemühen uns Ihr Anliegen schnellstmöglich zu beantworten.Danke @pkerchner Hallo Pierre, Sie können uns Ihre Frage gerne per DM schicken. Wir bemühen uns Ihr Anliegen schnellstmöglich zu beantworten.Danke "07.11.2016 13:55:07" [] Boehringer @TheseAreMyScars thanks, we will make sure to do so. Regards, PA @TheseAreMyScars thanks, we will make sure to do so. Regards, PA "07.11.2016 09:05:18" [{"text":"MotivationMonday", "indices":[34, 51]}, {"text":"T2D", "indices":[52, 56]}, {"text":"diabetes", "indices":[57, 66]}] Boehringer A reminder to always be yourself! #MotivationMonday #T2D #diabetes https://t.co/5g90meSBLN A reminder to always be yourself! #MotivationMonday #T2D #diabetes https://t.co/5g90meSBLN "04.11.2016 10:30:20" [{"text":"2016WCC", "indices":[40, 48]}, {"text":"CancerCongress", "indices":[99, 114]}] Boehringer Thanks to @uicc for hosting a fantastic #2016WCC in Paris! We are honoured to have been a sponsor! #CancerCongress… https://t.co/9ZiqBDVv7t Thanks to @uicc for hosting a fantastic #2016WCC in Paris! We are honoured to have been a sponsor! #CancerCongress… https://t.co/9ZiqBDVv7t "03.11.2016 12:49:22" [{"text":"oncology", "indices":[37, 46]}, {"text":"2016WCC", "indices":[76, 84]}] Boehringer Want to know more about our exciting #oncology pipeline? Visit our booth at #2016WCC for info on the latest R&D, an… https://t.co/8QnEPBik9l Want to know more about our exciting #oncology pipeline? Visit our booth at #2016WCC for info on the latest R&D, an… https://t.co/8QnEPBik9l "03.11.2016 07:20:03" [] Boehringer @CarolR905 We understand your frustration and apologise. We are working to improve the app and have noted this issue. Thank you! @CarolR905 We understand your frustration and apologise. We are working to improve the app and have noted this issue. Thank you! "03.11.2016 07:18:58" [] Boehringer @CarolR905 At this time unfortunately not. We are collecting suggestions for the next version. We will add this great idea to the list! @CarolR905 At this time unfortunately not. We are collecting suggestions for the next version. We will add this great idea to the list! "02.11.2016 10:01:32" [{"text":"lungcancer", "indices":[51, 62]}, {"text":"2016WCC", "indices":[101, 109]}] Boehringer We’ve been privileged to work with truly inspiring #lungcancer patients and HCPs. Visit our booth at #2016WCC to fi… https://t.co/UOLccZF9oa We’ve been privileged to work with truly inspiring #lungcancer patients and HCPs. Visit our booth at #2016WCC to fi… https://t.co/UOLccZF9oa "01.11.2016 13:25:14" [{"text":"lungcancer", "indices":[57, 68]}, {"text":"2016WCC", "indices":[94, 102]}] Boehringer Listen to Prof Pascal Piedbois discuss the importance of #lungcancer patient education at our #2016WCC lounge sessi… https://t.co/0hBZhS4nNZ Listen to Prof Pascal Piedbois discuss the importance of #lungcancer patient education at our #2016WCC lounge sessi… https://t.co/0hBZhS4nNZ "01.11.2016 13:10:24" [{"text":"2016WCC", "indices":[4, 12]}, {"text":"lungcancer", "indices":[31, 42]}] Boehringer Our #2016WCC lounge session on #lungcancer is about to start! Prof Dame @FallowfieldLJ of @SussexUni will chair the… https://t.co/UusYmk0G97 Our #2016WCC lounge session on #lungcancer is about to start! Prof Dame @FallowfieldLJ of @SussexUni will chair the… https://t.co/UusYmk0G97 "01.11.2016 12:31:09" [{"text":"lungcancer", "indices":[22, 33]}] Boehringer What questions should #lungcancer patients ask their HCP? Prof Ian Olver of @UniversitySA reveals all in our… https://t.co/L1zZi5naid What questions should #lungcancer patients ask their HCP? Prof Ian Olver of @UniversitySA reveals all in our… https://t.co/L1zZi5naid "01.11.2016 10:45:20" [{"text":"lungcancer", "indices":[59, 70]}, {"text":"2016WCC", "indices":[91, 99]}] Boehringer Hear more from Dr Jesme Fox of @globalungcancer on gaps in #lungcancer patient info at our #2016WCC lounge session… https://t.co/jTjFyAovVu Hear more from Dr Jesme Fox of @globalungcancer on gaps in #lungcancer patient info at our #2016WCC lounge session… https://t.co/jTjFyAovVu "01.11.2016 09:15:19" [{"text":"2016WCC", "indices":[9, 17]}, {"text":"LCAM", "indices":[124, 129]}] Boehringer Join our #2016WCC lounge session today to hear Prof Pierre Fumoleau discuss reflecting the patient’s voice in cancer policy #LCAM Join our #2016WCC lounge session today to hear Prof Pierre Fumoleau discuss reflecting the patient’s voice in cancer policy #LCAM "31.10.2016 16:01:08" [{"text":"2016WCC", "indices":[27, 35]}, {"text":"lungcancer", "indices":[100, 111]}] Boehringer We’ve arrived in Paris for #2016WCC! Excited to collaborate with world experts on the importance of #lungcancer inf… https://t.co/KbF4cX6ZJB We’ve arrived in Paris for #2016WCC! Excited to collaborate with world experts on the importance of #lungcancer inf… https://t.co/KbF4cX6ZJB "31.10.2016 09:05:18" [{"text":"T2D", "indices":[41, 45]}, {"text":"MotivationMonday", "indices":[74, 91]}, {"text":"diabetes", "indices":[92, 101]}] Boehringer How motivated are you feeling to conquer #T2D this Monday? Comment below! #MotivationMonday #diabetes https://t.co/lBeJUbKw8S How motivated are you feeling to conquer #T2D this Monday? Comment below! #MotivationMonday #diabetes https://t.co/lBeJUbKw8S "30.10.2016 13:01:19" [{"text":"AASD2016", "indices":[27, 36]}, {"text":"Taipei", "indices":[55, 62]}] Boehringer Today marks the end of the #AASD2016 annual meeting in #Taipei! We hope the participants enjoyed a productive and informative congress. Today marks the end of the #AASD2016 annual meeting in #Taipei! We hope the participants enjoyed a productive and informative congress. "30.10.2016 11:01:02" [{"text":"IntroDia", "indices":[0, 9]}, {"text":"T2D", "indices":[20, 24]}, {"text":"AASD2016", "indices":[95, 104]}] Boehringer #IntroDia: Treating #T2D is as much about medication as it is about psychological challenges #AASD2016 … https://t.co/lQtghKva2x #IntroDia: Treating #T2D is as much about medication as it is about psychological challenges #AASD2016 … https://t.co/lQtghKva2x "30.10.2016 09:30:26" [{"text":"WSD16", "indices":[47, 53]}] Boehringer We saw some great support for @WStrokeCampaign #WSD16 initiative yesterday. What did you do to raise awareness? Com… https://t.co/JAKVZBIaWD We saw some great support for @WStrokeCampaign #WSD16 initiative yesterday. What did you do to raise awareness? Com… https://t.co/JAKVZBIaWD "29.10.2016 17:35:08" [{"text":"diabetes", "indices":[81, 90]}] Boehringer Did you enjoy our physician/patient videos which show how conversations impact #diabetes patients? https://t.co/N05EEHSXfW Did you enjoy our physician/patient videos which show how conversations impact #diabetes patients? https://t.co/N05EEHSXfW "29.10.2016 10:00:45" [{"text":"IntroDia", "indices":[0, 9]}, {"text":"T2D", "indices":[79, 83]}, {"text":"AASD2016", "indices":[94, 103]}] Boehringer #IntroDia: What challenges do you think physicians face when speaking to their #T2D patients? #AASD2016 … https://t.co/HD8tAMrIy5 #IntroDia: What challenges do you think physicians face when speaking to their #T2D patients? #AASD2016 … https://t.co/HD8tAMrIy5 "29.10.2016 08:50:10" [{"text":"DYK", "indices":[0, 4]}, {"text":"stroke", "indices":[47, 54]}, {"text":"WSD16", "indices":[84, 90]}, {"text":"afib", "indices":[108, 113]}] Boehringer #DYK atrial fibrillation increases the risk of #stroke by x5? RT to raise awareness #WSD16 @WStrokeCampaign #afib https://t.co/yUjMt1pd0g #DYK atrial fibrillation increases the risk of #stroke by x5? RT to raise awareness #WSD16 @WStrokeCampaign #afib https://t.co/yUjMt1pd0g "29.10.2016 08:30:27" [{"text":"WSD16", "indices":[3, 9]}, {"text":"stroke", "indices":[82, 89]}, {"text":"afib", "indices":[90, 95]}] Boehringer On #WSD16, we want to raise awareness of the link between atrial fibrillation and #stroke #afib https://t.co/ZFGUyfJEQH On #WSD16, we want to raise awareness of the link between atrial fibrillation and #stroke #afib https://t.co/ZFGUyfJEQH "29.10.2016 07:27:56" [{"text":"conversation", "indices":[30, 43]}, {"text":"T2D", "indices":[77, 81]}, {"text":"patient", "indices":[82, 90]}, {"text":"management", "indices":[91, 102]}] Boehringer Again you voted ENCOURAGING #conversation. See how this positively impacts #T2D #patient #management https://t.co/vPm97xhMd5 Again you voted ENCOURAGING #conversation. See how this positively impacts #T2D #patient #management https://t.co/vPm97xhMd5 "28.10.2016 13:07:29" [] Boehringer @dcleverley That's a good point! Thank you for your feedback and stay tuned for the next video tomorrow! -NR @dcleverley That's a good point! Thank you for your feedback and stay tuned for the next video tomorrow! -NR "28.10.2016 13:00:54" [{"text":"2016WCC", "indices":[23, 31]}] Boehringer We’re proud to sponsor #2016WCC hosted by @uicc and @laliguecancer. Keep following to find out what we will be up t… https://t.co/eGjY1bQU4T We’re proud to sponsor #2016WCC hosted by @uicc and @laliguecancer. Keep following to find out what we will be up t… https://t.co/eGjY1bQU4T "28.10.2016 08:14:57" [] Boehringer @fikristarter Thanks for your comment! Watch the next video to see how the encouraging response changed conversation https://t.co/SW3yY3LH4V @fikristarter Thanks for your comment! Watch the next video to see how the encouraging response changed conversation https://t.co/SW3yY3LH4V "28.10.2016 08:12:29" [] Boehringer @aaasshraf Thanks for engaging! Watch how the conversation continues after the doctor's encouraging response here: https://t.co/SW3yY3LH4V @aaasshraf Thanks for engaging! Watch how the conversation continues after the doctor's encouraging response here: https://t.co/SW3yY3LH4V "28.10.2016 07:56:26" [] Boehringer You voted for an ENCOURAGING response. How would you like the Dr to respond? Reply @boehringer ENCOURAGING or DIS… https://t.co/EYEEqTIVQW You voted for an ENCOURAGING response. How would you like the Dr to respond? Reply @boehringer ENCOURAGING or DIS… https://t.co/EYEEqTIVQW "27.10.2016 22:01:30" [{"text":"diabetes", "indices":[43, 52]}, {"text":"AASD2016", "indices":[53, 62]}] Boehringer 10% of the adult population in Taiwan have #diabetes #AASD2016 https://t.co/ma8HZRo51g https://t.co/zjhDWTIN6S 10% of the adult population in Taiwan have #diabetes #AASD2016 https://t.co/ma8HZRo51g https://t.co/zjhDWTIN6S "27.10.2016 07:26:50" [] Boehringer You voted for an ENCOURAGING response. How should the Dr respond now? Reply @boehringer with either encouraging … https://t.co/zS2UYfRF6k You voted for an ENCOURAGING response. How should the Dr respond now? Reply @boehringer with either encouraging … https://t.co/zS2UYfRF6k "27.10.2016 07:06:57" [{"text":"milestone", "indices":[0, 10]}] Boehringer #milestone two billion pigs worldwide vaccinated against Porcine Circovirus Disease with Ingelvac CircoFLEX® https://t.co/UcIwaIcHk5 #milestone two billion pigs worldwide vaccinated against Porcine Circovirus Disease with Ingelvac CircoFLEX® https://t.co/UcIwaIcHk5 "26.10.2016 22:01:54" [{"text":"China", "indices":[30, 36]}, {"text":"diabetes", "indices":[42, 51]}, {"text":"AASD2016", "indices":[52, 61]}] Boehringer Approx. 110 million people in #China have #diabetes #AASD2016 Find out more here https://t.co/ma8HZRo51g https://t.co/8QW786rwse Approx. 110 million people in #China have #diabetes #AASD2016 Find out more here https://t.co/ma8HZRo51g https://t.co/8QW786rwse "26.10.2016 12:10:17" [{"text":"diabetes", "indices":[73, 82]}] Boehringer How do conversations between patients and physicians impact a patient's #diabetes management? Watch our new videos… https://t.co/SBFYX3CVqb How do conversations between patients and physicians impact a patient's #diabetes management? Watch our new videos… https://t.co/SBFYX3CVqb "26.10.2016 12:06:33" [] Boehringer Our adalimumab biosimilar candidate shows similar efficacy and safety profile to Humira® in pivotal Phase 3 study https://t.co/zQoacI4JHD Our adalimumab biosimilar candidate shows similar efficacy and safety profile to Humira® in pivotal Phase 3 study https://t.co/zQoacI4JHD "26.10.2016 08:30:30" [{"text":"T2D", "indices":[106, 110]}] Boehringer How should the doctor continue? You choose! Reply @boehringer with either ENCOURAGING or DISCOURAGING #T2D… https://t.co/Kgit682CRz How should the doctor continue? You choose! Reply @boehringer with either ENCOURAGING or DISCOURAGING #T2D… https://t.co/Kgit682CRz "26.10.2016 06:01:03" [{"text":"AASD2016", "indices":[1, 10]}, {"text":"Taipei", "indices":[52, 59]}] Boehringer '#AASD2016 starts tomorrow in the beautiful city of #Taipei. Check out this year's programme here https://t.co/I0rG3mZP0l '#AASD2016 starts tomorrow in the beautiful city of #Taipei. Check out this year's programme here https://t.co/I0rG3mZP0l "25.10.2016 07:00:59" [{"text":"IntroDia", "indices":[28, 37]}, {"text":"T2D", "indices":[95, 99]}, {"text":"AASD2016", "indices":[101, 110]}] Boehringer Want to find out more about #IntroDia, the largest survey investigating early conversations in #T2D? #AASD2016 … https://t.co/brKoTfQGFg Want to find out more about #IntroDia, the largest survey investigating early conversations in #T2D? #AASD2016 … https://t.co/brKoTfQGFg "24.10.2016 12:57:33" [{"text":"Taipei", "indices":[28, 35]}, {"text":"AASD2016", "indices":[52, 61]}, {"text":"T2D", "indices":[78, 82]}, {"text":"diabetes", "indices":[83, 92]}] Boehringer Will you be travelling ✈ to #Taipei for this year's #AASD2016 annual meeting? #T2D #diabetes https://t.co/GbSGQpURzG Will you be travelling ✈ to #Taipei for this year's #AASD2016 annual meeting? #T2D #diabetes https://t.co/GbSGQpURzG "24.10.2016 08:15:28" [{"text":"MotivationMonday", "indices":[46, 63]}, {"text":"T2D", "indices":[64, 68]}, {"text":"diabetes", "indices":[69, 78]}] Boehringer You are what you eat, share this if you agree #MotivationMonday #T2D #diabetes https://t.co/A0FUHRz9OZ You are what you eat, share this if you agree #MotivationMonday #T2D #diabetes https://t.co/A0FUHRz9OZ "21.10.2016 08:05:21" [{"text":"AnimalHealth", "indices":[0, 13]}] Boehringer #AnimalHealth Three research projects selected to win 2016 European PRRS Research Award worth €75,000… https://t.co/bF7Wp7PX3i #AnimalHealth Three research projects selected to win 2016 European PRRS Research Award worth €75,000… https://t.co/bF7Wp7PX3i "20.10.2016 23:15:19" [{"text":"AML", "indices":[92, 96]}] Boehringer We will join @LLSusa, @FoundationATCG, @INC_Research, and others in a trial to help advance #AML treatments. https://t.co/AxhD5XrgQm We will join @LLSusa, @FoundationATCG, @INC_Research, and others in a trial to help advance #AML treatments. https://t.co/AxhD5XrgQm "20.10.2016 13:02:41" [{"text":"AML", "indices":[94, 98]}] Boehringer We are collaborating with @LLSusa, leading cancer centers, and biopharma companies to advance #AML treatments https://t.co/AxhD5XrgQm We are collaborating with @LLSusa, leading cancer centers, and biopharma companies to advance #AML treatments https://t.co/AxhD5XrgQm "19.10.2016 16:20:55" [{"text":"IPF", "indices":[83, 87]}, {"text":"DIAwards", "indices":[97, 106]}] Boehringer We're thrilled to win Bronze at @_digital_impact awards - here's a reminder of our #IPF campaign #DIAwards https://t.co/fXXVejYc3E We're thrilled to win Bronze at @_digital_impact awards - here's a reminder of our #IPF campaign #DIAwards https://t.co/fXXVejYc3E "19.10.2016 11:45:25" [{"text":"UEGWeek", "indices":[32, 40]}, {"text":"biosimilars", "indices":[104, 116]}] Boehringer It's our last day in Vienna for #UEGWeek, make sure to visit our booth before we pack up for next year. #biosimilars It's our last day in Vienna for #UEGWeek, make sure to visit our booth before we pack up for next year. #biosimilars "18.10.2016 16:15:06" [{"text":"UEGWeek", "indices":[74, 82]}, {"text":"biosimilars", "indices":[91, 103]}] Boehringer Take a break from your busy schedule and come visit us at our booth X2/33 #UEGWeek to talk #biosimilars https://t.co/Cfn80X86YL Take a break from your busy schedule and come visit us at our booth X2/33 #UEGWeek to talk #biosimilars https://t.co/Cfn80X86YL "18.10.2016 16:05:22" [{"text":"BeatAML", "indices":[31, 39]}, {"text":"cancer", "indices":[104, 111]}] Boehringer We are pleased to join @LLSusa #BeatAML Master Trial to help advance treatments for the deadliest blood #cancer https://t.co/AxhD5XrgQm We are pleased to join @LLSusa #BeatAML Master Trial to help advance treatments for the deadliest blood #cancer https://t.co/AxhD5XrgQm "17.10.2016 13:27:08" [{"text":"T2D", "indices":[32, 36]}, {"text":"foodshopping", "indices":[99, 112]}, {"text":"WorldFoodDay", "indices":[113, 126]}, {"text":"diabetes", "indices":[127, 136]}] Boehringer Our poll showed 44% of you with #T2D think unhealthy food being cheaper is a challenging aspect of #foodshopping #WorldFoodDay #diabetes Our poll showed 44% of you with #T2D think unhealthy food being cheaper is a challenging aspect of #foodshopping #WorldFoodDay #diabetes "17.10.2016 08:40:56" [{"text":"Biosimilars", "indices":[57, 69]}, {"text":"UEGWeek", "indices":[71, 79]}] Boehringer Come visit us at our booth X2/33 for more information on #Biosimilars! #UEGWeek https://t.co/fmY2nJJ15i Come visit us at our booth X2/33 for more information on #Biosimilars! #UEGWeek https://t.co/fmY2nJJ15i "17.10.2016 08:01:23" [{"text":"MotivationMonday", "indices":[0, 17]}, {"text":"health", "indices":[48, 55]}, {"text":"T2D", "indices":[104, 108]}] Boehringer #MotivationMonday Taking the 1st step to better #health is always the hardest, but it will be worth it #T2D https://t.co/LcrhZSGnhK #MotivationMonday Taking the 1st step to better #health is always the hardest, but it will be worth it #T2D https://t.co/LcrhZSGnhK "16.10.2016 07:00:48" [{"text":"Biosimilars", "indices":[24, 36]}, {"text":"UEGWeek", "indices":[70, 78]}] Boehringer Find out more about our #Biosimilars. Visit our booth X2/33 tomorrow #UEGWeek Find out more about our #Biosimilars. Visit our booth X2/33 tomorrow #UEGWeek "15.10.2016 07:00:52" [{"text":"UEGWeek", "indices":[0, 8]}, {"text":"biosimilars", "indices":[83, 95]}] Boehringer #UEGWeek has officially started. Make sure to visit our booth on Monday for latest #biosimilars information! #UEGWeek has officially started. Make sure to visit our booth on Monday for latest #biosimilars information! "14.10.2016 14:40:17" [{"text":"UEGWeek", "indices":[12, 20]}, {"text":"Vienna", "indices":[53, 60]}, {"text":"Biosimilars", "indices":[62, 74]}] Boehringer We'll be at #UEGWeek from Monday onwards! See you in #Vienna! #Biosimilars We'll be at #UEGWeek from Monday onwards! See you in #Vienna! #Biosimilars "14.10.2016 13:21:03" [{"text":"T2D", "indices":[32, 36]}, {"text":"WorldFoodDay", "indices":[115, 128]}, {"text":"diabetes", "indices":[129, 138]}] Boehringer Our poll showed 32% of you with #T2D think longer preperation time is the most challenging part of healthy cooking #WorldFoodDay #diabetes Our poll showed 32% of you with #T2D think longer preperation time is the most challenging part of healthy cooking #WorldFoodDay #diabetes "14.10.2016 09:45:40" [{"text":"WorldFoodDay", "indices":[0, 13]}, {"text":"T2D", "indices":[40, 44]}] Boehringer #WorldFoodDay is coming up! If you have #T2D, in your opinion what is the biggest challenge when it comes to food shopping? #WorldFoodDay is coming up! If you have #T2D, in your opinion what is the biggest challenge when it comes to food shopping? "13.10.2016 09:46:14" [{"text":"WorldFoodDay", "indices":[0, 13]}, {"text":"T2D", "indices":[40, 44]}] Boehringer #WorldFoodDay is coming up. If you have #T2D, in your opinion, what is the most challenging part of healthy cooking? #WorldFoodDay is coming up. If you have #T2D, in your opinion, what is the most challenging part of healthy cooking? "13.10.2016 07:41:11" [] Boehringer @Boehringer announces agreement with @CevaSanteAnimal for the sale of certain @merial assets https://t.co/oGbqNH8lIn @Boehringer announces agreement with @CevaSanteAnimal for the sale of certain @merial assets https://t.co/oGbqNH8lIn "12.10.2016 14:08:04" [] Boehringer @schneiderleonid the accusations are referring to a time before Dr Wenz worked with us. Please understand that we can’t comment on this. >PA @schneiderleonid the accusations are referring to a time before Dr Wenz worked with us. Please understand that we can’t comment on this. >PA "11.10.2016 15:25:51" [] Boehringer @schneiderleonid The accusations are referring to a time before Dr Wenz worked with us. We don’t doubt the quality of her work at Boehringer @schneiderleonid The accusations are referring to a time before Dr Wenz worked with us. We don’t doubt the quality of her work at Boehringer "11.10.2016 15:22:48" [{"text":"ESMO16", "indices":[14, 21]}] Boehringer @JolandaGreve #ESMO16 Congress has shown many new compounds could significantly prolong the lives of cancer patients. There is hope. >PA @JolandaGreve #ESMO16 Congress has shown many new compounds could significantly prolong the lives of cancer patients. There is hope. >PA "11.10.2016 14:15:07" [{"text":"DYK", "indices":[0, 4]}] Boehringer #DYK ESMO was founded in 1975? Our expert discusses how the congress has changed since he’s been attending in our 1… https://t.co/JxIVwpgXhi #DYK ESMO was founded in 1975? Our expert discusses how the congress has changed since he’s been attending in our 1… https://t.co/JxIVwpgXhi "11.10.2016 13:14:50" [{"text":"ESMO16", "indices":[133, 140]}] Boehringer NSCLC is a devastating disease which is the biggest killer from all cancers. Watch an overview of NSCLC here https://t.co/UNCORHa1Xy #ESMO16 NSCLC is a devastating disease which is the biggest killer from all cancers. Watch an overview of NSCLC here https://t.co/UNCORHa1Xy #ESMO16 "11.10.2016 12:15:10" [{"text":"10things", "indices":[12, 21]}, {"text":"lungcancer", "indices":[77, 88]}] Boehringer For our 9th #10things video our expert tells us why he was excited to meet #lungcancer patient groups at this yea… https://t.co/KgAb03xupx For our 9th #10things video our expert tells us why he was excited to meet #lungcancer patient groups at this yea… https://t.co/KgAb03xupx "11.10.2016 10:15:07" [{"text":"ESMO16", "indices":[40, 47]}, {"text":"10things", "indices":[63, 72]}] Boehringer Did you see any world leading experts @ #ESMO16? Watch our 8th #10things video to hear who our expert saw… https://t.co/BZgEdueV8g Did you see any world leading experts @ #ESMO16? Watch our 8th #10things video to hear who our expert saw… https://t.co/BZgEdueV8g "11.10.2016 09:32:41" [{"text":"ESMO16", "indices":[52, 59]}, {"text":"cancer", "indices":[66, 73]}] Boehringer Our recommendations on who to follow for the latest #ESMO16 & #cancer news continues: @pharmaphorum @ClevelandClinic :) Our recommendations on who to follow for the latest #ESMO16 & #cancer news continues: @pharmaphorum @ClevelandClinic :) "11.10.2016 08:16:14" [{"text":"ESMO16", "indices":[130, 137]}] Boehringer @KolpBen Thanks! :) Glad you enjoy our campaign. - 3 more videos coming out today, this time from experts we interviewed at ESMO. #ESMO16 @KolpBen Thanks! :) Glad you enjoy our campaign. - 3 more videos coming out today, this time from experts we interviewed at ESMO. #ESMO16 "11.10.2016 08:00:25" [{"text":"10things", "indices":[18, 27]}, {"text":"ESMO", "indices":[77, 82]}] Boehringer Check out our 7th #10things video our expert looks back on the last 5 yrs @ #ESMO & his most outstanding memory… https://t.co/UpClW9VsPc Check out our 7th #10things video our expert looks back on the last 5 yrs @ #ESMO & his most outstanding memory… https://t.co/UpClW9VsPc "10.10.2016 15:05:21" [{"text":"mentalhealth", "indices":[90, 103]}, {"text":"WMHD16", "indices":[105, 112]}] Boehringer Can you spot 6 emotions? Tweet us which ones! Improving social cognition is key to better #mentalhealth #WMHD16… https://t.co/MYy8t1PUED Can you spot 6 emotions? Tweet us which ones! Improving social cognition is key to better #mentalhealth #WMHD16… https://t.co/MYy8t1PUED "10.10.2016 14:00:12" [{"text":"ESMO16", "indices":[100, 107]}, {"text":"lungcancer", "indices":[109, 120]}] Boehringer "I jump out the door & say, lets go for a run then!" full video here https://t.co/IhJlKvGz6k #ESMO16 #lungcancer https://t.co/aVFokeAKjc "I jump out the door & say, lets go for a run then!" full video here https://t.co/IhJlKvGz6k #ESMO16 #lungcancer https://t.co/aVFokeAKjc "10.10.2016 13:10:23" [{"text":"Mindfulness", "indices":[0, 12]}, {"text":"relax", "indices":[31, 37]}, {"text":"mind", "indices":[55, 60]}] Boehringer #Mindfulness is a great way to #relax & focus your #mind! Focus in on nature for 5 mins & let your mind relax… https://t.co/2UMS9JBQPl #Mindfulness is a great way to #relax & focus your #mind! Focus in on nature for 5 mins & let your mind relax… https://t.co/2UMS9JBQPl "10.10.2016 12:30:39" [{"text":"lungcancer", "indices":[24, 35]}, {"text":"immunotherapy", "indices":[40, 54]}, {"text":"ESMO16", "indices":[83, 90]}, {"text":"10things", "indices":[91, 100]}] Boehringer Want to hear more about #lungcancer and #immunotherapy? Ed. session today at 14:45 #ESMO16 #10things https://t.co/194w4FGu2R Want to hear more about #lungcancer and #immunotherapy? Ed. session today at 14:45 #ESMO16 #10things https://t.co/194w4FGu2R "10.10.2016 12:01:04" [{"text":"ESMO16", "indices":[59, 66]}] Boehringer Further results of LUX-Lung 7 trial have been presented at #ESMO16, check out the results so far here https://t.co/sAOwMdeZ9A Further results of LUX-Lung 7 trial have been presented at #ESMO16, check out the results so far here https://t.co/sAOwMdeZ9A "10.10.2016 11:49:57" [{"text":"10things", "indices":[11, 20]}, {"text":"ESMO16", "indices":[76, 83]}] Boehringer 6th in our #10things video series experts tell us what excites them about #ESMO16 & why they come every year… https://t.co/P9s3Sua5fe 6th in our #10things video series experts tell us what excites them about #ESMO16 & why they come every year… https://t.co/P9s3Sua5fe "10.10.2016 11:35:16" [{"text":"JAMAInternalMed", "indices":[26, 42]}, {"text":"Afib", "indices":[124, 129]}] Boehringer Read the Editor’s Note in #JAMAInternalMed? Safety/efficacy comparison of dabigatran vs rivaroxaban https://t.co/eWafUe4hTK #Afib Read the Editor’s Note in #JAMAInternalMed? Safety/efficacy comparison of dabigatran vs rivaroxaban https://t.co/eWafUe4hTK #Afib "10.10.2016 11:10:16" [{"text":"WMHD16", "indices":[34, 41]}] Boehringer Want to test your perception this #WMHD16? Which numbers are normal & which are inversed (no cheating!)?… https://t.co/iRha3byJNT Want to test your perception this #WMHD16? Which numbers are normal & which are inversed (no cheating!)?… https://t.co/iRha3byJNT "10.10.2016 10:30:28" [] Boehringer Do you think a cancer cure is around the corner? Head over to Vienna @ 13:00 to hear this keynote lecture!… https://t.co/lsHUieHIDT Do you think a cancer cure is around the corner? Head over to Vienna @ 13:00 to hear this keynote lecture!… https://t.co/lsHUieHIDT "10.10.2016 10:20:54" [{"text":"10things", "indices":[14, 23]}, {"text":"ESMO16", "indices":[71, 78]}, {"text":"cancer", "indices":[105, 112]}] Boehringer Watch our 5th #10things video from a colleague who was proud to be @ #ESMO16 to join the fight against #cancer https://t.co/ZtRLAS806J Watch our 5th #10things video from a colleague who was proud to be @ #ESMO16 to join the fight against #cancer https://t.co/ZtRLAS806J "10.10.2016 10:00:33" [{"text":"mentalhealth", "indices":[57, 70]}] Boehringer Mindfulness is a great way to destress + look after your #mentalhealth. Try this exercise ! Breathe in & out… https://t.co/h33M4Anxpf Mindfulness is a great way to destress + look after your #mentalhealth. Try this exercise ! Breathe in & out… https://t.co/h33M4Anxpf "10.10.2016 08:30:17" [{"text":"ESMO16", "indices":[72, 79]}, {"text":"10things", "indices":[100, 109]}] Boehringer Check out today's special symposium at 11:00! What is your highlight of #ESMO16? Tweet and tell us! #10things https://t.co/4952n7Tn5I Check out today's special symposium at 11:00! What is your highlight of #ESMO16? Tweet and tell us! #10things https://t.co/4952n7Tn5I "10.10.2016 08:18:08" [{"text":"thinkingdifferently", "indices":[36, 56]}, {"text":"mentalhealth", "indices":[63, 76]}] Boehringer It's World Mental Health day! We're #thinkingdifferently about #mentalhealth & how brainteasers & mindfulness help… https://t.co/vz2ZJYmNAU It's World Mental Health day! We're #thinkingdifferently about #mentalhealth & how brainteasers & mindfulness help… https://t.co/vz2ZJYmNAU "10.10.2016 08:00:24" [{"text":"T2D", "indices":[79, 83]}, {"text":"MotivationMonday", "indices":[84, 101]}, {"text":"diabetes", "indices":[102, 111]}] Boehringer Remember to always be supportive to your friends & family members who have #T2D #MotivationMonday #diabetes https://t.co/1mfpIirljq Remember to always be supportive to your friends & family members who have #T2D #MotivationMonday #diabetes https://t.co/1mfpIirljq "09.10.2016 14:21:37" [] Boehringer @Za_Ye Thanks for your comment, we found this story really emotional and inspiring too. Regards, PA @Za_Ye Thanks for your comment, we found this story really emotional and inspiring too. Regards, PA "09.10.2016 14:19:58" [] Boehringer @edemergen many people are not aware that anybody can get lung cancer, independent of smoking history. Regards, PA @edemergen many people are not aware that anybody can get lung cancer, independent of smoking history. Regards, PA "09.10.2016 12:01:16" [{"text":"DidYouKnow", "indices":[0, 11]}, {"text":"lungcancer", "indices":[47, 58]}] Boehringer #DidYouKnow there are several ways to diagnose #lungcancer? How many different methods of diagnosis can you name?… https://t.co/K6RCiUmv9C #DidYouKnow there are several ways to diagnose #lungcancer? How many different methods of diagnosis can you name?… https://t.co/K6RCiUmv9C "09.10.2016 11:01:07" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[75, 86]}, {"text":"ESMO16", "indices":[120, 127]}] Boehringer #PRESS Overall survival data announced from afatinib head-to-head trial in #lungcancer patients https://t.co/j5NV2L6weT #ESMO16 #PRESS Overall survival data announced from afatinib head-to-head trial in #lungcancer patients https://t.co/j5NV2L6weT #ESMO16 "09.10.2016 08:00:51" [{"text":"ESMO16", "indices":[47, 54]}] Boehringer 6th on our list of top presentations to see at #ESMO16 is this educational session - tweet us if you're going!… https://t.co/QAq0LOXWu7 6th on our list of top presentations to see at #ESMO16 is this educational session - tweet us if you're going!… https://t.co/QAq0LOXWu7 "09.10.2016 07:00:49" [{"text":"10things", "indices":[4, 13]}, {"text":"CRC", "indices":[90, 94]}, {"text":"ESMO16", "indices":[109, 116]}] Boehringer Our #10things series continues today in 1hour, find out about the molecular challenges in #CRC in Copenhagen #ESMO16 https://t.co/nzr4cx95qe Our #10things series continues today in 1hour, find out about the molecular challenges in #CRC in Copenhagen #ESMO16 https://t.co/nzr4cx95qe "09.10.2016 06:15:13" [{"text":"PRESS", "indices":[0, 6]}, {"text":"ESMO16", "indices":[96, 103]}] Boehringer #PRESS: LUME-Colon 1 Ph III results of nintedanib in patients with mCRC presented today @myESMO #ESMO16 https://t.co/HuCu8v6iz8 #PRESS: LUME-Colon 1 Ph III results of nintedanib in patients with mCRC presented today @myESMO #ESMO16 https://t.co/HuCu8v6iz8 "09.10.2016 06:15:13" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[75, 86]}, {"text":"ESMO16", "indices":[107, 114]}] Boehringer #PRESS LUXLung7 head-to-head data:Latest research on 1st-line treatment of #lungcancer patients presented@ #ESMO16 https://t.co/j5NV2L6weT #PRESS LUXLung7 head-to-head data:Latest research on 1st-line treatment of #lungcancer patients presented@ #ESMO16 https://t.co/j5NV2L6weT "09.10.2016 06:00:45" [{"text":"HCPs", "indices":[0, 5]}, {"text":"lungcancer", "indices":[30, 41]}, {"text":"ESMO16", "indices":[77, 84]}] Boehringer #HCPs: Expert perspectives in #lungcancer head-to-head trials: Dr Keith Kerr #ESMO16 https://t.co/lICdGgyT9j #HCPs: Expert perspectives in #lungcancer head-to-head trials: Dr Keith Kerr #ESMO16 https://t.co/lICdGgyT9j "08.10.2016 13:00:19" [{"text":"lungcancer", "indices":[26, 37]}, {"text":"ESMO16", "indices":[104, 111]}] Boehringer We're so inspired by this #lungcancer story! Let us know if you are too, full https://t.co/IhJlKvGz6k #ESMO16 https://t.co/ihueVi7kof We're so inspired by this #lungcancer story! Let us know if you are too, full https://t.co/IhJlKvGz6k #ESMO16 https://t.co/ihueVi7kof "08.10.2016 12:01:01" [{"text":"lungcancer", "indices":[23, 34]}] Boehringer Expert perspectives in #lungcancer: Dr Barbara Melosky tells us the benefit of conducting head-to-head trials.… https://t.co/my4S5EoqtS Expert perspectives in #lungcancer: Dr Barbara Melosky tells us the benefit of conducting head-to-head trials.… https://t.co/my4S5EoqtS "08.10.2016 11:00:52" [{"text":"10things", "indices":[61, 70]}, {"text":"ESMO16", "indices":[71, 78]}] Boehringer Head over to room Zagreb at 13:00 to find out the solutions! #10things #ESMO16 https://t.co/pE9hC5Iu57 Head over to room Zagreb at 13:00 to find out the solutions! #10things #ESMO16 https://t.co/pE9hC5Iu57 "08.10.2016 09:45:24" [] Boehringer Here’s video 4 ! This colleague’s excited to see new data for 1st time, meet leading experts & see you all there!… https://t.co/lyog5leLPB Here’s video 4 ! This colleague’s excited to see new data for 1st time, meet leading experts & see you all there!… https://t.co/lyog5leLPB "08.10.2016 09:22:20" [{"text":"ESMO16", "indices":[11, 18]}, {"text":"cancer", "indices":[25, 32]}] Boehringer For latest #ESMO16 & #cancer news, check out: @bioworld @globalungcancer @EuropeanCancer @OncologyAdvance For latest #ESMO16 & #cancer news, check out: @bioworld @globalungcancer @EuropeanCancer @OncologyAdvance "08.10.2016 09:00:22" [{"text":"cancer", "indices":[74, 81]}] Boehringer In our 3rd video a colleague speaks on being excited to liaise with the #cancer community & bring new data to the… https://t.co/svV7UllJNx In our 3rd video a colleague speaks on being excited to liaise with the #cancer community & bring new data to the… https://t.co/svV7UllJNx "08.10.2016 08:08:23" [{"text":"ESMO16", "indices":[96, 103]}] Boehringer Watch our 2nd video from a colleague who’s excited about interacting with renowned experts at #ESMO16 … https://t.co/Lzlf2v8Xt1 Watch our 2nd video from a colleague who’s excited about interacting with renowned experts at #ESMO16 … https://t.co/Lzlf2v8Xt1 "08.10.2016 07:27:57" [] Boehringer @lostfoundpets thanks for sharing. We will forward it to our colleagues. Regards, PA @lostfoundpets thanks for sharing. We will forward it to our colleagues. Regards, PA "08.10.2016 07:26:03" [] Boehringer @DeniseFurtado10 thanks for reaching out. Please share with us your email as DM so our colleagues in Brazil can contact you. Regards, PA @DeniseFurtado10 thanks for reaching out. Please share with us your email as DM so our colleagues in Brazil can contact you. Regards, PA "08.10.2016 07:19:57" [{"text":"ESMO16", "indices":[23, 30]}, {"text":"lungcancer", "indices":[83, 94]}] Boehringer What excites you about #ESMO16? Watch our 1st in 10 videos from colleagues & #lungcancer experts on what excites… https://t.co/huHmHLpsDN What excites you about #ESMO16? Watch our 1st in 10 videos from colleagues & #lungcancer experts on what excites… https://t.co/huHmHLpsDN "08.10.2016 07:00:38" [{"text":"10things", "indices":[84, 93]}, {"text":"ESMO16", "indices":[94, 101]}] Boehringer Find out about the molecular profile of NSCLC patients - special symposium at 11:00 #10things #ESMO16 https://t.co/hU8mWXMpn0 Find out about the molecular profile of NSCLC patients - special symposium at 11:00 #10things #ESMO16 https://t.co/hU8mWXMpn0 "08.10.2016 05:00:34" [{"text":"ESMO16", "indices":[34, 41]}] Boehringer 10 presentations not to miss this #ESMO16 - tweet us which ones you are attending. - No.2 is today at 08:00… https://t.co/YWn5n4hRqM 10 presentations not to miss this #ESMO16 - tweet us which ones you are attending. - No.2 is today at 08:00… https://t.co/YWn5n4hRqM "07.10.2016 15:48:50" [] Boehringer @apothekerineke Vriendelijk dank voor uw bericht. We nemen contact met u op. @apothekerineke Vriendelijk dank voor uw bericht. We nemen contact met u op. "07.10.2016 12:55:11" [{"text":"Afib", "indices":[107, 112]}, {"text":"JAMAInternalMed", "indices":[113, 129]}] Boehringer Latest realworld findings: Safety/efficacy comparison of dabigatran vs rivaroxaban https://t.co/XrkUnpAErz #Afib #JAMAInternalMed Latest realworld findings: Safety/efficacy comparison of dabigatran vs rivaroxaban https://t.co/XrkUnpAErz #Afib #JAMAInternalMed "07.10.2016 12:54:32" [{"text":"lungcancer", "indices":[69, 80]}] Boehringer "I'm the same person you met 5 yrs ago, I'm just walking around with #lungcancer" Watch the full video here:… https://t.co/WouGRGIyhO "I'm the same person you met 5 yrs ago, I'm just walking around with #lungcancer" Watch the full video here:… https://t.co/WouGRGIyhO "07.10.2016 10:00:34" [{"text":"ESMO16", "indices":[53, 60]}] Boehringer We're kicking off our 10 presentations not to miss @ #ESMO16 with this opening session! Head to Copenhagen @ 12 to… https://t.co/Px581Z5p3H We're kicking off our 10 presentations not to miss @ #ESMO16 with this opening session! Head to Copenhagen @ 12 to… https://t.co/Px581Z5p3H "07.10.2016 09:40:20" [] Boehringer @lostfoundpets Thanks for reaching out to us. Our colleagues would like to get in touch. Could you send us your email via direct message? NR @lostfoundpets Thanks for reaching out to us. Our colleagues would like to get in touch. Could you send us your email via direct message? NR "07.10.2016 09:00:29" [{"text":"ESMO16", "indices":[0, 7]}, {"text":"lungcancer", "indices":[51, 62]}] Boehringer #ESMO16 is fast approaching ⏰, find out more about #lungcancer from our infographic https://t.co/IdhmyImE4V #ESMO16 is fast approaching ⏰, find out more about #lungcancer from our infographic https://t.co/IdhmyImE4V "07.10.2016 08:01:13" [{"text":"PRESS", "indices":[0, 6]}, {"text":"Afib", "indices":[90, 95]}, {"text":"JAMAInternalMed", "indices":[96, 112]}] Boehringer #PRESS: New study on safety/efficacy of dabigatran vs rivaroxaban https://t.co/d4J6X8n2W1 #Afib #JAMAInternalMed #PRESS: New study on safety/efficacy of dabigatran vs rivaroxaban https://t.co/d4J6X8n2W1 #Afib #JAMAInternalMed "07.10.2016 08:01:04" [{"text":"PRESS", "indices":[0, 6]}, {"text":"ESMO16", "indices":[14, 21]}, {"text":"lungcancer", "indices":[95, 106]}] Boehringer #PRESS latest #ESMO16 data: test to help identify pts who could benefit from specific types of #lungcancer treatment https://t.co/Rfd8CKkdVj #PRESS latest #ESMO16 data: test to help identify pts who could benefit from specific types of #lungcancer treatment https://t.co/Rfd8CKkdVj "06.10.2016 14:36:10" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[96, 107]}, {"text":"ESMO16", "indices":[133, 140]}] Boehringer #PRESS"VeriStrat test has potential to be clinically useful for guiding TKI therapy in squamous #lungcancer" https://t.co/Rfd8CK2D3L #ESMO16 #PRESS"VeriStrat test has potential to be clinically useful for guiding TKI therapy in squamous #lungcancer" https://t.co/Rfd8CK2D3L #ESMO16 "06.10.2016 09:01:10" [{"text":"healthyhearts", "indices":[45, 59]}, {"text":"WorldHeartDay", "indices":[93, 107]}] Boehringer The smallest change can make a difference to #healthyhearts. What have you changed following #WorldHeartDay? https://t.co/gWOV4L2UMQ The smallest change can make a difference to #healthyhearts. What have you changed following #WorldHeartDay? https://t.co/gWOV4L2UMQ "05.10.2016 17:45:16" [{"text":"10things", "indices":[0, 9]}, {"text":"ESMO16", "indices":[40, 47]}] Boehringer #10things, part 1: why should you go to #ESMO16? - stay tuned for part 2! https://t.co/sih02Gvs6B #10things, part 1: why should you go to #ESMO16? - stay tuned for part 2! https://t.co/sih02Gvs6B "05.10.2016 13:14:23" [{"text":"ESMO16", "indices":[16, 23]}, {"text":"10things", "indices":[48, 57]}, {"text":"Copenhagen", "indices":[88, 99]}] Boehringer Who's attending #ESMO16? We're excited to share #10things about this year's congress in #Copenhagen https://t.co/uXvHWoCZQx Who's attending #ESMO16? We're excited to share #10things about this year's congress in #Copenhagen https://t.co/uXvHWoCZQx "05.10.2016 12:31:30" [{"text":"ESMO16", "indices":[44, 51]}] Boehringer Hi @scheffleronko! Sure, we will tweet from #ESMO16. Thanks for reaching out & stay tuned! Hi @scheffleronko! Sure, we will tweet from #ESMO16. Thanks for reaching out & stay tuned! "04.10.2016 11:00:38" [{"text":"MotivationMonday", "indices":[0, 17]}, {"text":"T2D", "indices":[28, 32]}, {"text":"diabetes", "indices":[72, 81]}] Boehringer #MotivationMonday Don't let #T2D stop you from achieving great things - #diabetes https://t.co/6XDXqIc9dU #MotivationMonday Don't let #T2D stop you from achieving great things - #diabetes https://t.co/6XDXqIc9dU "04.10.2016 09:00:24" [{"text":"Afib", "indices":[0, 5]}, {"text":"stroke", "indices":[24, 31]}, {"text":"heart", "indices":[70, 76]}] Boehringer #Afib can ↑ the risk of #stroke by up to x5. Find out more about your #heart at https://t.co/V02D1iCBWR… https://t.co/4i887cRVeU #Afib can ↑ the risk of #stroke by up to x5. Find out more about your #heart at https://t.co/V02D1iCBWR… https://t.co/4i887cRVeU "04.10.2016 08:01:33" [{"text":"healthyheart", "indices":[54, 67]}, {"text":"WorldHeartDay", "indices":[79, 93]}] Boehringer Power your heart by swapping an unhealthy snack for a #healthyheart super food #WorldHeartDay Power your heart by swapping an unhealthy snack for a #healthyheart super food #WorldHeartDay "30.09.2016 12:00:52" [{"text":"2016WCC", "indices":[0, 8]}] Boehringer #2016WCC registered attendees are invited to join @UICC’s sweepstake on social media https://t.co/yX1fqWOPek #2016WCC registered attendees are invited to join @UICC’s sweepstake on social media https://t.co/yX1fqWOPek "30.09.2016 09:30:13" [{"text":"WorldHeartDay", "indices":[63, 77]}] Boehringer .@worldheartfed What's been your favourite activity so far for #WorldHeartDay? Reminders here:… https://t.co/W46QvaiuDu .@worldheartfed What's been your favourite activity so far for #WorldHeartDay? Reminders here:… https://t.co/W46QvaiuDu "30.09.2016 08:30:49" [{"text":"GPFAM", "indices":[0, 6]}, {"text":"IPFWorldWeek", "indices":[13, 26]}, {"text":"IPF", "indices":[60, 64]}] Boehringer #GPFAM & #IPFWorldWeek are over, but we have a range of #IPF videos&eBooks for you to view throughout the year https://t.co/DCRwwH0zN4 #GPFAM & #IPFWorldWeek are over, but we have a range of #IPF videos&eBooks for you to view throughout the year https://t.co/DCRwwH0zN4 "30.09.2016 08:19:01" [{"text":"CancerCongress", "indices":[26, 41]}, {"text":"2016WCC", "indices":[87, 95]}] Boehringer Join us at the 2016 World #CancerCongress in Paris with @UICC & participate in the #2016WCC sweepstake… https://t.co/DJy3yLDSYr Join us at the 2016 World #CancerCongress in Paris with @UICC & participate in the #2016WCC sweepstake… https://t.co/DJy3yLDSYr "30.09.2016 07:33:27" [{"text":"Press", "indices":[0, 6]}] Boehringer #Press: Boehringer Ingelheim returns development & commercial rights of olmutinib to Hanmi Pharmaceutical https://t.co/YxzbsHeDZr #Press: Boehringer Ingelheim returns development & commercial rights of olmutinib to Hanmi Pharmaceutical https://t.co/YxzbsHeDZr "30.09.2016 06:30:43" [{"text":"asthma", "indices":[10, 17]}, {"text":"relaxing", "indices":[32, 41]}] Boehringer Don't let #asthma stop you from #relaxing. Share a pic/vid of you relaxing despite asthma for a chance to win 200… https://t.co/0LnVM1Hup8 Don't let #asthma stop you from #relaxing. Share a pic/vid of you relaxing despite asthma for a chance to win 200… https://t.co/0LnVM1Hup8 "29.09.2016 18:10:21" [{"text":"collaboration", "indices":[4, 18]}, {"text":"research", "indices":[39, 48]}, {"text":"immune", "indices":[60, 67]}, {"text":"oncology", "indices":[68, 77]}, {"text":"oncology", "indices":[97, 106]}] Boehringer New #collaboration complements ongoing #research efforts in #immune-#oncology and broad clinical #oncology pipeline https://t.co/37Dks0p1kw New #collaboration complements ongoing #research efforts in #immune-#oncology and broad clinical #oncology pipeline https://t.co/37Dks0p1kw "29.09.2016 13:10:31" [{"text":"DYK", "indices":[0, 4]}, {"text":"afib", "indices":[5, 10]}, {"text":"heartrhythm", "indices":[30, 42]}, {"text":"WorldHeartDay", "indices":[98, 112]}] Boehringer #DYK #afib is the most common #heartrhythm disorder? Can you guess what some of the symptoms are? #WorldHeartDay https://t.co/h8I7fFR3Vi #DYK #afib is the most common #heartrhythm disorder? Can you guess what some of the symptoms are? #WorldHeartDay https://t.co/h8I7fFR3Vi "29.09.2016 13:05:43" [{"text":"DontStopWithAsthma", "indices":[70, 89]}, {"text":"LoveContinued", "indices":[90, 104]}] Boehringer We received this great entry from Eloise for our previous competition #DontStopWithAsthma #LoveContinued. https://t.co/JUovchm588 We received this great entry from Eloise for our previous competition #DontStopWithAsthma #LoveContinued. https://t.co/JUovchm588 "29.09.2016 12:08:22" [{"text":"collaboration", "indices":[14, 28]}, {"text":"Research", "indices":[47, 56]}, {"text":"immune", "indices":[84, 91]}, {"text":"oncology", "indices":[92, 101]}] Boehringer New strategic #collaboration with Sarah Cannon #Research institute to develop novel #immune-#oncology therapies https://t.co/37Dks0p1kw New strategic #collaboration with Sarah Cannon #Research institute to develop novel #immune-#oncology therapies https://t.co/37Dks0p1kw "29.09.2016 12:01:47" [{"text":"WorldHeartDay", "indices":[20, 34]}] Boehringer Thrilled to support #WorldHeartDay. See our Healthy❤ selfie! Share yours with .@worldheartfed too… https://t.co/iZ3R6JkWrt Thrilled to support #WorldHeartDay. See our Healthy❤ selfie! Share yours with .@worldheartfed too… https://t.co/iZ3R6JkWrt "29.09.2016 10:05:18" [{"text":"WorldHeartDay", "indices":[9, 23]}, {"text":"poweryourlife", "indices":[73, 87]}] Boehringer ❤️ For #WorldHeartDay why not cut down on sugary foods & beverages #poweryourlife ❤️ For #WorldHeartDay why not cut down on sugary foods & beverages #poweryourlife "29.09.2016 09:01:06" [{"text":"DYK", "indices":[0, 4]}, {"text":"WorldHeartDay", "indices":[87, 101]}] Boehringer #DYK it’s important not to eat so many processed foods which can be high in sugar+ fat #WorldHeartDay #DYK it’s important not to eat so many processed foods which can be high in sugar+ fat #WorldHeartDay "29.09.2016 08:00:59" [{"text":"diet", "indices":[15, 20]}, {"text":"healthyheart", "indices":[38, 51]}, {"text":"WorldHeartDay", "indices":[106, 120]}] Boehringer ❤️ A healthy #diet contributes to a #healthyheart - why not make your snacks healthy throughout the day #WorldHeartDay ❤️ ❤️ A healthy #diet contributes to a #healthyheart - why not make your snacks healthy throughout the day #WorldHeartDay ❤️ "29.09.2016 07:25:08" [{"text":"WorldHeartDay", "indices":[26, 40]}, {"text":"heart", "indices":[54, 60]}, {"text":"poweryourlife", "indices":[66, 80]}] Boehringer As you know the theme for #WorldHeartDay is fuel your #heart ❤️ + #poweryourlife ! What are you doing differently today? As you know the theme for #WorldHeartDay is fuel your #heart ❤️ + #poweryourlife ! What are you doing differently today? "29.09.2016 07:01:04" [{"text":"oncolytic", "indices":[4, 14]}, {"text":"virus", "indices":[15, 21]}] Boehringer New #oncolytic #virus platform may offer significant advantages compared to others currently under https://t.co/ZGOcXd3y0O New #oncolytic #virus platform may offer significant advantages compared to others currently under https://t.co/ZGOcXd3y0O "28.09.2016 15:00:57" [{"text":"PRESS", "indices":[0, 6]}] Boehringer #PRESS: Boehringer boosts immune-oncology pipeline through collaboration with Viratherapeutics https://t.co/ZGOcXd3y0O #PRESS: Boehringer boosts immune-oncology pipeline through collaboration with Viratherapeutics https://t.co/ZGOcXd3y0O "28.09.2016 12:13:02" [{"text":"NEWS", "indices":[0, 5]}, {"text":"oncolytic", "indices":[79, 89]}, {"text":"virus", "indices":[90, 96]}] Boehringer #NEWS: Boehringer announces long-term collaboration to develop next generation #oncolytic #virus platform https://t.co/ZGOcXd3y0O #NEWS: Boehringer announces long-term collaboration to develop next generation #oncolytic #virus platform https://t.co/ZGOcXd3y0O "28.09.2016 11:33:07" [{"text":"BlueUp4PF", "indices":[14, 24]}, {"text":"pulmonary", "indices":[36, 46]}, {"text":"fibrosis", "indices":[47, 56]}, {"text":"GPFAM", "indices":[107, 113]}] Boehringer Check out our #BlueUp4PF selfie for #pulmonary #fibrosis awareness month to help spread disease awareness! #GPFAM… https://t.co/LyLjaOsQGt Check out our #BlueUp4PF selfie for #pulmonary #fibrosis awareness month to help spread disease awareness! #GPFAM… https://t.co/LyLjaOsQGt "28.09.2016 08:28:06" [{"text":"WorldHeartDay", "indices":[49, 63]}] Boehringer Encourage others to live heart-healthy lives for #WorldHeartDay! Visit our Tagboard for inspiration!… https://t.co/aVnVCWprop Encourage others to live heart-healthy lives for #WorldHeartDay! Visit our Tagboard for inspiration!… https://t.co/aVnVCWprop "27.09.2016 11:27:28" [{"text":"WorldHeartDay", "indices":[51, 65]}, {"text":"Tagboard", "indices":[102, 111]}] Boehringer Many activities will be taking place worldwide for #WorldHeartDay-has your event been featured on our #Tagboard yet? https://t.co/zbWL2eOJaF Many activities will be taking place worldwide for #WorldHeartDay-has your event been featured on our #Tagboard yet? https://t.co/zbWL2eOJaF "26.09.2016 14:09:43" [{"text":"WorldHeartDay", "indices":[14, 28]}, {"text":"afib", "indices":[104, 109]}, {"text":"CVD", "indices":[110, 114]}] Boehringer The theme for #WorldHeartDay is 'fuel your heart❤️+power your life'. What will you do to ↓ your risk of #afib+#CVD? https://t.co/LjIECxsXwC The theme for #WorldHeartDay is 'fuel your heart❤️+power your life'. What will you do to ↓ your risk of #afib+#CVD? https://t.co/LjIECxsXwC "26.09.2016 08:41:23" [{"text":"PRESS", "indices":[0, 6]}, {"text":"AnimalHealth", "indices":[96, 109]}] Boehringer #PRESS - Preventing disease: One billion pigs vaccinated with Ingelvac PRRS MLV® by @Boehringer #AnimalHealth https://t.co/Ic159jQ78K #PRESS - Preventing disease: One billion pigs vaccinated with Ingelvac PRRS MLV® by @Boehringer #AnimalHealth https://t.co/Ic159jQ78K "25.09.2016 09:00:54" [{"text":"WorldHeartDay", "indices":[54, 68]}] Boehringer Useful tools to support your events or activities for #WorldHeartDay - download here: https://t.co/5BRVx7VtG5 https://t.co/T2wCgQ6SOn Useful tools to support your events or activities for #WorldHeartDay - download here: https://t.co/5BRVx7VtG5 https://t.co/T2wCgQ6SOn "23.09.2016 19:01:17" [{"text":"DYK", "indices":[0, 4]}, {"text":"CVD", "indices":[5, 9]}, {"text":"afib", "indices":[31, 36]}, {"text":"heartrhythm", "indices":[54, 66]}, {"text":"heartfact", "indices":[77, 87]}, {"text":"WorldHeartDay", "indices":[88, 102]}] Boehringer #DYK #CVD is a risk factor for #afib, the most common #heartrhythm disorder? #heartfact #WorldHeartDay #DYK #CVD is a risk factor for #afib, the most common #heartrhythm disorder? #heartfact #WorldHeartDay "23.09.2016 16:15:23" [{"text":"IPF", "indices":[61, 65]}, {"text":"patientsurvey", "indices":[66, 80]}, {"text":"IPFWorldWeek", "indices":[125, 138]}] Boehringer Thank you @EU_IPFF & Dr Wijsenbeek for your views on our #IPF #patientsurvey results. Missed it? https://t.co/5gCcfTyaxo #IPFWorldWeek Thank you @EU_IPFF & Dr Wijsenbeek for your views on our #IPF #patientsurvey results. Missed it? https://t.co/5gCcfTyaxo #IPFWorldWeek "23.09.2016 14:14:28" [{"text":"WorldHeartDay", "indices":[69, 83]}] Boehringer Our Tagboard showcases the events & initiatives taking place for #WorldHeartDay on 29th Sep - check it out: https://t.co/zbWL2eOJaF Our Tagboard showcases the events & initiatives taking place for #WorldHeartDay on 29th Sep - check it out: https://t.co/zbWL2eOJaF "23.09.2016 08:25:29" [{"text":"IPF", "indices":[40, 44]}, {"text":"patientsurvey", "indices":[45, 59]}] Boehringer Find out what a Dr has to say about our #IPF #patientsurvey. Watch this then hear from @EU_IPFF on… https://t.co/woFDXco9ll Find out what a Dr has to say about our #IPF #patientsurvey. Watch this then hear from @EU_IPFF on… https://t.co/woFDXco9ll "22.09.2016 16:48:31" [{"text":"IPF", "indices":[16, 20]}, {"text":"patientsurvey", "indices":[21, 35]}] Boehringer Did you see our #IPF #patientsurvey results on Tuesday? Visit https://t.co/mjJYW3JlV8 or watch a short clip below… https://t.co/M540vk3aPG Did you see our #IPF #patientsurvey results on Tuesday? Visit https://t.co/mjJYW3JlV8 or watch a short clip below… https://t.co/M540vk3aPG "21.09.2016 15:00:36" [{"text":"IPFWorldWeek", "indices":[5, 18]}, {"text":"IPF", "indices":[65, 69]}, {"text":"IPFWorld", "indices":[94, 103]}] Boehringer It’s #IPFWorldWeek & we're sharing a new patient eBook about #IPF https://t.co/Qlw8aCara2 #IPFWorld https://t.co/N2Frac7RLQ It’s #IPFWorldWeek & we're sharing a new patient eBook about #IPF https://t.co/Qlw8aCara2 #IPFWorld https://t.co/N2Frac7RLQ "20.09.2016 15:00:55" [{"text":"IPF", "indices":[29, 33]}, {"text":"FacebookLIVE", "indices":[34, 47]}, {"text":"IPFWorldWeek", "indices":[124, 137]}] Boehringer See how we get ready for our #IPF #FacebookLIVE broadcasts and check out our Instagram Story today! https://t.co/5gCcfTyaxo #IPFWorldWeek See how we get ready for our #IPF #FacebookLIVE broadcasts and check out our Instagram Story today! https://t.co/5gCcfTyaxo #IPFWorldWeek "20.09.2016 12:24:36" [{"text":"NEWS", "indices":[0, 5]}, {"text":"Survey", "indices":[7, 14]}, {"text":"IPF", "indices":[42, 46]}] Boehringer #NEWS: #Survey reveals 9/10 patients with #IPF were happy with the way their doctor told them about their diagnosis https://t.co/O1nNEzKAX7 #NEWS: #Survey reveals 9/10 patients with #IPF were happy with the way their doctor told them about their diagnosis https://t.co/O1nNEzKAX7 "20.09.2016 11:24:59" [{"text":"IPF", "indices":[45, 49]}, {"text":"FacebookLIVE", "indices":[50, 63]}] Boehringer Lights, Camera, Action…are you ready for our #IPF #FacebookLIVE broadcast in 5 minutes? https://t.co/mjJYW3JlV8… https://t.co/KQtGNJ9RGO Lights, Camera, Action…are you ready for our #IPF #FacebookLIVE broadcast in 5 minutes? https://t.co/mjJYW3JlV8… https://t.co/KQtGNJ9RGO "19.09.2016 16:05:18" [{"text":"FOTD", "indices":[0, 5]}] Boehringer #FOTD Learning new things produces physical changes in your brain structure. https://t.co/PKbt95YG61 #FOTD Learning new things produces physical changes in your brain structure. https://t.co/PKbt95YG61 "19.09.2016 15:00:28" [{"text":"DYK", "indices":[0, 4]}, {"text":"IPF", "indices":[32, 36]}, {"text":"IPFWorldWeek", "indices":[125, 138]}] Boehringer #DYK what is most important for #IPF patients at diagnosis? See what our experts think all this week https://t.co/mjJYW3JlV8 #IPFWorldWeek #DYK what is most important for #IPF patients at diagnosis? See what our experts think all this week https://t.co/mjJYW3JlV8 #IPFWorldWeek "19.09.2016 14:41:32" [{"text":"FOTD", "indices":[0, 5]}, {"text":"IPF", "indices":[111, 115]}] Boehringer #FOTD Researchers suggest that the brain can store 2.5 million GB of data-equivalent to 300 years worth of TV. #IPF https://t.co/ToYXvuLK6E #FOTD Researchers suggest that the brain can store 2.5 million GB of data-equivalent to 300 years worth of TV. #IPF https://t.co/ToYXvuLK6E "17.09.2016 13:05:13" [{"text":"IPFworldweek", "indices":[16, 29]}, {"text":"IPF", "indices":[107, 111]}] Boehringer Diese Woche ist #IPFworldweek: Verfolgen Sie Umfrageergebnisse über die alltäglichen Herausforderungen von #IPF-Patienten. Diese Woche ist #IPFworldweek: Verfolgen Sie Umfrageergebnisse über die alltäglichen Herausforderungen von #IPF-Patienten. "16.09.2016 17:13:57" [{"text":"FOTD", "indices":[0, 5]}] Boehringer #FOTD People forget 40% of what they learn after 20 mins and 77% of what they learn after 6 days https://t.co/OlCzbLgib6 #FOTD People forget 40% of what they learn after 20 mins and 77% of what they learn after 6 days https://t.co/OlCzbLgib6 "16.09.2016 14:00:47" [{"text":"EASD2016", "indices":[20, 29]}, {"text":"T2D", "indices":[90, 94]}] Boehringer We hope you enjoyed #EASD2016 as much as we did! What was your highlight from this year’s #T2D congress? We hope you enjoyed #EASD2016 as much as we did! What was your highlight from this year’s #T2D congress? "16.09.2016 13:40:12" [{"text":"IPF", "indices":[4, 8]}, {"text":"patientsurvey", "indices":[9, 23]}] Boehringer New #IPF #patientsurvey data next week on importance of information. For now we’re sharing facts & games - Enjoy! New #IPF #patientsurvey data next week on importance of information. For now we’re sharing facts & games - Enjoy! "16.09.2016 13:03:30" [{"text":"NEWS", "indices":[0, 5]}, {"text":"CHMP", "indices":[78, 83]}] Boehringer #NEWS @EMA_News Empagliflozin/linagliptin combination approval recommended by #CHMP https://t.co/ELcwQgggIg #NEWS @EMA_News Empagliflozin/linagliptin combination approval recommended by #CHMP https://t.co/ELcwQgggIg "16.09.2016 08:01:50" [] Boehringer "You have to take it seriously, because it will cost you your life" Share Monda's Story https://t.co/gb0xjrBx4K "You have to take it seriously, because it will cost you your life" Share Monda's Story https://t.co/gb0xjrBx4K "15.09.2016 08:01:37" [{"text":"CVD", "indices":[0, 4]}, {"text":"T2D", "indices":[20, 24]}, {"text":"Munich", "indices":[75, 82]}, {"text":"CVDinT2D", "indices":[97, 106]}, {"text":"EASD2016", "indices":[107, 116]}] Boehringer #CVD is linked with #T2D, which affects 415M people globally - that's 250X #Munich's population! #CVDinT2D #EASD2016 https://t.co/kCBjVIgY4y #CVD is linked with #T2D, which affects 415M people globally - that's 250X #Munich's population! #CVDinT2D #EASD2016 https://t.co/kCBjVIgY4y "14.09.2016 12:54:47" [{"text":"CVDinT2D", "indices":[39, 48]}, {"text":"EASD2016", "indices":[49, 58]}] Boehringer Well done; 42% of you chose correctly. #CVDinT2D #EASD2016 The answer is https://t.co/YqDUNo6UXH Well done; 42% of you chose correctly. #CVDinT2D #EASD2016 The answer is https://t.co/YqDUNo6UXH "14.09.2016 11:27:25" [{"text":"pulmonary", "indices":[5, 15]}, {"text":"fibrosis", "indices":[16, 25]}, {"text":"BlueUpforPF", "indices":[90, 102]}, {"text":"GPFAM", "indices":[117, 123]}] Boehringer It's #pulmonary #fibrosis month and we'd love to hear your plans! Are you joining in with #BlueUpforPF with @PFFORG? #GPFAM It's #pulmonary #fibrosis month and we'd love to hear your plans! Are you joining in with #BlueUpforPF with @PFFORG? #GPFAM "14.09.2016 07:37:43" [{"text":"T2D", "indices":[48, 52]}, {"text":"CVD", "indices":[59, 63]}, {"text":"EASD2016", "indices":[111, 120]}] Boehringer How much shorter life-expectancy do people with #T2D & #CVD have compared with people w/o either condition?#EASD2016 How much shorter life-expectancy do people with #T2D & #CVD have compared with people w/o either condition?#EASD2016 "13.09.2016 09:02:15" [{"text":"T2D", "indices":[22, 26]}, {"text":"CVDinT2D", "indices":[50, 59]}, {"text":"EASD2016", "indices":[61, 70]}, {"text":"quiz", "indices":[71, 76]}] Boehringer What % of people with #T2D are expected to die of #CVDinT2D? #EASD2016 #quiz What % of people with #T2D are expected to die of #CVDinT2D? #EASD2016 #quiz "12.09.2016 12:02:16" [{"text":"CVDinT2D", "indices":[50, 59]}, {"text":"T2D", "indices":[83, 87]}] Boehringer "You wouldn’t think it would affect your heart" #CVDinT2D Watch Monda's story of #T2D https://t.co/gb0xjrBx4K "You wouldn’t think it would affect your heart" #CVDinT2D Watch Monda's story of #T2D https://t.co/gb0xjrBx4K "12.09.2016 11:46:48" [] Boehringer @enedinapneumo we are committed to deliver innovative solutions for the management of COPD! @enedinapneumo we are committed to deliver innovative solutions for the management of COPD! "12.09.2016 11:44:52" [] Boehringer @paulnery to quit smoking is an essential step in managing COPD @paulnery to quit smoking is an essential step in managing COPD "12.09.2016 08:01:30" [{"text":"EASD2016", "indices":[47, 56]}, {"text":"T2D", "indices":[91, 95]}, {"text":"CVDinT2D", "indices":[96, 105]}] Boehringer Are you looking after your heart ❤? Throughout #EASD2016 we'll be focusing on CV health in #T2D #CVDinT2D https://t.co/42FsOlpZ61 Are you looking after your heart ❤? Throughout #EASD2016 we'll be focusing on CV health in #T2D #CVDinT2D https://t.co/42FsOlpZ61 "12.09.2016 07:01:23" [{"text":"EASD2016", "indices":[22, 31]}] Boehringer Are you in Munich for #EASD2016? Follow @EASDnews for more information Are you in Munich for #EASD2016? Follow @EASDnews for more information "11.09.2016 12:01:33" [{"text":"EASD2016", "indices":[0, 9]}] Boehringer #EASD2016 starts tomorrow in the beautiful city of Munich. Check out this year's @EASDnews programme here https://t.co/dOaI6lkOPB #EASD2016 starts tomorrow in the beautiful city of Munich. Check out this year's @EASDnews programme here https://t.co/dOaI6lkOPB "09.09.2016 17:01:26" [] Boehringer .@EU_Commission Orphan Drug Designation for development of nintedanib in SSc w/associated ILD-an important milestone https://t.co/PSRO8RmTxB .@EU_Commission Orphan Drug Designation for development of nintedanib in SSc w/associated ILD-an important milestone https://t.co/PSRO8RmTxB "09.09.2016 14:28:24" [] Boehringer @ladyghie2 Hi Josie, thanks for reaching out. Please discuss optimal management for your condition with your doctor. -NR @ladyghie2 Hi Josie, thanks for reaching out. Please discuss optimal management for your condition with your doctor. -NR "09.09.2016 13:41:12" [{"text":"ERSLDN2016", "indices":[70, 81]}, {"text":"LondonCalling", "indices":[82, 96]}, {"text":"asthma", "indices":[98, 105]}] Boehringer .@MonicaEfH addresses why gaps remain in doctor-patient conversations #ERSLDN2016 #LondonCalling #asthma https://t.co/O5G2FibjHS .@MonicaEfH addresses why gaps remain in doctor-patient conversations #ERSLDN2016 #LondonCalling #asthma https://t.co/O5G2FibjHS "09.09.2016 12:31:34" [] Boehringer .@EU_Commission & @US_FDA granted Orphan Drug Designation for development of nintedanib in SSc with associated ILD https://t.co/PSRO8RmTxB .@EU_Commission & @US_FDA granted Orphan Drug Designation for development of nintedanib in SSc with associated ILD https://t.co/PSRO8RmTxB "09.09.2016 12:00:44" [] Boehringer On Monday we will be launching our 'Hidden Heart' ❤ challenge on Instagram. Follow us for more info here https://t.co/0Uj4yy3nSA On Monday we will be launching our 'Hidden Heart' ❤ challenge on Instagram. Follow us for more info here https://t.co/0Uj4yy3nSA "09.09.2016 10:27:02" [{"text":"bakerstreet221b", "indices":[23, 39]}, {"text":"asthma", "indices":[66, 73]}, {"text":"ERSLDN2016", "indices":[83, 94]}, {"text":"LondonCalling", "indices":[95, 109]}] Boehringer .@MonicaEfH is outside #bakerstreet221b to investigate unreported #asthma symptoms #ERSLDN2016 #LondonCalling https://t.co/4SaZB4KxjW .@MonicaEfH is outside #bakerstreet221b to investigate unreported #asthma symptoms #ERSLDN2016 #LondonCalling https://t.co/4SaZB4KxjW "09.09.2016 08:01:07" [] Boehringer On Monday we will be launching our 'Hidden Heart' ❤ challenge on Facebook. Follow us for more info here https://t.co/CAiy12j24O On Monday we will be launching our 'Hidden Heart' ❤ challenge on Facebook. Follow us for more info here https://t.co/CAiy12j24O "08.09.2016 15:23:15" [{"text":"IPF", "indices":[57, 61]}, {"text":"ERSLDN2016", "indices":[71, 82]}, {"text":"LondonCalling", "indices":[83, 97]}] Boehringer Watch Dr. Maher discussing reduction of exacerbations in #IPF patients #ERSLDN2016 #LondonCalling https://t.co/Sw99AGtzJE Watch Dr. Maher discussing reduction of exacerbations in #IPF patients #ERSLDN2016 #LondonCalling https://t.co/Sw99AGtzJE "08.09.2016 15:09:51" [{"text":"COPD", "indices":[84, 89]}] Boehringer @Boehringer Interesting to see many of you disagree with the @WHO’s prediction that #COPD will become the 3rd biggest killer by 2030 @Boehringer Interesting to see many of you disagree with the @WHO’s prediction that #COPD will become the 3rd biggest killer by 2030 "08.09.2016 11:43:47" [] Boehringer @EarlJennifer Thanks for reaching out! Please direct message us for a number to contact. Best regards- NR @EarlJennifer Thanks for reaching out! Please direct message us for a number to contact. Best regards- NR "08.09.2016 08:00:25" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[96, 107]}] Boehringer #PRESS @Annals_Oncology publishes latest data adding to robust body of evidence for afatinib in #lungcancer https://t.co/NL9tLedqAb #PRESS @Annals_Oncology publishes latest data adding to robust body of evidence for afatinib in #lungcancer https://t.co/NL9tLedqAb "08.09.2016 06:10:05" [{"text":"PRESS", "indices":[0, 6]}, {"text":"lungcancer", "indices":[104, 115]}] Boehringer #PRESS latest news: afatinib dose adjustment improved tolerability w/out apparent impact on efficacy in #lungcancer https://t.co/NL9tLedqAb #PRESS latest news: afatinib dose adjustment improved tolerability w/out apparent impact on efficacy in #lungcancer https://t.co/NL9tLedqAb "07.09.2016 19:30:04" [{"text":"ERSLDN2016", "indices":[4, 15]}, {"text":"asthma", "indices":[66, 73]}, {"text":"IPF", "indices":[74, 78]}, {"text":"COPD", "indices":[79, 84]}] Boehringer Now #ERSLDN2016 is over, we're reflecting on everything we learnt #asthma #IPF #COPD https://t.co/mT9PfZjXWO Now #ERSLDN2016 is over, we're reflecting on everything we learnt #asthma #IPF #COPD https://t.co/mT9PfZjXWO "07.09.2016 18:00:40" [{"text":"ERSLDN2016", "indices":[0, 11]}, {"text":"Milan", "indices":[100, 106]}] Boehringer #ERSLDN2016 You've been a blast! Thanks to everyone that followed us & we're looking forward to #Milan next year https://t.co/uxT774rETO #ERSLDN2016 You've been a blast! Thanks to everyone that followed us & we're looking forward to #Milan next year https://t.co/uxT774rETO "07.09.2016 16:57:11" [{"text":"ChangeCOPD", "indices":[22, 33]}, {"text":"ERSLDN2016", "indices":[75, 86]}] Boehringer What are you doing to #ChangeCOPD? You have the power to change the future #ERSLDN2016 https://t.co/yYtktxcZU7 What are you doing to #ChangeCOPD? You have the power to change the future #ERSLDN2016 https://t.co/yYtktxcZU7 "07.09.2016 16:25:03" [{"text":"COPD", "indices":[34, 39]}, {"text":"ERSLDN2016", "indices":[41, 52]}] Boehringer How can we change the outlook for #COPD? #ERSLDN2016 @ERSTalk https://t.co/V8oiHnP3e5 How can we change the outlook for #COPD? #ERSLDN2016 @ERSTalk https://t.co/V8oiHnP3e5 "07.09.2016 15:32:08" [{"text":"LondonUnderground", "indices":[38, 56]}, {"text":"IPF", "indices":[75, 79]}, {"text":"ERSLDN2016", "indices":[90, 101]}, {"text":"LondonCalling", "indices":[102, 116]}] Boehringer Dr. Maher managed to push through the #LondonUnderground crowds to discuss #IPF treatment #ERSLDN2016 #LondonCalling https://t.co/XDuprIrpJR Dr. Maher managed to push through the #LondonUnderground crowds to discuss #IPF treatment #ERSLDN2016 #LondonCalling https://t.co/XDuprIrpJR "07.09.2016 08:09:30" [{"text":"EASD2016", "indices":[62, 71]}, {"text":"T2D", "indices":[73, 77]}, {"text":"diabetes", "indices":[78, 87]}] Boehringer Will you be jetting off ✈ to Munich next week for this year's #EASD2016? #T2D #diabetes https://t.co/8cLUWdBw8n Will you be jetting off ✈ to Munich next week for this year's #EASD2016? #T2D #diabetes https://t.co/8cLUWdBw8n "07.09.2016 06:40:19" [{"text":"AsthmaXchange", "indices":[82, 96]}] Boehringer HCPs: See PCP opinions on referral between 1° and 2° care https://t.co/vqOC517v12 #AsthmaXchange collab. w/ @IPCRG HCPs: See PCP opinions on referral between 1° and 2° care https://t.co/vqOC517v12 #AsthmaXchange collab. w/ @IPCRG "06.09.2016 17:40:32" [{"text":"HCPs", "indices":[0, 5]}, {"text":"asthma", "indices":[49, 56]}, {"text":"AsthmaXchange", "indices":[82, 96]}] Boehringer #HCPs: SIMPLES structured approach to 1° care of #asthma: https://t.co/Z6mMCvB7Nk #AsthmaXchange collab. w/ @IPCRG #HCPs: SIMPLES structured approach to 1° care of #asthma: https://t.co/Z6mMCvB7Nk #AsthmaXchange collab. w/ @IPCRG "06.09.2016 15:41:42" [{"text":"COPD", "indices":[45, 50]}, {"text":"ERSLDN2016", "indices":[73, 84]}, {"text":"LondonCalling", "indices":[85, 99]}, {"text":"LSE", "indices":[100, 104]}] Boehringer We need to help avoid the downward spiral in #COPD, says Prof. Calverley #ERSLDN2016 #LondonCalling #LSE https://t.co/KXFQanP0Wf We need to help avoid the downward spiral in #COPD, says Prof. Calverley #ERSLDN2016 #LondonCalling #LSE https://t.co/KXFQanP0Wf "06.09.2016 12:04:38" [{"text":"COPD", "indices":[41, 46]}, {"text":"ERSLDN2016", "indices":[93, 104]}] Boehringer Do you think that, as the @WHO predicts, #COPD will become the third biggest killer by 2030? #ERSLDN2016 Do you think that, as the @WHO predicts, #COPD will become the third biggest killer by 2030? #ERSLDN2016 "06.09.2016 08:40:28" [{"text":"HCPs", "indices":[0, 5]}, {"text":"asthma", "indices":[51, 58]}, {"text":"AsthmaXchange", "indices":[95, 109]}] Boehringer #HCPs: Effective communication is key to improving #asthma management: https://t.co/4rEJbTtvul #AsthmaXchange collab w/ @IPCRG #HCPs: Effective communication is key to improving #asthma management: https://t.co/4rEJbTtvul #AsthmaXchange collab w/ @IPCRG "06.09.2016 07:50:01" [{"text":"DYK", "indices":[0, 4]}, {"text":"IPF", "indices":[26, 30]}, {"text":"ERSLDN2016", "indices":[36, 47]}] Boehringer #DYK what the symptoms of #IPF are? #ERSLDN2016 https://t.co/KKZm3aUkhI #DYK what the symptoms of #IPF are? #ERSLDN2016 https://t.co/KKZm3aUkhI "05.09.2016 18:40:23" [{"text":"HCPs", "indices":[0, 5]}, {"text":"asthma", "indices":[47, 54]}, {"text":"AsthmaXchange", "indices":[86, 100]}] Boehringer #HCPs: Want to learn more about shared care in #asthma? Visit https://t.co/vqOC517v12 #AsthmaXchange collab. w/ @IPCRG #HCPs: Want to learn more about shared care in #asthma? Visit https://t.co/vqOC517v12 #AsthmaXchange collab. w/ @IPCRG "05.09.2016 16:52:14" [{"text":"London", "indices":[27, 34]}, {"text":"COPD", "indices":[82, 87]}] Boehringer Look who we bumped into in #London! @russwinn66 thank you for sharing your story. #COPD https://t.co/xAucc6BS7t Look who we bumped into in #London! @russwinn66 thank you for sharing your story. #COPD https://t.co/xAucc6BS7t "05.09.2016 14:50:23" [{"text":"COPD", "indices":[25, 30]}, {"text":"ChangeCOPD", "indices":[50, 61]}, {"text":"ERSLDN2016", "indices":[104, 115]}] Boehringer Imagine a future without #COPD. What can we do to #ChangeCOPD & improve quality of ife of patients? #ERSLDN2016 https://t.co/R5Eb8XY7Ug Imagine a future without #COPD. What can we do to #ChangeCOPD & improve quality of ife of patients? #ERSLDN2016 https://t.co/R5Eb8XY7Ug "05.09.2016 13:15:33" [{"text":"DYK", "indices":[0, 4]}, {"text":"asthma", "indices":[5, 12]}, {"text":"ERSLDN2016", "indices":[108, 119]}] Boehringer #DYK #asthma symptoms have a detrimental effect on work, education, sleep, social life & relationships? #ERSLDN2016 https://t.co/Xn0lcty7c1 #DYK #asthma symptoms have a detrimental effect on work, education, sleep, social life & relationships? #ERSLDN2016 https://t.co/Xn0lcty7c1 "05.09.2016 12:35:19" [{"text":"asthma", "indices":[64, 71]}, {"text":"ERSLDN2016", "indices":[72, 83]}] Boehringer We're discussing what’s new for children & adolescents with #asthma #ERSLDN2016 https://t.co/cpz7uP59uy We're discussing what’s new for children & adolescents with #asthma #ERSLDN2016 https://t.co/cpz7uP59uy "05.09.2016 12:06:33" [{"text":"DYK", "indices":[0, 4]}, {"text":"IPF", "indices":[9, 13]}, {"text":"ERSLDN2016", "indices":[59, 70]}] Boehringer #DYK all #IPF patients are at risk of acute exacerbations? #ERSLDN2016 https://t.co/ljiVMvVVDi #DYK all #IPF patients are at risk of acute exacerbations? #ERSLDN2016 https://t.co/ljiVMvVVDi "05.09.2016 10:45:23" [{"text":"treatment", "indices":[14, 24]}, {"text":"patients", "indices":[44, 53]}, {"text":"ERSLDN2016", "indices":[73, 84]}] Boehringer The impact of #treatment decisions today on #patients’ lives. Tomorrow - #ERSLDN2016 Press Briefing Today @ 2pm https://t.co/3NPSYmxoeg The impact of #treatment decisions today on #patients’ lives. Tomorrow - #ERSLDN2016 Press Briefing Today @ 2pm https://t.co/3NPSYmxoeg "05.09.2016 10:40:11" [{"text":"HCPs", "indices":[0, 5]}, {"text":"asthma", "indices":[26, 33]}, {"text":"AsthmaXchange", "indices":[87, 101]}] Boehringer #HCPs: Lorraine skips her #asthma meds. See what Dr Weber does https://t.co/f9hHfeFjmF #AsthmaXchange collab. w/ @IPCRG #HCPs: Lorraine skips her #asthma meds. See what Dr Weber does https://t.co/f9hHfeFjmF #AsthmaXchange collab. w/ @IPCRG "05.09.2016 10:35:08" [{"text":"HCPs", "indices":[0, 5]}, {"text":"asthma", "indices":[19, 26]}, {"text":"AsthmaXchange", "indices":[84, 98]}] Boehringer #HCPs: Learn about #asthma diagnosis, management, treatment https://t.co/tGJPZEg0aa #AsthmaXchange collab. w/ @IPCRG #HCPs: Learn about #asthma diagnosis, management, treatment https://t.co/tGJPZEg0aa #AsthmaXchange collab. w/ @IPCRG "05.09.2016 08:35:10" [{"text":"London", "indices":[9, 16]}, {"text":"ERSLDN2016", "indices":[21, 32]}, {"text":"asthma", "indices":[61, 68]}, {"text":"COPD", "indices":[69, 74]}, {"text":"IPF", "indices":[81, 85]}, {"text":"LondonCalling", "indices":[86, 100]}] Boehringer Who's in #London for #ERSLDN2016? Follow us for more info on #asthma #COPD & #IPF #LondonCalling https://t.co/celOBtnTzt Who's in #London for #ERSLDN2016? Follow us for more info on #asthma #COPD & #IPF #LondonCalling https://t.co/celOBtnTzt "05.09.2016 07:11:24" [{"text":"COPD", "indices":[73, 78]}, {"text":"ERSLDN2016", "indices":[80, 91]}, {"text":"LondonCalling", "indices":[92, 106]}, {"text":"BigBen", "indices":[107, 114]}] Boehringer Prof. Calverley reminds us that time waits for no one & neither does #COPD! #ERSLDN2016 #LondonCalling #BigBen https://t.co/zmiCNCTDBj Prof. Calverley reminds us that time waits for no one & neither does #COPD! #ERSLDN2016 #LondonCalling #BigBen https://t.co/zmiCNCTDBj "05.09.2016 06:28:17" [{"text":"HCPs", "indices":[0, 5]}, {"text":"Asthma", "indices":[25, 32]}] Boehringer #HCPs: check out our new #Asthma Xchange website in collab. w/ @IPCRG: https://t.co/4rEJbTtvul https://t.co/yZIXjAOLE0 #HCPs: check out our new #Asthma Xchange website in collab. w/ @IPCRG: https://t.co/4rEJbTtvul https://t.co/yZIXjAOLE0 "04.09.2016 15:21:05" [{"text":"COPD", "indices":[37, 42]}, {"text":"ChangeCOPD", "indices":[66, 77]}, {"text":"ERSLDN2016", "indices":[79, 90]}] Boehringer What does the next 30 years hold for #COPD? You have the power to #ChangeCOPD! #ERSLDN2016 https://t.co/p6UY0Nacae What does the next 30 years hold for #COPD? You have the power to #ChangeCOPD! #ERSLDN2016 https://t.co/p6UY0Nacae "04.09.2016 12:35:10" [{"text":"COPD", "indices":[53, 58]}, {"text":"ChangeCOPD", "indices":[60, 71]}, {"text":"ERSLDN2016", "indices":[72, 83]}] Boehringer What can we expect by 2030? What about the burden of #COPD? #ChangeCOPD #ERSLDN2016 https://t.co/Y7dcQ3Po5r What can we expect by 2030? What about the burden of #COPD? #ChangeCOPD #ERSLDN2016 https://t.co/Y7dcQ3Po5r "04.09.2016 10:47:59" [{"text":"IPF", "indices":[65, 69]}, {"text":"ERSLDN2016", "indices":[128, 139]}] Boehringer @Boehringer Well done if you guessed 3mil people are affected by #IPF Look out for our to find out more about the condition #ERSLDN2016 @Boehringer Well done if you guessed 3mil people are affected by #IPF Look out for our to find out more about the condition #ERSLDN2016 "04.09.2016 10:45:10" [{"text":"DYK", "indices":[0, 4]}, {"text":"COPD", "indices":[28, 33]}, {"text":"ERSLDN2016", "indices":[106, 117]}] Boehringer #DYK @WHO estimates by 2030 #COPD will join Ischaemic Heart Disease & Stroke as top 3 causes of death #ERSLDN2016 https://t.co/eRxP4SasTx #DYK @WHO estimates by 2030 #COPD will join Ischaemic Heart Disease & Stroke as top 3 causes of death #ERSLDN2016 https://t.co/eRxP4SasTx "04.09.2016 08:08:27" [{"text":"BankofEngland", "indices":[7, 21]}, {"text":"IPF", "indices":[73, 77]}, {"text":"ERSLDN2016", "indices":[78, 89]}] Boehringer At the #BankofEngland Dr. Toby Maher talks about dropping 'health stock' #IPF #ERSLDN2016 https://t.co/YwL4sk91lH At the #BankofEngland Dr. Toby Maher talks about dropping 'health stock' #IPF #ERSLDN2016 https://t.co/YwL4sk91lH "03.09.2016 10:46:46" [{"text":"DYK", "indices":[0, 4]}, {"text":"IPF", "indices":[37, 41]}, {"text":"ERSLDN2016", "indices":[52, 63]}] Boehringer #DYK how many people are affected by #IPF globally? #ERSLDN2016 #DYK how many people are affected by #IPF globally? #ERSLDN2016 "03.09.2016 10:27:50" [] Boehringer @xilede Thanks for letting us know :) PA @xilede Thanks for letting us know :) PA "03.09.2016 09:42:25" [] Boehringer @zixian thanks for letting us know :) Best regards, Patricia @zixian thanks for letting us know :) Best regards, Patricia "03.09.2016 05:30:29" [{"text":"ERSLDN2016", "indices":[0, 11]}, {"text":"respiratory", "indices":[47, 59]}, {"text":"asthma", "indices":[68, 75]}, {"text":"COPD", "indices":[76, 81]}, {"text":"IPF", "indices":[82, 86]}] Boehringer #ERSLDN2016 is coming to London, follow us for #respiratory updates #asthma #COPD #IPF https://t.co/s9LuBFGdkz #ERSLDN2016 is coming to London, follow us for #respiratory updates #asthma #COPD #IPF https://t.co/s9LuBFGdkz "02.09.2016 18:00:45" [{"text":"ERSLDN2016", "indices":[61, 72]}] Boehringer We'll be at the world's largest respiratory congress 3-7 Sep #ERSLDN2016 https://t.co/3exxPA1nyy We'll be at the world's largest respiratory congress 3-7 Sep #ERSLDN2016 https://t.co/3exxPA1nyy "01.09.2016 12:56:47" [] Boehringer @amon14001 Thank you for tweeting us! You can find our job opportunities worldwide here - https://t.co/u4FJOdai2G -NR @amon14001 Thank you for tweeting us! You can find our job opportunities worldwide here - https://t.co/u4FJOdai2G -NR "31.08.2016 14:05:13" [{"text":"ESCcongress", "indices":[8, 20]}, {"text":"afib", "indices":[48, 53]}] Boehringer Amazing #ESCcongress! All the latest real-world #afib news being shared. Check out all our activities here: https://t.co/OOkCQPW9uj Amazing #ESCcongress! All the latest real-world #afib news being shared. Check out all our activities here: https://t.co/OOkCQPW9uj "31.08.2016 14:00:38" [{"text":"ESCcongress", "indices":[17, 29]}, {"text":"afib", "indices":[84, 89]}] Boehringer Thanks to all at #ESCcongress for valuable insights & knowledge from real-world #afib practice https://t.co/QcFfb4AOPf Thanks to all at #ESCcongress for valuable insights & knowledge from real-world #afib practice https://t.co/QcFfb4AOPf "31.08.2016 13:05:13" [{"text":"ESCcongress", "indices":[33, 45]}, {"text":"afib", "indices":[103, 108]}] Boehringer See expert videos filmed live at #ESCcongress on our dedicated ESC webpage - all the latest real-world #afib news https://t.co/OOkCQPW9uj See expert videos filmed live at #ESCcongress on our dedicated ESC webpage - all the latest real-world #afib news https://t.co/OOkCQPW9uj "31.08.2016 12:48:23" [{"text":"afib", "indices":[62, 67]}, {"text":"DVT", "indices":[74, 78]}, {"text":"ESCcongress", "indices":[104, 116]}] Boehringer Head over to our Instagram page to read real-world tips about #afib & #DVT: https://t.co/5gCcfTyaxo #ESCcongress https://t.co/4SniYjC3mN Head over to our Instagram page to read real-world tips about #afib & #DVT: https://t.co/5gCcfTyaxo #ESCcongress https://t.co/4SniYjC3mN "31.08.2016 08:39:37" [{"text":"afib", "indices":[15, 20]}, {"text":"ESCCongress", "indices":[48, 60]}, {"text":"afib", "indices":[122, 127]}, {"text":"stroke", "indices":[128, 135]}] Boehringer What's next in #afib management? Reporting from #ESCCongress - our latest expert video is online! https://t.co/9xlH68YgcD #afib #stroke What's next in #afib management? Reporting from #ESCCongress - our latest expert video is online! https://t.co/9xlH68YgcD #afib #stroke "31.08.2016 08:00:04" [{"text":"anticoagulation", "indices":[44, 60]}, {"text":"ESCCongress", "indices":[79, 91]}] Boehringer Missed it? Expert video on breakthroughs in #anticoagulation. Sneak peak here! #ESCCongress https://t.co/ykXyeffi0C Missed it? Expert video on breakthroughs in #anticoagulation. Sneak peak here! #ESCCongress https://t.co/ykXyeffi0C "31.08.2016 07:01:54" [{"text":"ESCcongress", "indices":[0, 12]}, {"text":"afib", "indices":[68, 73]}] Boehringer #ESCcongress Sharing real world insights across the globe. Seen our #afib expert videos captured LIVE? All here: https://t.co/OOkCQPW9uj #ESCcongress Sharing real world insights across the globe. Seen our #afib expert videos captured LIVE? All here: https://t.co/OOkCQPW9uj "31.08.2016 05:36:48" [{"text":"realworldevidence", "indices":[24, 42]}, {"text":"anticoagulation", "indices":[46, 62]}, {"text":"afib", "indices":[69, 74]}, {"text":"ESCCongress", "indices":[131, 143]}] Boehringer Want to know more about #realworldevidence in #anticoagulation & #afib? Watch our latest expert video: https://t.co/eh5U86nOca #ESCCongress Want to know more about #realworldevidence in #anticoagulation & #afib? Watch our latest expert video: https://t.co/eh5U86nOca #ESCCongress "30.08.2016 15:00:07" [{"text":"ESCCongress", "indices":[34, 46]}, {"text":"realworldevidence", "indices":[53, 71]}] Boehringer Checked out Prof Pinto's video on #ESCCongress & #realworldevidence yet? Full video on our website, mini clip https://t.co/anSObtQPJt Checked out Prof Pinto's video on #ESCCongress & #realworldevidence yet? Full video on our website, mini clip https://t.co/anSObtQPJt "30.08.2016 14:20:15" [{"text":"realworldevidence", "indices":[20, 38]}, {"text":"anticoagulation", "indices":[42, 58]}, {"text":"ESCCongress", "indices":[101, 113]}] Boehringer What’s the value of #realworldevidence in #anticoagulation? Get the lowdown in our new video! Teaser #ESCCongress https://t.co/0ww384GPe4 What’s the value of #realworldevidence in #anticoagulation? Get the lowdown in our new video! Teaser #ESCCongress https://t.co/0ww384GPe4 "30.08.2016 14:00:32" [{"text":"anticoagulation", "indices":[36, 52]}, {"text":"ESCCongress", "indices":[117, 129]}, {"text":"afib", "indices":[130, 135]}] Boehringer Hear the expert view on advances in #anticoagulation over the last 10 years. NEW video here: https://t.co/crJ50K0ePd #ESCCongress #afib Hear the expert view on advances in #anticoagulation over the last 10 years. NEW video here: https://t.co/crJ50K0ePd #ESCCongress #afib "30.08.2016 13:45:14" [{"text":"realworldevidence", "indices":[47, 65]}, {"text":"ESCCongress", "indices":[108, 120]}] Boehringer Prof Pinto tells us how @escardio has advanced #realworldevidence knowledge-sharing https://t.co/plk9XFCZo7 #ESCCongress Prof Pinto tells us how @escardio has advanced #realworldevidence knowledge-sharing https://t.co/plk9XFCZo7 #ESCCongress "30.08.2016 13:25:27" [{"text":"anticoagulation", "indices":[21, 37]}, {"text":"hottopics", "indices":[49, 59]}, {"text":"afib", "indices":[63, 68]}, {"text":"ESCCongress", "indices":[87, 99]}] Boehringer Personal videos from #anticoagulation experts on #hottopics in #afib, captured LIVE at #ESCCongress. Videos here: https://t.co/OOkCQPW9uj Personal videos from #anticoagulation experts on #hottopics in #afib, captured LIVE at #ESCCongress. Videos here: https://t.co/OOkCQPW9uj "30.08.2016 08:38:47" [{"text":"dabigatran", "indices":[70, 81]}, {"text":"afib", "indices":[85, 90]}, {"text":"ESCCongress", "indices":[100, 112]}] Boehringer 1st results from GLORIA™-AF Registry on safety & effectiveness of #dabigatran in #afib patients #ESCCongress https://t.co/GRxsXNuip5 1st results from GLORIA™-AF Registry on safety & effectiveness of #dabigatran in #afib patients #ESCCongress https://t.co/GRxsXNuip5 "30.08.2016 06:22:14" [] Boehringer @NESLOPGIAN El medicamento no está disponible en este momento, el mismo estará nuevamente disponible a partir de noviembre de este año. >PA @NESLOPGIAN El medicamento no está disponible en este momento, el mismo estará nuevamente disponible a partir de noviembre de este año. >PA "29.08.2016 15:30:23" [{"text":"HCPs", "indices":[0, 5]}, {"text":"ESCCongress2016", "indices":[91, 107]}, {"text":"afib", "indices":[108, 113]}, {"text":"dabigatran", "indices":[114, 125]}] Boehringer #HCPs: 1st outcome results from GLORIA™-AF Registry – starts in 15’ in Sarajevo, Village 2 #ESCCongress2016 #afib #dabigatran #HCPs: 1st outcome results from GLORIA™-AF Registry – starts in 15’ in Sarajevo, Village 2 #ESCCongress2016 #afib #dabigatran "29.08.2016 14:24:19" [{"text":"anticoagulation", "indices":[36, 52]}, {"text":"ESCCongress2016", "indices":[117, 133]}, {"text":"afib", "indices":[134, 139]}] Boehringer Hear the expert view on advances in #anticoagulation over the last 10 years. NEW video here: https://t.co/crJ50K0ePd #ESCCongress2016 #afib Hear the expert view on advances in #anticoagulation over the last 10 years. NEW video here: https://t.co/crJ50K0ePd #ESCCongress2016 #afib "29.08.2016 11:00:08" [{"text":"anticoagulation", "indices":[40, 56]}, {"text":"ESCCongress2016", "indices":[93, 109]}] Boehringer Latest expert video on breakthroughs in #anticoagulation launching this pm. Sneak peak here! #ESCCongress2016 https://t.co/WkEQpgzGRM Latest expert video on breakthroughs in #anticoagulation launching this pm. Sneak peak here! #ESCCongress2016 https://t.co/WkEQpgzGRM "28.08.2016 15:33:31" [{"text":"ESCCongress2016", "indices":[34, 50]}, {"text":"realworldevidence", "indices":[57, 75]}] Boehringer Checked out Prof Pinto's video on #ESCCongress2016 & #realworldevidence yet? Full video on our website! - mini clip: https://t.co/gzJco01I5b Checked out Prof Pinto's video on #ESCCongress2016 & #realworldevidence yet? Full video on our website! - mini clip: https://t.co/gzJco01I5b "28.08.2016 13:00:19" [{"text":"HCPs", "indices":[0, 5]}, {"text":"afib", "indices":[12, 17]}, {"text":"ESCCongress2016", "indices":[48, 64]}] Boehringer #HCPs - New #afib guidelines announced today at #ESCCongress2016. Click on the link to find out more: https://t.co/nBhoIdwpVE #HCPs - New #afib guidelines announced today at #ESCCongress2016. Click on the link to find out more: https://t.co/nBhoIdwpVE "28.08.2016 12:46:27" [{"text":"realworldevidence", "indices":[59, 77]}, {"text":"ESCCongress2016", "indices":[120, 136]}] Boehringer NEW video - Prof Pinto tells us how @escardio has advanced #realworldevidence knowledge-sharing https://t.co/plk9XFCZo7 #ESCCongress2016 NEW video - Prof Pinto tells us how @escardio has advanced #realworldevidence knowledge-sharing https://t.co/plk9XFCZo7 #ESCCongress2016 "28.08.2016 12:30:48" [{"text":"afib", "indices":[12, 17]}, {"text":"anticoagulant", "indices":[50, 64]}, {"text":"ESCCongress2016", "indices":[92, 108]}] Boehringer How much do #afib patients want to participate in #anticoagulant treatment decision-making? #ESCCongress2016 https://t.co/3wMlDxl6j3 How much do #afib patients want to participate in #anticoagulant treatment decision-making? #ESCCongress2016 https://t.co/3wMlDxl6j3 "28.08.2016 12:01:26" [{"text":"patientsurvey", "indices":[4, 18]}, {"text":"ESCCongress2016", "indices":[30, 46]}, {"text":"afib", "indices":[77, 82]}] Boehringer New #patientsurvey results at #ESCCongress2016 demonstrate how perception of #afib differs country by country https://t.co/MRm7eHxCVb New #patientsurvey results at #ESCCongress2016 demonstrate how perception of #afib differs country by country https://t.co/MRm7eHxCVb "27.08.2016 09:01:16" [{"text":"afib", "indices":[29, 34]}, {"text":"stroke", "indices":[35, 42]}, {"text":"ESCCongress2016", "indices":[99, 115]}] Boehringer New videos featuring leading #afib #stroke experts offering insights into hot topics! Coming soon! #ESCCongress2016 https://t.co/jF9cSdoAli New videos featuring leading #afib #stroke experts offering insights into hot topics! Coming soon! #ESCCongress2016 https://t.co/jF9cSdoAli "26.08.2016 14:31:21" [{"text":"HCPs", "indices":[0, 5]}, {"text":"realworldevidence", "indices":[23, 41]}, {"text":"ESCCongress201", "indices":[100, 115]}] Boehringer #HCPs: What sources of #realworldevidence provide knowledge on treatment performance beyond trials? #ESCCongress201 https://t.co/uSOhoKb5lC #HCPs: What sources of #realworldevidence provide knowledge on treatment performance beyond trials? #ESCCongress201 https://t.co/uSOhoKb5lC "26.08.2016 13:57:54" [{"text":"realworldevidence", "indices":[88, 106]}, {"text":"ESCCongress2016", "indices":[118, 134]}] Boehringer @Boehringer Answer: FACT! Social networking sites & patient forums can form part of #realworldevidence collection #ESCCongress2016 @Boehringer Answer: FACT! Social networking sites & patient forums can form part of #realworldevidence collection #ESCCongress2016 "26.08.2016 08:52:36" [{"text":"HCPs", "indices":[0, 5]}, {"text":"FactorFiction", "indices":[13, 27]}, {"text":"realworldevidence", "indices":[33, 51]}, {"text":"socialmedia", "indices":[72, 84]}, {"text":"ESCCongress2016", "indices":[86, 102]}] Boehringer #HCPs: Final #FactorFiction Q5: "#realworldevidence can be collected on #socialmedia" #ESCCongress2016 #HCPs: Final #FactorFiction Q5: "#realworldevidence can be collected on #socialmedia" #ESCCongress2016 "25.08.2016 14:32:00" [{"text":"realworldevidence", "indices":[59, 77]}, {"text":"ESCcongress2016", "indices":[127, 143]}] Boehringer @Boehringer This one is FICTION. Lots of different ppl use #realworldevidence e.g. patients, governments, academics & more #ESCcongress2016 @Boehringer This one is FICTION. Lots of different ppl use #realworldevidence e.g. patients, governments, academics & more #ESCcongress2016 "25.08.2016 12:05:28" [{"text":"HCPs", "indices":[0, 5]}, {"text":"ESCCongress2016", "indices":[32, 48]}, {"text":"afib", "indices":[102, 107]}] Boehringer #HCPs: We're looking forward to #ESCCongress2016 in Rome later this week! RT if you're going as well! #afib https://t.co/zPBJEYsHZ8 #HCPs: We're looking forward to #ESCCongress2016 in Rome later this week! RT if you're going as well! #afib https://t.co/zPBJEYsHZ8 "25.08.2016 11:03:09" [{"text":"AnimalHealth", "indices":[31, 44]}] Boehringer George Heidgerken, our head of #AnimalHealth, spoke with @AnimalPharm about Innovation in the Asian market: https://t.co/K2USZumTp0 George Heidgerken, our head of #AnimalHealth, spoke with @AnimalPharm about Innovation in the Asian market: https://t.co/K2USZumTp0 "25.08.2016 08:53:11" [{"text":"HCPs", "indices":[0, 5]}, {"text":"FactorFiction", "indices":[7, 21]}, {"text":"realworldevidence", "indices":[75, 93]}, {"text":"ESCCongress2016", "indices":[95, 111]}] Boehringer #HCPs: #FactorFiction Q4: "Only Drs treating the disease are interested in #realworldevidence" #ESCCongress2016 #HCPs: #FactorFiction Q4: "Only Drs treating the disease are interested in #realworldevidence" #ESCCongress2016 "25.08.2016 08:02:45" [{"text":"FDA", "indices":[65, 69]}, {"text":"realworldevidence", "indices":[78, 96]}, {"text":"ESCcongress2016", "indices":[97, 113]}] Boehringer @Boehringer If you guessed FACT, then you are correct! Here’s an #FDA view on #realworldevidence #ESCcongress2016: https://t.co/SzsrgRB80X @Boehringer If you guessed FACT, then you are correct! Here’s an #FDA view on #realworldevidence #ESCcongress2016: https://t.co/SzsrgRB80X "25.08.2016 01:36:52" [] Boehringer @jLTuerosNavea thanks for your Feedback, we really appreciate it. Best regards, PA @jLTuerosNavea thanks for your Feedback, we really appreciate it. Best regards, PA "24.08.2016 14:31:33" [{"text":"HCPs", "indices":[0, 5]}, {"text":"realworldevidence", "indices":[15, 33]}, {"text":"ESCCongress2016", "indices":[98, 114]}] Boehringer #HCPs: How can #realworldevidence ↑ physician understanding about treatment use in clinical care? #ESCCongress2016 https://t.co/YkYEiH1p62 #HCPs: How can #realworldevidence ↑ physician understanding about treatment use in clinical care? #ESCCongress2016 https://t.co/YkYEiH1p62 "24.08.2016 08:46:53" [{"text":"HCPs", "indices":[0, 5]}, {"text":"FactorFiction", "indices":[7, 21]}, {"text":"realworldevidence", "indices":[80, 98]}, {"text":"ESCCongress2016", "indices":[100, 116]}] Boehringer #HCPs: #FactorFiction Q3: “Reg' authorities e.g. FDA EMA use & see value of #realworldevidence” #ESCCongress2016 #HCPs: #FactorFiction Q3: “Reg' authorities e.g. FDA EMA use & see value of #realworldevidence” #ESCCongress2016 "23.08.2016 14:32:45" [{"text":"realworldevidence", "indices":[22, 40]}] Boehringer @Boehringer FICTION - #realworldevidence for just 1 medicine can involve millions of patients’ data collected across many decades @Boehringer FICTION - #realworldevidence for just 1 medicine can involve millions of patients’ data collected across many decades "23.08.2016 13:01:58" [{"text":"ESCCongress2016", "indices":[19, 35]}, {"text":"HCPs", "indices":[48, 53]}, {"text":"afib", "indices":[102, 107]}, {"text":"stroke", "indices":[108, 115]}] Boehringer Looking forward to #ESCCongress2016? >27,000 #HCPs are attending, so make sure you don't miss out! #afib #stroke https://t.co/mf1lTotQqw Looking forward to #ESCCongress2016? >27,000 #HCPs are attending, so make sure you don't miss out! #afib #stroke https://t.co/mf1lTotQqw "23.08.2016 11:58:39" [{"text":"HCPs", "indices":[0, 5]}, {"text":"FactorFiction", "indices":[7, 21]}, {"text":"realworldevidence", "indices":[27, 45]}, {"text":"ESCCongress2016", "indices":[98, 114]}] Boehringer #HCPs: #FactorFiction Q2. "#realworldevidence for 1 medicine gathers data from >100k patients" #ESCCongress2016 #HCPs: #FactorFiction Q2. "#realworldevidence for 1 medicine gathers data from >100k patients" #ESCCongress2016 "23.08.2016 06:00:45" [{"text":"ESCCongress2016", "indices":[32, 48]}, {"text":"realworldevidence", "indices":[63, 81]}, {"text":"afib", "indices":[82, 87]}, {"text":"stroke", "indices":[88, 95]}] Boehringer New announcements coming up for #ESCCongress2016. Any guesses? #realworldevidence #afib #stroke https://t.co/QtEo4rAfeu New announcements coming up for #ESCCongress2016. Any guesses? #realworldevidence #afib #stroke https://t.co/QtEo4rAfeu "22.08.2016 17:44:28" [{"text":"realworldevidence", "indices":[35, 53]}] Boehringer @Boehringer 55% correct - Fiction! #realworldevidence is a term used to describe data collected OUTSIDE of a randomised controlled trial. @Boehringer 55% correct - Fiction! #realworldevidence is a term used to describe data collected OUTSIDE of a randomised controlled trial. "22.08.2016 16:10:15" [{"text":"HCPs", "indices":[0, 5]}, {"text":"FactorFiction", "indices":[7, 21]}, {"text":"realworldevidence", "indices":[74, 92]}, {"text":"ESCCongress2016", "indices":[97, 113]}] Boehringer #HCPs: #FactorFiction quiz - starting today! As a warm up, who knows what #realworldevidence is? #ESCCongress2016 https://t.co/iW6EfbAoex #HCPs: #FactorFiction quiz - starting today! As a warm up, who knows what #realworldevidence is? #ESCCongress2016 https://t.co/iW6EfbAoex "22.08.2016 15:07:21" [{"text":"HCPs", "indices":[0, 5]}, {"text":"FactorFiction", "indices":[7, 21]}, {"text":"realworldevidence", "indices":[27, 45]}, {"text":"ESCCongress2016", "indices":[93, 109]}] Boehringer #HCPs: #FactorFiction Q1: "#realworldevidence is collected in a randomised controlled trial" #ESCCongress2016 #HCPs: #FactorFiction Q1: "#realworldevidence is collected in a randomised controlled trial" #ESCCongress2016 "22.08.2016 14:44:48" [{"text":"HCPs", "indices":[0, 5]}, {"text":"realworldevidence", "indices":[30, 48]}, {"text":"FactorFiction", "indices":[54, 68]}, {"text":"ESCCongress2016", "indices":[87, 103]}] Boehringer #HCPs: What do you know about #realworldevidence? Our #FactorFiction quiz starts today #ESCCongress2016 https://t.co/jenfs56Lle #HCPs: What do you know about #realworldevidence? Our #FactorFiction quiz starts today #ESCCongress2016 https://t.co/jenfs56Lle "22.08.2016 09:27:38" [] Boehringer @RutlandStroke @sas_freeman @keeling_michael @StrokeNeurol @StrokeFocus Well Done! :) @RutlandStroke @sas_freeman @keeling_michael @StrokeNeurol @StrokeFocus Well Done! :) "22.08.2016 08:29:22" [{"text":"COPD", "indices":[0, 5]}, {"text":"YourTime", "indices":[88, 97]}] Boehringer #COPD affects 210 mill people worldwide. By 2030 it will be 3rd leading cause of death. #YourTime to act is now. https://t.co/ZDF0aWik5Q #COPD affects 210 mill people worldwide. By 2030 it will be 3rd leading cause of death. #YourTime to act is now. https://t.co/ZDF0aWik5Q "19.08.2016 14:24:09" [{"text":"ESO", "indices":[45, 49]}, {"text":"Stroke", "indices":[50, 57]}, {"text":"AngelsInitiative", "indices":[58, 75]}] Boehringer @ESOstroke so are we! See you in November :) #ESO #Stroke #AngelsInitiative @ESOstroke so are we! See you in November :) #ESO #Stroke #AngelsInitiative "19.08.2016 14:15:14" [{"text":"career", "indices":[123, 130]}, {"text":"careers", "indices":[131, 139]}] Boehringer There's one thing we're really proud of: many employees around the world are happy to work for us: https://t.co/X5WQi8TEPB #career #careers There's one thing we're really proud of: many employees around the world are happy to work for us: https://t.co/X5WQi8TEPB #career #careers "19.08.2016 10:03:45" [{"text":"FutureJustHappened", "indices":[85, 104]}] Boehringer Take a look at this quick collection of last week’s latest trends & innovations. #FutureJustHappened https://t.co/uRlmZnW80X via @futurism Take a look at this quick collection of last week’s latest trends & innovations. #FutureJustHappened https://t.co/uRlmZnW80X via @futurism "15.08.2016 12:17:18" [{"text":"idarucizumab", "indices":[60, 73]}] Boehringer Press: Launch of RE-VECTO global program to capture data on #idarucizumab usage in clinical practice https://t.co/czagbg2Ofc Press: Launch of RE-VECTO global program to capture data on #idarucizumab usage in clinical practice https://t.co/czagbg2Ofc "15.08.2016 11:48:32" [{"text":"MotivationMonday", "indices":[0, 17]}, {"text":"asthma", "indices":[34, 41]}] Boehringer #MotivationMonday: Don't let your #asthma symptoms hold you back from relaxing & enjoying the things you want to do https://t.co/BzCYEaGg5N #MotivationMonday: Don't let your #asthma symptoms hold you back from relaxing & enjoying the things you want to do https://t.co/BzCYEaGg5N "15.08.2016 09:30:31" [] Boehringer @Therizinosaur To make this delicious meal, we consider it best to use fine-chopped garlic. Best Regards, PA @Therizinosaur To make this delicious meal, we consider it best to use fine-chopped garlic. Best Regards, PA "12.08.2016 12:33:32" [{"text":"International", "indices":[5, 19]}, {"text":"YouthDay", "indices":[20, 29]}, {"text":"GenY", "indices":[55, 60]}] Boehringer It's #International #YouthDay! Find out how members of #GenY see themselves&their employers https://t.co/CqRSGftYBZ https://t.co/CF3ce7XWkl It's #International #YouthDay! Find out how members of #GenY see themselves&their employers https://t.co/CqRSGftYBZ https://t.co/CF3ce7XWkl "12.08.2016 09:10:22" [] Boehringer @willow_peck If you prefer, we can also contact you. Would you be willing to share your contact via DM with us? Thanks! PA @willow_peck If you prefer, we can also contact you. Would you be willing to share your contact via DM with us? Thanks! PA "12.08.2016 08:27:42" [] Boehringer @willow_peck tks for contacting us. Please contact medinfo.bra@boehringer-ingelheim.com and they will provide you more infos. Regards, PA @willow_peck tks for contacting us. Please contact medinfo.bra@boehringer-ingelheim.com and they will provide you more infos. Regards, PA "08.08.2016 12:26:50" [{"text":"T2D", "indices":[84, 88]}, {"text":"FriendshipDay", "indices":[96, 110]}] Boehringer Our poll showed that 45% of you think exercising together is the best way to help a #T2D friend #FriendshipDay https://t.co/aya6xrv8SK Our poll showed that 45% of you think exercising together is the best way to help a #T2D friend #FriendshipDay https://t.co/aya6xrv8SK "05.08.2016 07:02:20" [{"text":"FriendshipDay", "indices":[0, 14]}, {"text":"diabetes", "indices":[88, 97]}] Boehringer #FriendshipDay is coming up, what do you think is the best way to support a friend with #diabetes? #FriendshipDay is coming up, what do you think is the best way to support a friend with #diabetes? "03.08.2016 18:25:11" [] Boehringer H1 2016: @Boehringer reached strategic milestones with decisive impact on the company’s future development https://t.co/NWIhP52BuI H1 2016: @Boehringer reached strategic milestones with decisive impact on the company’s future development https://t.co/NWIhP52BuI "03.08.2016 08:10:18" [] Boehringer Growth in all core businesses at @Boehringer. Half-year net sales of approximately 7.3 billion euros https://t.co/NWIhP52BuI Growth in all core businesses at @Boehringer. Half-year net sales of approximately 7.3 billion euros https://t.co/NWIhP52BuI "01.08.2016 18:01:26" [{"text":"OTD", "indices":[0, 4]}, {"text":"business", "indices":[19, 28]}, {"text":"celebrate", "indices":[82, 92]}, {"text":"innovation", "indices":[93, 104]}] Boehringer #OTD 131 years ago #business operations started at the @Boehringer HQ. We want to #celebrate #innovation with you! https://t.co/A422tfzG40 #OTD 131 years ago #business operations started at the @Boehringer HQ. We want to #celebrate #innovation with you! https://t.co/A422tfzG40 "30.07.2016 16:58:51" [{"text":"HCPs", "indices":[0, 5]}, {"text":"Respiratory", "indices":[110, 122]}, {"text":"COPD", "indices":[123, 128]}, {"text":"doctors", "indices":[129, 137]}] Boehringer #HCPs: we have launched the new design of the https://t.co/Nudl9iguOM with lots of new content. Check it out! #Respiratory #COPD #doctors #HCPs: we have launched the new design of the https://t.co/Nudl9iguOM with lots of new content. Check it out! #Respiratory #COPD #doctors "29.07.2016 14:41:58" [{"text":"business", "indices":[4, 13]}, {"text":"society", "indices":[18, 26]}, {"text":"socialenterprise", "indices":[110, 127]}, {"text":"MakingMoreHealth", "indices":[128, 145]}] Boehringer Can #business&#society get on track & find new approaches to help each other? https://t.co/36xoymmGhs #socialenterprise #MakingMoreHealth Can #business&#society get on track & find new approaches to help each other? https://t.co/36xoymmGhs #socialenterprise #MakingMoreHealth "27.07.2016 14:12:05" [{"text":"SocialResponsibility", "indices":[0, 21]}, {"text":"socialcommitment", "indices":[66, 83]}] Boehringer #SocialResponsibility is important to us. Find out more about our #socialcommitment: https://t.co/RQjRh39hMe https://t.co/PqbxtiDSz8 #SocialResponsibility is important to us. Find out more about our #socialcommitment: https://t.co/RQjRh39hMe https://t.co/PqbxtiDSz8 "26.07.2016 14:58:00" [] Boehringer @originpharma we are doing good, thanks and how are you? >PA & NR @originpharma we are doing good, thanks and how are you? >PA & NR "22.07.2016 20:20:24" [{"text":"stroke", "indices":[70, 77]}, {"text":"hospitals", "indices":[103, 113]}] Boehringer Press: @Boehringer & @ESOstroke want to build a community of 1500 #stroke centres and stroke ready #hospitals https://t.co/bGUQuagxpK Press: @Boehringer & @ESOstroke want to build a community of 1500 #stroke centres and stroke ready #hospitals https://t.co/bGUQuagxpK "21.07.2016 14:02:21" [{"text":"TBT", "indices":[0, 4]}, {"text":"IPCRG2016", "indices":[25, 35]}, {"text":"asthma", "indices":[104, 111]}] Boehringer #TBT Dr Gruffyd-Jones at #IPCRG2016 – “the first point of contact is the primary care doctors or nurse” #asthma https://t.co/nBJYdgZwq5 #TBT Dr Gruffyd-Jones at #IPCRG2016 – “the first point of contact is the primary care doctors or nurse” #asthma https://t.co/nBJYdgZwq5 "21.07.2016 05:20:11" [{"text":"stroke", "indices":[68, 75]}, {"text":"strokecare", "indices":[88, 99]}] Boehringer Press: Find out how @Boehringer & @ESOstroke team up to take on #stroke and improve #strokecare https://t.co/bGUQuagxpK Press: Find out how @Boehringer & @ESOstroke team up to take on #stroke and improve #strokecare https://t.co/bGUQuagxpK "20.07.2016 17:50:15" [{"text":"strokecare", "indices":[17, 28]}, {"text":"lives", "indices":[38, 44]}, {"text":"disability", "indices":[57, 68]}] Boehringer Press: Improving #strokecare can save #lives and prevent #disability. Find out about the Angels Initiative's goal on https://t.co/bGUQuagxpK Press: Improving #strokecare can save #lives and prevent #disability. Find out about the Angels Initiative's goal on https://t.co/bGUQuagxpK "20.07.2016 08:05:14" [{"text":"stroke", "indices":[85, 92]}] Boehringer Press: @Boehringer & @ESOstroke launch the Angels Initiative aiming at improving #stroke care across Europe https://t.co/bGUQuagxpK Press: @Boehringer & @ESOstroke launch the Angels Initiative aiming at improving #stroke care across Europe https://t.co/bGUQuagxpK "15.07.2016 09:00:58" [{"text":"new", "indices":[63, 67]}, {"text":"medicines", "indices":[77, 87]}, {"text":"areas", "indices":[92, 98]}] Boehringer Press: @Boehringer & @UoDLifeSciences team up to develop a #new class of #medicines for #areas of unmet medical need https://t.co/XEgVV3eseZ Press: @Boehringer & @UoDLifeSciences team up to develop a #new class of #medicines for #areas of unmet medical need https://t.co/XEgVV3eseZ "14.07.2016 18:30:10" [{"text":"asthma", "indices":[14, 21]}, {"text":"work", "indices":[55, 60]}] Boehringer Dont let your #asthma be the reason for missing out at #work. Find out more @ https://t.co/HptFq5c2Gh https://t.co/NVYi5DyFqP Dont let your #asthma be the reason for missing out at #work. Find out more @ https://t.co/HptFq5c2Gh https://t.co/NVYi5DyFqP "14.07.2016 15:01:04" [{"text":"molecules", "indices":[14, 24]}, {"text":"cell", "indices":[31, 36]}, {"text":"disease", "indices":[73, 81]}] Boehringer Press: PROTAC #molecules use a #cell’s natural disposal system to remove #disease causing proteins. Find out more: https://t.co/XEgVV3eseZ Press: PROTAC #molecules use a #cell’s natural disposal system to remove #disease causing proteins. Find out more: https://t.co/XEgVV3eseZ "14.07.2016 09:20:05" [{"text":"new", "indices":[80, 84]}, {"text":"medicines", "indices":[94, 104]}, {"text":"patients", "indices":[109, 118]}] Boehringer Press: Find out how @Boehringer & @UoDLifeSciences collaborate to develop a #new class of #medicines for #patients https://t.co/XEgVV3eseZ Press: Find out how @Boehringer & @UoDLifeSciences collaborate to develop a #new class of #medicines for #patients https://t.co/XEgVV3eseZ "13.07.2016 16:50:17" [{"text":"therapy", "indices":[75, 83]}, {"text":"metastatic", "indices":[87, 98]}, {"text":"breastcancer", "indices":[99, 112]}] Boehringer Press: Study to evaluate potential of novel combination to further improve #therapy of #metastatic #breastcancer https://t.co/VIGz22yNbE Press: Study to evaluate potential of novel combination to further improve #therapy of #metastatic #breastcancer https://t.co/VIGz22yNbE "13.07.2016 12:07:56" [{"text":"NEWS", "indices":[0, 5]}] Boehringer #NEWS: @Boehringer & Eli Lilly announce clinical trial collaboration in metastatic breast cancer https://t.co/VIGz22yNbE #NEWS: @Boehringer & Eli Lilly announce clinical trial collaboration in metastatic breast cancer https://t.co/VIGz22yNbE "11.07.2016 12:02:04" [{"text":"diabetes", "indices":[41, 50]}, {"text":"WorldPopulationDay", "indices":[95, 114]}] Boehringer 415 million people across the world have #diabetes. By 2040 this will increase to 642 million. #WorldPopulationDay https://t.co/M7H5BqI9to 415 million people across the world have #diabetes. By 2040 this will increase to 642 million. #WorldPopulationDay https://t.co/M7H5BqI9to "07.07.2016 13:26:02" [] Boehringer Marina von Keyserlingk and Daniel Weary win first Ruminant Well-being Award sponsored by @Boehringer Animal Health https://t.co/1DafAizzWE Marina von Keyserlingk and Daniel Weary win first Ruminant Well-being Award sponsored by @Boehringer Animal Health https://t.co/1DafAizzWE "04.07.2016 08:01:26" [{"text":"diabetes", "indices":[12, 21]}, {"text":"MotivationMonday", "indices":[49, 66]}, {"text":"T2D", "indices":[67, 71]}] Boehringer Who is your #diabetes hero and why? Let us know! #MotivationMonday #T2D https://t.co/RIyvFky0v2 Who is your #diabetes hero and why? Let us know! #MotivationMonday #T2D https://t.co/RIyvFky0v2 "01.07.2016 06:55:13" [{"text":"diabetes", "indices":[48, 57]}, {"text":"FridayFacts", "indices":[82, 94]}] Boehringer According to @IntDiabetesFed 1 in 11 adults has #diabetes https://t.co/ajvxoClQAf #FridayFacts https://t.co/TS6gUWSiMM According to @IntDiabetesFed 1 in 11 adults has #diabetes https://t.co/ajvxoClQAf #FridayFacts https://t.co/TS6gUWSiMM "30.06.2016 14:01:44" [{"text":"HCPs", "indices":[0, 5]}, {"text":"neurologists", "indices":[6, 19]}, {"text":"stroke", "indices":[133, 140]}] Boehringer #HCPs #neurologists from all over Europe are coming together to share their knowledge. Welcome to Ingelheim! https://t.co/7Gudyomqwn #stroke #HCPs #neurologists from all over Europe are coming together to share their knowledge. Welcome to Ingelheim! https://t.co/7Gudyomqwn #stroke "30.06.2016 08:27:16" [{"text":"IPF", "indices":[4, 8]}, {"text":"OFEV", "indices":[49, 54]}, {"text":"biomarkers", "indices":[65, 76]}] Boehringer 1st #IPF patient enrolled in new study exploring #OFEV effect on #biomarkers indicating scarring in lungs: https://t.co/Mgxt2WbQqB 1st #IPF patient enrolled in new study exploring #OFEV effect on #biomarkers indicating scarring in lungs: https://t.co/Mgxt2WbQqB "29.06.2016 18:10:14" [{"text":"inspirational", "indices":[13, 27]}, {"text":"systemic", "indices":[88, 97]}, {"text":"sclerosis", "indices":[98, 108]}, {"text":"WSD16", "indices":[109, 115]}] Boehringer Not seen our #inspirational patient video yet? Then follow this link to hear more about #systemic #sclerosis #WSD16 https://t.co/wCgr0UwbB2 Not seen our #inspirational patient video yet? Then follow this link to hear more about #systemic #sclerosis #WSD16 https://t.co/wCgr0UwbB2 "29.06.2016 14:10:08" [{"text":"WorldSclerodermaDay", "indices":[5, 25]}, {"text":"systemic", "indices":[99, 108]}, {"text":"sclerosis", "indices":[109, 119]}] Boehringer It's #WorldSclerodermaDay & we're launching Ilaria's story: an honest insight into living with #systemic #sclerosis https://t.co/wCgr0UwbB2 It's #WorldSclerodermaDay & we're launching Ilaria's story: an honest insight into living with #systemic #sclerosis https://t.co/wCgr0UwbB2 "29.06.2016 13:00:37" [{"text":"HCPs", "indices":[0, 5]}, {"text":"stroke", "indices":[131, 138]}] Boehringer #HCPs: we’re excited to announce the Kick-off Workshop for the Angels Initiative - July 1st-3rd https://t.co/7Gudyomqwn @ESOstroke #stroke #HCPs: we’re excited to announce the Kick-off Workshop for the Angels Initiative - July 1st-3rd https://t.co/7Gudyomqwn @ESOstroke #stroke "28.06.2016 13:02:44" [] Boehringer We appreciate @Fscleroderma's "Hand in Hand for Scleroderma" theme for World Scleroderma Day tomorrow https://t.co/Kuqlv47Esz We appreciate @Fscleroderma's "Hand in Hand for Scleroderma" theme for World Scleroderma Day tomorrow https://t.co/Kuqlv47Esz "27.06.2016 13:05:16" [{"text":"sclerosis", "indices":[54, 64]}] Boehringer We are committed to supporting patients with systemic #sclerosis, as are @Fscleroderma & @SclerodermaCAN. Follow them to see more. We are committed to supporting patients with systemic #sclerosis, as are @Fscleroderma & @SclerodermaCAN. Follow them to see more. "27.06.2016 10:30:26" [] Boehringer NVLE's image (https://t.co/uF90HMcptn) shows support for @Fscleroderma's "Hand in Hand for Scleroderma" theme https://t.co/xtwCauXlkP NVLE's image (https://t.co/uF90HMcptn) shows support for @Fscleroderma's "Hand in Hand for Scleroderma" theme https://t.co/xtwCauXlkP "27.06.2016 09:26:03" [{"text":"IPF", "indices":[52, 56]}] Boehringer New analysis in @ATSBlueEditor examines subgroup of #IPF patients identified using broader diagnostic criteria:https://t.co/r7V7iY6TEI New analysis in @ATSBlueEditor examines subgroup of #IPF patients identified using broader diagnostic criteria:https://t.co/r7V7iY6TEI "27.06.2016 05:10:10" [{"text":"Boehringer", "indices":[0, 11]}, {"text":"Sanofi", "indices":[16, 23]}] Boehringer #Boehringer and #Sanofi have signed contracts to swap businesses as announced in Dec 2015 https://t.co/8sQJbUosB8 #Boehringer and #Sanofi have signed contracts to swap businesses as announced in Dec 2015 https://t.co/8sQJbUosB8 "24.06.2016 15:00:26" [{"text":"IPCRG2016", "indices":[27, 37]}, {"text":"asthma", "indices":[105, 112]}] Boehringer Catch Dr. Gruffyd-Jones at #IPCRG2016 – “3 hours per week on average were being lost because of people's #asthma” https://t.co/qX07HdlnV7 Catch Dr. Gruffyd-Jones at #IPCRG2016 – “3 hours per week on average were being lost because of people's #asthma” https://t.co/qX07HdlnV7 "23.06.2016 14:24:04" [{"text":"scleroderma", "indices":[71, 83]}] Boehringer Here's why we think the work @SclerodermaCAN are doing is so important #scleroderma https://t.co/ayV3w193tw Here's why we think the work @SclerodermaCAN are doing is so important #scleroderma https://t.co/ayV3w193tw "22.06.2016 12:20:21" [{"text":"T2D", "indices":[106, 110]}, {"text":"DOC", "indices":[111, 115]}] Boehringer It was close, but most of you like outdoor sports or the gym to get exercise. Whatever it is, keep it up! #T2D #DOC It was close, but most of you like outdoor sports or the gym to get exercise. Whatever it is, keep it up! #T2D #DOC "22.06.2016 09:16:21" [] Boehringer @hansungip Warm greetings Back! PA @hansungip Warm greetings Back! PA "22.06.2016 08:25:55" [] Boehringer @zarin33 Comunicamos que o medicamento Efortil (Cloridrato de Etilefrina) foi descontinuado desde Dezembro/2015. - TP @zarin33 Comunicamos que o medicamento Efortil (Cloridrato de Etilefrina) foi descontinuado desde Dezembro/2015. - TP "21.06.2016 15:31:31" [{"text":"T2D", "indices":[98, 102]}, {"text":"TuesdayTips", "indices":[103, 115]}] Boehringer Make veggies more exciting by roasting them in the oven with olive oil, pepper, garlic and basil! #T2D #TuesdayTips https://t.co/89jX8HlRlY Make veggies more exciting by roasting them in the oven with olive oil, pepper, garlic and basil! #T2D #TuesdayTips https://t.co/89jX8HlRlY "20.06.2016 09:30:11" [{"text":"T2D", "indices":[47, 51]}, {"text":"DOC", "indices":[52, 56]}] Boehringer What's your favourite way of getting exercise? #T2D #DOC What's your favourite way of getting exercise? #T2D #DOC "17.06.2016 12:00:39" [{"text":"systemic", "indices":[10, 19]}, {"text":"sclerosis", "indices":[20, 30]}] Boehringer Want more #systemic #sclerosis patient stories? Our NEW animation is for you: https://t.co/aYI9zO3mMp Want more #systemic #sclerosis patient stories? Our NEW animation is for you: https://t.co/aYI9zO3mMp "17.06.2016 06:32:16" [] Boehringer @CamsSilveira, a Boehringer segue as determinações da Anvisa, infelizmente, não poderemos seguir com o patrocínio solicitado. Obrigado. -TP @CamsSilveira, a Boehringer segue as determinações da Anvisa, infelizmente, não poderemos seguir com o patrocínio solicitado. Obrigado. -TP "16.06.2016 11:49:33" [{"text":"DYK", "indices":[0, 4]}, {"text":"systemic", "indices":[31, 40]}, {"text":"sclerosis", "indices":[41, 51]}] Boehringer #DYK that there is no cure for #systemic #sclerosis? Hear what our patient has to say on this: https://t.co/5snXbWAmYM #DYK that there is no cure for #systemic #sclerosis? Hear what our patient has to say on this: https://t.co/5snXbWAmYM "15.06.2016 10:30:04" [{"text":"scleroderma", "indices":[21, 33]}] Boehringer It's 1/2 way through #scleroderma Awareness Month and we've got another patient quote for you. https://t.co/TATIrotPcp It's 1/2 way through #scleroderma Awareness Month and we've got another patient quote for you. https://t.co/TATIrotPcp "14.06.2016 20:02:08" [{"text":"2016ADA", "indices":[12, 20]}, {"text":"CVDinT2D", "indices":[49, 58]}] Boehringer Last day of #2016ADA! We hope you've enjoyed the #CVDinT2D tips and city comparisons - which ones resonate with you? https://t.co/89a4NJKTsf Last day of #2016ADA! We hope you've enjoyed the #CVDinT2D tips and city comparisons - which ones resonate with you? https://t.co/89a4NJKTsf "14.06.2016 15:07:04" [{"text":"kidney", "indices":[11, 18]}, {"text":"EMPAREGOUTCOME", "indices":[29, 44]}] Boehringer PRESS: New #kidney data from #EMPAREGOUTCOME published in @NEJM today ➡ https://t.co/2WGohVRQoo PRESS: New #kidney data from #EMPAREGOUTCOME published in @NEJM today ➡ https://t.co/2WGohVRQoo "14.06.2016 15:02:31" [{"text":"T2D", "indices":[66, 70]}, {"text":"medicaljargon", "indices":[72, 86]}] Boehringer What is an SGLT2-inhibitor and how are they taken by someone with #T2D? #medicaljargon explained https://t.co/IPnG3UcO4j What is an SGLT2-inhibitor and how are they taken by someone with #T2D? #medicaljargon explained https://t.co/IPnG3UcO4j "14.06.2016 11:41:56" [{"text":"EAACI2016", "indices":[10, 20]}, {"text":"asthma", "indices":[38, 45]}] Boehringer Onsite at #EAACI2016 - don't miss the #asthma management poster session. 15.30-17.00 CET, Poster Zone 1 Onsite at #EAACI2016 - don't miss the #asthma management poster session. 15.30-17.00 CET, Poster Zone 1 "14.06.2016 11:32:19" [{"text":"ChatAsthma", "indices":[68, 79]}] Boehringer @visu_bio as promised, here is the storify of yesterday's tweetchat #ChatAsthma https://t.co/k5AgrY0e6s feel free to share! - Regards, PA @visu_bio as promised, here is the storify of yesterday's tweetchat #ChatAsthma https://t.co/k5AgrY0e6s feel free to share! - Regards, PA "14.06.2016 11:28:07" [{"text":"ChatAsthma", "indices":[23, 34]}, {"text":"EAACI2016", "indices":[113, 123]}, {"text":"hcsmeu", "indices":[124, 131]}, {"text":"asthma", "indices":[132, 139]}] Boehringer In case you missed our #ChatAsthma tweetchat yesterday w/ @russell_doc here's a wrap up: https://t.co/k5AgrY0e6s #EAACI2016 #hcsmeu #asthma In case you missed our #ChatAsthma tweetchat yesterday w/ @russell_doc here's a wrap up: https://t.co/k5AgrY0e6s #EAACI2016 #hcsmeu #asthma "14.06.2016 08:29:53" [{"text":"Systemic", "indices":[0, 9]}, {"text":"sclerosis", "indices":[10, 20]}] Boehringer #Systemic #sclerosis insights: Listen to a patient from Denmark describe scarring in her lungs https://t.co/lruLFyuvQp #Systemic #sclerosis insights: Listen to a patient from Denmark describe scarring in her lungs https://t.co/lruLFyuvQp "13.06.2016 20:01:59" [{"text":"T2D", "indices":[54, 58]}, {"text":"2016ADA", "indices":[98, 106]}, {"text":"CVDinT2D", "indices":[107, 116]}] Boehringer Here are just 3 useful tips to look after your ❤ with #T2D, see more here https://t.co/fDe2uPKYr9 #2016ADA #CVDinT2D https://t.co/7IekXqTBdn Here are just 3 useful tips to look after your ❤ with #T2D, see more here https://t.co/fDe2uPKYr9 #2016ADA #CVDinT2D https://t.co/7IekXqTBdn "13.06.2016 15:02:22" [{"text":"T2D", "indices":[74, 78]}, {"text":"2016ADA", "indices":[108, 116]}] Boehringer NewOrleans was under Spanish rule in the 18th century. See pic to compare #T2D rates in Louisiana and Spain #2016ADA https://t.co/w7W4WgsSLy NewOrleans was under Spanish rule in the 18th century. See pic to compare #T2D rates in Louisiana and Spain #2016ADA https://t.co/w7W4WgsSLy "13.06.2016 14:50:13" [{"text":"ChatAsthma", "indices":[62, 73]}] Boehringer Dear all, thank you for participating in our live tweet chat! #ChatAsthma. What a great discussion! We need to do more for asthma patients! Dear all, thank you for participating in our live tweet chat! #ChatAsthma. What a great discussion! We need to do more for asthma patients! "13.06.2016 14:14:06" [{"text":"ChatAsthma", "indices":[74, 85]}, {"text":"EAACI2016", "indices":[93, 103]}] Boehringer Thanks @russell_doc for hosting & thanks everyone who participated in #ChatAsthma during #EAACI2016. See u next time https://t.co/B6tUUFN8o0 Thanks @russell_doc for hosting & thanks everyone who participated in #ChatAsthma during #EAACI2016. See u next time https://t.co/B6tUUFN8o0 "13.06.2016 14:11:30" [{"text":"asthma", "indices":[57, 64]}, {"text":"Chatasthma", "indices":[74, 85]}, {"text":"EAACI2016", "indices":[86, 96]}] Boehringer @russell_doc Patient-HCP relationship is key to optimise #asthma control. #Chatasthma #EAACI2016 @russell_doc Patient-HCP relationship is key to optimise #asthma control. #Chatasthma #EAACI2016 "13.06.2016 14:06:47" [{"text":"ChatAsthma", "indices":[51, 62]}] Boehringer @visu_bio @russell_doc thanks for participating in #ChatAsthma - we will share a summary of the tweetchat tomorrow. Make sure to follow us @visu_bio @russell_doc thanks for participating in #ChatAsthma - we will share a summary of the tweetchat tomorrow. Make sure to follow us "13.06.2016 13:52:24" [{"text":"ChatAsthma", "indices":[51, 62]}, {"text":"EAACI2016", "indices":[63, 73]}] Boehringer In the final few minutes, get your questions in... #ChatAsthma #EAACI2016 In the final few minutes, get your questions in... #ChatAsthma #EAACI2016 "13.06.2016 13:51:18" [{"text":"ChatAsthma", "indices":[109, 120]}, {"text":"EAACI2016", "indices":[121, 131]}, {"text":"asthma", "indices":[132, 139]}] Boehringer It's important that patients use their inhalers correctly & as prescribed, even if they are feeling well #ChatAsthma #EAACI2016 #asthma It's important that patients use their inhalers correctly & as prescribed, even if they are feeling well #ChatAsthma #EAACI2016 #asthma "13.06.2016 13:46:19" [{"text":"Allergicasthma", "indices":[14, 29]}, {"text":"ChatAsthma", "indices":[92, 103]}, {"text":"EAACI2016", "indices":[104, 114]}, {"text":"asthma", "indices":[115, 122]}] Boehringer .@russell_doc #Allergicasthma can often be well managed in primary care without phenotyping #ChatAsthma #EAACI2016 #asthma .@russell_doc #Allergicasthma can often be well managed in primary care without phenotyping #ChatAsthma #EAACI2016 #asthma "13.06.2016 13:45:44" [{"text":"ChatAsthma", "indices":[71, 82]}, {"text":"EAACI2016", "indices":[83, 93]}, {"text":"hcsmeu", "indices":[94, 101]}] Boehringer @russell_doc @76whit see https://t.co/8von3P9iX2 for more information. #ChatAsthma #EAACI2016 #hcsmeu @russell_doc @76whit see https://t.co/8von3P9iX2 for more information. #ChatAsthma #EAACI2016 #hcsmeu "13.06.2016 13:34:47" [{"text":"Mhealth", "indices":[22, 30]}, {"text":"chatasthma", "indices":[57, 68]}, {"text":"eaaci2016", "indices":[69, 79]}, {"text":"hcsmeu", "indices":[80, 87]}] Boehringer @russell_doc consider #Mhealth to enhance action plans - #chatasthma #eaaci2016 #hcsmeu @russell_doc consider #Mhealth to enhance action plans - #chatasthma #eaaci2016 #hcsmeu "13.06.2016 13:25:00" [{"text":"asthma", "indices":[103, 110]}, {"text":"ChatAsthma", "indices":[127, 138]}] Boehringer @visu_bio good q but not the appropriate tweetchat to discuss treatment. Our focus is on the burden of #asthma symptoms today. #ChatAsthma @visu_bio good q but not the appropriate tweetchat to discuss treatment. Our focus is on the burden of #asthma symptoms today. #ChatAsthma "13.06.2016 13:09:03" [{"text":"ChatAsthma", "indices":[0, 11]}, {"text":"asthma", "indices":[82, 89]}] Boehringer #ChatAsthma the Royal College of Physicians 3 qs quiz is easy to take & asses #asthma symptoms https://t.co/FEmMJGL7dq #ChatAsthma the Royal College of Physicians 3 qs quiz is easy to take & asses #asthma symptoms https://t.co/FEmMJGL7dq "13.06.2016 13:02:00" [{"text":"ChatAsthma", "indices":[71, 82]}, {"text":"EAACI2016", "indices":[87, 97]}, {"text":"WalzingWithTheAllergens", "indices":[98, 122]}, {"text":"hcsmeu", "indices":[123, 130]}] Boehringer We're kicking off our live tweetchat w/ @russell_doc right now! Follow #ChatAsthma! - #EAACI2016 #WalzingWithTheAllergens #hcsmeu We're kicking off our live tweetchat w/ @russell_doc right now! Follow #ChatAsthma! - #EAACI2016 #WalzingWithTheAllergens #hcsmeu "13.06.2016 12:48:49" [{"text":"ChatAsthma", "indices":[41, 52]}, {"text":"EAACI2016", "indices":[94, 104]}] Boehringer .@russell_doc is in position to go LIVE. #ChatAsthma will be starting any min now. Follow us! #EAACI2016 https://t.co/JptWBP3TFq .@russell_doc is in position to go LIVE. #ChatAsthma will be starting any min now. Follow us! #EAACI2016 https://t.co/JptWBP3TFq "13.06.2016 11:26:48" [{"text":"ChatAsthma", "indices":[25, 36]}] Boehringer @visu_bio We are hosting #ChatAsthma this afternoon at 3pm CET on the symptoms of asthma, led by @russell_doc! Hope you can join! PA @visu_bio We are hosting #ChatAsthma this afternoon at 3pm CET on the symptoms of asthma, led by @russell_doc! Hope you can join! PA "13.06.2016 10:19:02" [{"text":"ChatAsthma", "indices":[74, 85]}] Boehringer @FlorinDanPopesc thank you for sharing the message. Hope you can join our #ChatAsthma at 3pm. Regards, PA @FlorinDanPopesc thank you for sharing the message. Hope you can join our #ChatAsthma at 3pm. Regards, PA "13.06.2016 10:05:21" [{"text":"asthma", "indices":[48, 55]}, {"text":"ChatAsthma", "indices":[93, 104]}, {"text":"hcsmeu", "indices":[105, 112]}, {"text":"EAACI2016", "indices":[113, 123]}] Boehringer Respiratory expert @russell_doc will be talking #asthma. Join the conversation today 3pm CET #ChatAsthma #hcsmeu #EAACI2016 Respiratory expert @russell_doc will be talking #asthma. Join the conversation today 3pm CET #ChatAsthma #hcsmeu #EAACI2016 "13.06.2016 09:28:07" [{"text":"EAACI2016", "indices":[13, 23]}, {"text":"asthma", "indices":[51, 58]}] Boehringer If you're at #EAACI2016 make sure visit our booth. #asthma https://t.co/nmXtVcqsj7 If you're at #EAACI2016 make sure visit our booth. #asthma https://t.co/nmXtVcqsj7 "13.06.2016 08:45:16" [{"text":"DYK", "indices":[0, 4]}, {"text":"T2D", "indices":[10, 14]}, {"text":"kidney", "indices":[27, 34]}, {"text":"dialysis", "indices":[66, 75]}, {"text":"2016ADA", "indices":[87, 95]}] Boehringer #DYK that #T2D can lead to #kidney failure, which could result in #dialysis treatment? #2016ADA #DYK that #T2D can lead to #kidney failure, which could result in #dialysis treatment? #2016ADA "13.06.2016 07:35:33" [{"text":"EAACI2016", "indices":[9, 19]}, {"text":"ChatAsthma", "indices":[40, 51]}] Boehringer We're at #EAACI2016 this week. Join our #ChatAsthma live tweet chat for more on managing asthma symptoms.Today3pmCET https://t.co/l2X52Yhoum We're at #EAACI2016 this week. Join our #ChatAsthma live tweet chat for more on managing asthma symptoms.Today3pmCET https://t.co/l2X52Yhoum "12.06.2016 18:00:56" [{"text":"T2D", "indices":[12, 16]}, {"text":"kidney", "indices":[31, 38]}, {"text":"CVD", "indices":[76, 80]}, {"text":"2016ADA", "indices":[81, 89]}] Boehringer People with #T2D and declining #kidney function are also at greater risk of #CVD #2016ADA https://t.co/nK1h7PQUwG People with #T2D and declining #kidney function are also at greater risk of #CVD #2016ADA https://t.co/nK1h7PQUwG "12.06.2016 17:03:11" [{"text":"NEWS", "indices":[0, 5]}, {"text":"T2D", "indices":[65, 69]}, {"text":"CV", "indices":[70, 73]}, {"text":"2016ADA", "indices":[87, 95]}] Boehringer #NEWS Boehringer Ingelheim & @LillyDiabetes announce further #T2D #CV risk data at #2016ADA https://t.co/cVTp1lzffh #NEWS Boehringer Ingelheim & @LillyDiabetes announce further #T2D #CV risk data at #2016ADA https://t.co/cVTp1lzffh "12.06.2016 15:01:37" [{"text":"DYK", "indices":[35, 39]}, {"text":"diabetes", "indices":[78, 87]}, {"text":"2016ADA", "indices":[95, 103]}] Boehringer 5% of New Orleanians are hispanic. #DYK hispanic groups make up nearly 13% of #diabetes cases? #2016ADA https://t.co/hTIaKVR1Oj 5% of New Orleanians are hispanic. #DYK hispanic groups make up nearly 13% of #diabetes cases? #2016ADA https://t.co/hTIaKVR1Oj "12.06.2016 09:01:05" [{"text":"Scleroderma", "indices":[0, 12]}] Boehringer #Scleroderma Awareness Month is well under way! This week we share insights from patients across all our channel https://t.co/LbieyBiHSk #Scleroderma Awareness Month is well under way! This week we share insights from patients across all our channel https://t.co/LbieyBiHSk "11.06.2016 16:01:55" [{"text":"NewOrleans", "indices":[18, 29]}, {"text":"Liverpool", "indices":[52, 62]}, {"text":"2016ADA", "indices":[97, 105]}] Boehringer Did you know that #NewOrleans is a sister city with #Liverpool in UK? How do the cities compare? #2016ADA https://t.co/fIcNKTtVhS Did you know that #NewOrleans is a sister city with #Liverpool in UK? How do the cities compare? #2016ADA https://t.co/fIcNKTtVhS "11.06.2016 15:06:24" [{"text":"NEWS", "indices":[0, 5]}, {"text":"2016ADA", "indices":[85, 93]}] Boehringer #NEWS Boehringer Ingelheim & @LillyDiabetes announce new data for linagliptin at #2016ADA https://t.co/e0AGnlHsft #NEWS Boehringer Ingelheim & @LillyDiabetes announce new data for linagliptin at #2016ADA https://t.co/e0AGnlHsft "11.06.2016 15:01:53" [{"text":"DYK", "indices":[0, 4]}, {"text":"T2D", "indices":[60, 64]}, {"text":"2016ADA", "indices":[85, 93]}] Boehringer #DYK how important it is to look after your ❤ when you have #T2D? Hear Monda's story #2016ADA https://t.co/kexWyU233J #DYK how important it is to look after your ❤ when you have #T2D? Hear Monda's story #2016ADA https://t.co/kexWyU233J "11.06.2016 13:01:41" [{"text":"Cardiostim2016", "indices":[25, 40]}, {"text":"afib", "indices":[97, 102]}, {"text":"stroke", "indices":[103, 110]}] Boehringer Today is the last day of #Cardiostim2016. Did you enjoy the congress? Favourite our tweet if so! #afib #stroke https://t.co/rdzPIw63Bj Today is the last day of #Cardiostim2016. Did you enjoy the congress? Favourite our tweet if so! #afib #stroke https://t.co/rdzPIw63Bj "11.06.2016 12:55:13" [{"text":"asthma", "indices":[26, 33]}, {"text":"ChatAsthma", "indices":[97, 108]}] Boehringer Appropriate management of #asthma symptoms can enable people to enjoy good quality of life. Join #ChatAsthma Monday! https://t.co/OGDvaIT5Kc Appropriate management of #asthma symptoms can enable people to enjoy good quality of life. Join #ChatAsthma Monday! https://t.co/OGDvaIT5Kc "11.06.2016 12:50:25" [{"text":"DYK", "indices":[0, 4]}, {"text":"diabetes", "indices":[22, 31]}, {"text":"kidney", "indices":[57, 64]}, {"text":"2016ADA", "indices":[74, 82]}, {"text":"T2D", "indices":[83, 87]}] Boehringer #DYK that people with #diabetes are at a greater risk of #kidney disease? #2016ADA #T2D https://t.co/kIzkCIdfwE #DYK that people with #diabetes are at a greater risk of #kidney disease? #2016ADA #T2D https://t.co/kIzkCIdfwE "11.06.2016 09:01:08" [{"text":"afib", "indices":[25, 30]}, {"text":"stroke", "indices":[45, 52]}] Boehringer The goal of treatment in #afib is to prevent #stroke. RT to encourage people to watch out for vital signs & symptoms https://t.co/AN6MQE3pqA The goal of treatment in #afib is to prevent #stroke. RT to encourage people to watch out for vital signs & symptoms https://t.co/AN6MQE3pqA "10.06.2016 16:33:11" [{"text":"DYK", "indices":[0, 4]}, {"text":"Respimat", "indices":[14, 23]}, {"text":"Dortmund", "indices":[63, 72]}, {"text":"COPD", "indices":[93, 98]}, {"text":"asthma", "indices":[99, 106]}] Boehringer #DYK how many #Respimat inhalers are produced every day in the #Dortmund microParts factory? #COPD #asthma #DYK how many #Respimat inhalers are produced every day in the #Dortmund microParts factory? #COPD #asthma "10.06.2016 15:02:21" [{"text":"2016ADA", "indices":[12, 20]}, {"text":"NewOrleans", "indices":[34, 45]}, {"text":"Orleans", "indices":[59, 67]}, {"text":"France", "indices":[71, 78]}] Boehringer This year's #2016ADA host city is #NewOrleans, named after #Orleans in #France. How do these cities compare? https://t.co/lg3QlghzEV This year's #2016ADA host city is #NewOrleans, named after #Orleans in #France. How do these cities compare? https://t.co/lg3QlghzEV "10.06.2016 14:42:23" [{"text":"tweetchat", "indices":[5, 15]}, {"text":"EAACI2016", "indices":[19, 29]}, {"text":"asthma", "indices":[70, 77]}, {"text":"ChatAsthma", "indices":[88, 99]}] Boehringer Live #tweetchat at #EAACI2016 on Monday 3pmCET. Discuss the impact of #asthma symptoms. #ChatAsthma w/ @russell_doc https://t.co/skNIN0QO7C Live #tweetchat at #EAACI2016 on Monday 3pmCET. Discuss the impact of #asthma symptoms. #ChatAsthma w/ @russell_doc https://t.co/skNIN0QO7C "10.06.2016 14:02:05" [{"text":"DYK", "indices":[0, 4]}, {"text":"Afib", "indices":[5, 10]}] Boehringer #DYK #Afib leads to a five-fold increase in the risk of stroke? For more info check out https://t.co/g4Cp77Sn0N https://t.co/HQe7b4r3Kp #DYK #Afib leads to a five-fold increase in the risk of stroke? For more info check out https://t.co/g4Cp77Sn0N https://t.co/HQe7b4r3Kp "10.06.2016 13:03:28" [] Boehringer @AlimKha81308804 Thx for tweeting us! You can find our job opportunities worldwide here - https://t.co/u4FJOdai2G - JF @AlimKha81308804 Thx for tweeting us! You can find our job opportunities worldwide here - https://t.co/u4FJOdai2G - JF "10.06.2016 12:31:00" [{"text":"DYK", "indices":[0, 4]}, {"text":"afib", "indices":[5, 10]}, {"text":"stroke", "indices":[32, 39]}, {"text":"afib", "indices":[87, 92]}, {"text":"Cardiostim2016", "indices":[94, 109]}] Boehringer #DYK #afib is a risk factor for #stroke? But how many people worldwide are affected by #afib? #Cardiostim2016 https://t.co/67ZoyIb8QF #DYK #afib is a risk factor for #stroke? But how many people worldwide are affected by #afib? #Cardiostim2016 https://t.co/67ZoyIb8QF "10.06.2016 09:30:02" [{"text":"systemic", "indices":[32, 41]}, {"text":"sclerosis", "indices":[42, 52]}] Boehringer Ready? More women than men have #systemic #sclerosis and mostly in the prime of their life, between 25-55 years https://t.co/bVO2tgtS6F Ready? More women than men have #systemic #sclerosis and mostly in the prime of their life, between 25-55 years https://t.co/bVO2tgtS6F "10.06.2016 09:18:19" [{"text":"afib", "indices":[32, 37]}, {"text":"Cardiostim2016", "indices":[41, 56]}, {"text":"patientsurvey", "indices":[62, 76]}] Boehringer Fascinating data on women & #afib at #Cardiostim2016. Our #patientsurvey explores gender & perceptions of afib: https://t.co/g4Cp77Sn0N Fascinating data on women & #afib at #Cardiostim2016. Our #patientsurvey explores gender & perceptions of afib: https://t.co/g4Cp77Sn0N "10.06.2016 09:12:07" [{"text":"asthma", "indices":[22, 29]}, {"text":"ChatAsthma", "indices":[87, 98]}, {"text":"hcsmeu", "indices":[99, 106]}] Boehringer Over 300 mill live w/ #asthma, learn about the impact. Join us live on 13th at 3pm CET #ChatAsthma #hcsmeu https://t.co/R8FTIPyn3y Over 300 mill live w/ #asthma, learn about the impact. Join us live on 13th at 3pm CET #ChatAsthma #hcsmeu https://t.co/R8FTIPyn3y "10.06.2016 09:01:04" [{"text":"Cardiostim2016", "indices":[8, 23]}, {"text":"Afib", "indices":[52, 57]}, {"text":"Stroke", "indices":[62, 69]}] Boehringer Press: @#Cardiostim2016 and want background info on #Afib and #Stroke? Check out https://t.co/0D7tdVYGhD: https://t.co/g4Cp77Sn0N Press: @#Cardiostim2016 and want background info on #Afib and #Stroke? Check out https://t.co/0D7tdVYGhD: https://t.co/g4Cp77Sn0N "09.06.2016 15:02:07" [{"text":"T2D", "indices":[51, 55]}, {"text":"medicaljargon", "indices":[57, 71]}] Boehringer What is an SGLT2-inhibitor and how does it work in #T2D? #medicaljargon explained https://t.co/gRv0GQMyuA What is an SGLT2-inhibitor and how does it work in #T2D? #medicaljargon explained https://t.co/gRv0GQMyuA "09.06.2016 14:56:49" [{"text":"ChatAsthma", "indices":[5, 16]}, {"text":"asthma", "indices":[73, 80]}, {"text":"EAACI2016", "indices":[91, 101]}, {"text":"hcsmeu", "indices":[102, 109]}] Boehringer Join #ChatAsthma with @russell_doc on Monday to talk about the impact of #asthma symptoms. #EAACI2016 #hcsmeu https://t.co/uGGVSiqiyf Join #ChatAsthma with @russell_doc on Monday to talk about the impact of #asthma symptoms. #EAACI2016 #hcsmeu https://t.co/uGGVSiqiyf "09.06.2016 13:01:53" [{"text":"DYK", "indices":[0, 4]}, {"text":"afib", "indices":[10, 15]}, {"text":"Cardiostim2016", "indices":[59, 74]}, {"text":"stroke", "indices":[75, 82]}] Boehringer #DYK that #afib is the most common heart rhythm condition? #Cardiostim2016 #stroke https://t.co/udKf63dzo6 #DYK that #afib is the most common heart rhythm condition? #Cardiostim2016 #stroke https://t.co/udKf63dzo6 "09.06.2016 11:30:18" [{"text":"afib", "indices":[38, 43]}, {"text":"stroke", "indices":[50, 57]}, {"text":"patientsurvey", "indices":[63, 77]}, {"text":"Cardiostim2016", "indices":[123, 138]}] Boehringer How does gender impact perceptions of #afib & #stroke? Our #patientsurvey explores… more here: https://t.co/sCfj4dUM7W #Cardiostim2016 How does gender impact perceptions of #afib & #stroke? Our #patientsurvey explores… more here: https://t.co/sCfj4dUM7W #Cardiostim2016 "09.06.2016 11:01:13" [{"text":"patientsurvey", "indices":[4, 18]}, {"text":"Cardiostim2016", "indices":[40, 55]}, {"text":"afib", "indices":[83, 88]}] Boehringer New #patientsurvey results announced at #Cardiostim2016 reveal that women perceive #afib as more serious than men https://t.co/ExcfmTaNwt New #patientsurvey results announced at #Cardiostim2016 reveal that women perceive #afib as more serious than men https://t.co/ExcfmTaNwt "09.06.2016 09:32:47" [{"text":"systemic", "indices":[14, 23]}, {"text":"sclerosis", "indices":[24, 34]}, {"text":"systemic", "indices":[77, 86]}, {"text":"sclerosis", "indices":[87, 97]}, {"text":"scleroderma", "indices":[99, 111]}] Boehringer It's our last #systemic #sclerosis quiz! Do you think more women or men have #systemic #sclerosis? #scleroderma It's our last #systemic #sclerosis quiz! Do you think more women or men have #systemic #sclerosis? #scleroderma "09.06.2016 08:14:58" [{"text":"afib", "indices":[23, 28]}, {"text":"patientsurvey", "indices":[29, 43]}] Boehringer Want background on our #afib #patientsurvey & why patient preferences re. treatment are so important? Video: https://t.co/lgFlXsMrK0 Want background on our #afib #patientsurvey & why patient preferences re. treatment are so important? Video: https://t.co/lgFlXsMrK0 "09.06.2016 07:00:05" [{"text":"systemic", "indices":[47, 56]}, {"text":"sclerosis", "indices":[57, 67]}] Boehringer Did you get it right. Up to 90% of people with #systemic #sclerosis may develop some scarring in the lung https://t.co/AdMLqKlUwR Did you get it right. Up to 90% of people with #systemic #sclerosis may develop some scarring in the lung https://t.co/AdMLqKlUwR "08.06.2016 20:02:00" [{"text":"2016ADA", "indices":[41, 49]}, {"text":"cardiovascular", "indices":[71, 86]}, {"text":"T2D", "indices":[97, 101]}] Boehringer Are you looking after your ❤? Throughout #2016ADA we'll be focusing on #cardiovascular health in #T2D https://t.co/PXxZ7MOSMi Are you looking after your ❤? Throughout #2016ADA we'll be focusing on #cardiovascular health in #T2D https://t.co/PXxZ7MOSMi "08.06.2016 14:02:14" [{"text":"systemic", "indices":[33, 42]}, {"text":"sclerosis", "indices":[43, 53]}] Boehringer REMINDER: All the answers to our #systemic #sclerosis quiz can be found in our factsheet. Read up and get involved: https://t.co/cMTqqfhzms REMINDER: All the answers to our #systemic #sclerosis quiz can be found in our factsheet. Read up and get involved: https://t.co/cMTqqfhzms "08.06.2016 10:00:40" [{"text":"Afib", "indices":[90, 95]}, {"text":"cardiostim2016", "indices":[96, 111]}] Boehringer HCPs: Our Symposium on NOAC reversal agents starts @14:00 in Room 1.1, Méditerranée level #Afib #cardiostim2016 https://t.co/PET2s2vgSn HCPs: Our Symposium on NOAC reversal agents starts @14:00 in Room 1.1, Méditerranée level #Afib #cardiostim2016 https://t.co/PET2s2vgSn "08.06.2016 09:45:06" [{"text":"afib", "indices":[22, 27]}, {"text":"patientsurvey", "indices":[28, 42]}, {"text":"stroke", "indices":[85, 92]}, {"text":"Cardiostim2016", "indices":[127, 142]}] Boehringer Want more info on our #afib #patientsurvey & the impact of age on perceptions of #stroke? Head to: https://t.co/dWKeNachqD #Cardiostim2016 Want more info on our #afib #patientsurvey & the impact of age on perceptions of #stroke? Head to: https://t.co/dWKeNachqD #Cardiostim2016 "08.06.2016 09:30:23" [{"text":"DYK", "indices":[0, 4]}, {"text":"afib", "indices":[10, 15]}, {"text":"stroke", "indices":[61, 68]}, {"text":"Cardiostim2016", "indices":[95, 110]}] Boehringer #DYK that #afib patients >65 are more knowledgeable about #stroke than younger AF patients? #Cardiostim2016 https://t.co/MI8tjytwMT #DYK that #afib patients >65 are more knowledgeable about #stroke than younger AF patients? #Cardiostim2016 https://t.co/MI8tjytwMT "08.06.2016 08:00:48" [{"text":"Cardiostim2016", "indices":[0, 15]}, {"text":"Afib", "indices":[92, 97]}, {"text":"Stroke", "indices":[98, 105]}] Boehringer #Cardiostim2016 has officially started! Follow @Cardiostim_ for the latest congress updates #Afib #Stroke https://t.co/i6H2j1aRpn #Cardiostim2016 has officially started! Follow @Cardiostim_ for the latest congress updates #Afib #Stroke https://t.co/i6H2j1aRpn "08.06.2016 07:52:05" [{"text":"systemic", "indices":[48, 57]}, {"text":"sclerosis", "indices":[58, 68]}] Boehringer Ready for our second quiz? How many people with #systemic #sclerosis may develop some scarring in the lung? Ready for our second quiz? How many people with #systemic #sclerosis may develop some scarring in the lung? "08.06.2016 07:00:41" [{"text":"Harvard", "indices":[33, 41]}, {"text":"research", "indices":[75, 84]}, {"text":"fibrotic", "indices":[88, 97]}, {"text":"diseases", "indices":[98, 107]}] Boehringer New collaboration to be open for #Harvard groups who want to contribute to #research on #fibrotic #diseases https://t.co/4KGoAoIr8j New collaboration to be open for #Harvard groups who want to contribute to #research on #fibrotic #diseases https://t.co/4KGoAoIr8j "08.06.2016 06:30:07" [{"text":"systemic", "indices":[79, 88]}, {"text":"sclerosis", "indices":[89, 99]}, {"text":"scleroderma", "indices":[100, 112]}] Boehringer Thank you to those who guessed. 2 million ppl worldwide are estimated to have #systemic #sclerosis #scleroderma https://t.co/VZqlJkEmcr Thank you to those who guessed. 2 million ppl worldwide are estimated to have #systemic #sclerosis #scleroderma https://t.co/VZqlJkEmcr "08.06.2016 06:00:35" [{"text":"afib", "indices":[19, 24]}, {"text":"patientsurvey", "indices":[25, 39]}, {"text":"Cardiostim2016", "indices":[53, 68]}] Boehringer More data from our #afib #patientsurvey coming up at #Cardiostim2016. For background, check out our Facebook LIVE! https://t.co/m78szZsdmP More data from our #afib #patientsurvey coming up at #Cardiostim2016. For background, check out our Facebook LIVE! https://t.co/m78szZsdmP "07.06.2016 19:00:55" [{"text":"Cardiostim2016", "indices":[6, 21]}, {"text":"Afib", "indices":[98, 103]}] Boehringer HCPs: #Cardiostim2016 starts tomorrow! Check out the Scientific programme https://t.co/Dlzo8oIr71 #Afib https://t.co/quVcS8vkDG HCPs: #Cardiostim2016 starts tomorrow! Check out the Scientific programme https://t.co/Dlzo8oIr71 #Afib https://t.co/quVcS8vkDG "07.06.2016 15:41:11" [{"text":"Cardiostim2016", "indices":[18, 33]}] Boehringer We're excited for #Cardiostim2016 taking place 8-11 June in Nice, France. Tell us what you're looking forward to! https://t.co/44xH7uQRXX We're excited for #Cardiostim2016 taking place 8-11 June in Nice, France. Tell us what you're looking forward to! https://t.co/44xH7uQRXX "07.06.2016 15:36:28" [{"text":"Harvard", "indices":[38, 46]}, {"text":"fibrotic", "indices":[87, 96]}] Boehringer Press: Find out how @Boehringer & #Harvard scientists want to collaborate to fight #fibrotic diseases: https://t.co/4KGoAoIr8j Press: Find out how @Boehringer & #Harvard scientists want to collaborate to fight #fibrotic diseases: https://t.co/4KGoAoIr8j "07.06.2016 15:31:05" [{"text":"T2D", "indices":[55, 59]}, {"text":"medicaljargon", "indices":[61, 75]}] Boehringer What is SGLT2 and why might it matter for someone with #T2D? #medicaljargon explained https://t.co/HawDj5nkW5 What is SGLT2 and why might it matter for someone with #T2D? #medicaljargon explained https://t.co/HawDj5nkW5 "07.06.2016 15:02:26" [{"text":"ASCO16", "indices":[0, 7]}, {"text":"lungcancer", "indices":[72, 83]}] Boehringer #ASCO16 has finished for this year, we are looking forward to 2017! ✈ #lungcancer #ASCO16 has finished for this year, we are looking forward to 2017! ✈ #lungcancer "07.06.2016 14:11:46" [{"text":"Harvard", "indices":[41, 49]}, {"text":"treatments", "indices":[70, 81]}, {"text":"fibrotic", "indices":[86, 95]}] Boehringer Press: @Boehringer will collaborate with #Harvard on finding advanced #treatments for #fibrotic diseases https://t.co/4KGoAoIr8j Press: @Boehringer will collaborate with #Harvard on finding advanced #treatments for #fibrotic diseases https://t.co/4KGoAoIr8j "07.06.2016 14:02:35" [{"text":"ASCO16", "indices":[36, 43]}] Boehringer Thank you for another great meeting #ASCO16, looking forward to next year already. What was your highlight? https://t.co/ittSFYVkQG Thank you for another great meeting #ASCO16, looking forward to next year already. What was your highlight? https://t.co/ittSFYVkQG "07.06.2016 13:45:13" [{"text":"ddt16", "indices":[83, 89]}] Boehringer See our live broadcast at 4pm CET on Facebook to hear about diverse collaborations #ddt16 https://t.co/Dc4hfu4PCf See our live broadcast at 4pm CET on Facebook to hear about diverse collaborations #ddt16 https://t.co/Dc4hfu4PCf "07.06.2016 13:02:25" [{"text":"ASCO16", "indices":[9, 16]}] Boehringer Although #ASCO16 is coming to a close, you can always find our latest news on our website, check it out: https://t.co/O9gVNtMxhG Although #ASCO16 is coming to a close, you can always find our latest news on our website, check it out: https://t.co/O9gVNtMxhG "07.06.2016 12:48:31" [{"text":"asthma", "indices":[42, 49]}, {"text":"IPCRG2016", "indices":[88, 98]}] Boehringer The patient-doctor relationship is key in #asthma care – get Dr Rodriguez’s perspective #IPCRG2016 https://t.co/rEQycLYjqb The patient-doctor relationship is key in #asthma care – get Dr Rodriguez’s perspective #IPCRG2016 https://t.co/rEQycLYjqb "07.06.2016 10:31:27" [{"text":"ddt16", "indices":[72, 78]}] Boehringer .@Boehringer dedicates this year’s Diversity-Day to the theme “networks”#ddt16 https://t.co/MIBCUqR2PU .@Boehringer dedicates this year’s Diversity-Day to the theme “networks”#ddt16 https://t.co/MIBCUqR2PU "07.06.2016 08:41:19" [{"text":"systemic", "indices":[66, 75]}, {"text":"sclerosis", "indices":[76, 86]}, {"text":"scleroderma", "indices":[99, 111]}] Boehringer First quiz of the week: DYK how many people are estimated to have #systemic #sclerosis, worldwide? #scleroderma First quiz of the week: DYK how many people are estimated to have #systemic #sclerosis, worldwide? #scleroderma "06.06.2016 18:20:12" [{"text":"ASCO16", "indices":[40, 47]}] Boehringer What has everyone been talking about at #ASCO16 so far? https://t.co/YIRaSB5skb What has everyone been talking about at #ASCO16 so far? https://t.co/YIRaSB5skb "06.06.2016 17:35:15" [{"text":"ASCO16", "indices":[79, 86]}] Boehringer New data underpin Boehringer's aspiration to be second in the 3rd gen TKI race #ASCO16 https://t.co/qHihbK9Pvs New data underpin Boehringer's aspiration to be second in the 3rd gen TKI race #ASCO16 https://t.co/qHihbK9Pvs "06.06.2016 16:05:21" [{"text":"DYK", "indices":[0, 4]}, {"text":"COPD", "indices":[97, 102]}, {"text":"asthma", "indices":[103, 110]}] Boehringer #DYK the microParts factory has the capacity to produce 40 million Respimat inhalers every year? #COPD #asthma https://t.co/2Ud4hvYbVb #DYK the microParts factory has the capacity to produce 40 million Respimat inhalers every year? #COPD #asthma https://t.co/2Ud4hvYbVb "06.06.2016 15:30:44" [{"text":"NewOrleans", "indices":[51, 62]}, {"text":"2016ADA", "indices":[103, 111]}] Boehringer Who's going to ADA this Friday? This year it is in #NewOrleans - how much do you know about this city? #2016ADA https://t.co/qZopgktACG Who's going to ADA this Friday? This year it is in #NewOrleans - how much do you know about this city? #2016ADA https://t.co/qZopgktACG "06.06.2016 15:10:27" [] Boehringer @benloewith thanks for getting in touch with us. I recommend reaching out directly to @BoehringerCA for more help. Thanks & Best - JF @benloewith thanks for getting in touch with us. I recommend reaching out directly to @BoehringerCA for more help. Thanks & Best - JF "06.06.2016 15:02:20" [{"text":"lungcancer", "indices":[20, 31]}, {"text":"ASCO16", "indices":[54, 61]}] Boehringer Find out more about #lungcancer from our backgrounder #ASCO16 https://t.co/TXOFi9bAdN Find out more about #lungcancer from our backgrounder #ASCO16 https://t.co/TXOFi9bAdN "06.06.2016 14:40:11" [{"text":"ASCO16", "indices":[81, 88]}] Boehringer .@globalungcancer has developed a great factsheet on immunotherapy, find it here #ASCO16 https://t.co/AnZBvWmmd0 .@globalungcancer has developed a great factsheet on immunotherapy, find it here #ASCO16 https://t.co/AnZBvWmmd0 "06.06.2016 14:15:39" [{"text":"lungcancer", "indices":[40, 51]}, {"text":"ASCO16", "indices":[83, 90]}] Boehringer Do you know what the different types of #lungcancer are? Tweet us and let us know! #ASCO16 Do you know what the different types of #lungcancer are? Tweet us and let us know! #ASCO16 "06.06.2016 14:01:06" [{"text":"systemic", "indices":[50, 59]}, {"text":"sclerosis", "indices":[60, 70]}, {"text":"scleroderma", "indices":[127, 139]}] Boehringer This week join us & test your knowledge about #systemic #sclerosis. Want a hint? All answers here: https://t.co/cMTqqfhzms #scleroderma This week join us & test your knowledge about #systemic #sclerosis. Want a hint? All answers here: https://t.co/cMTqqfhzms #scleroderma "06.06.2016 12:15:15" [{"text":"asthma", "indices":[61, 68]}] Boehringer Dr de Sousa tells us “there is a lot of sick leave caused by #asthma which can be avoided by improving treatment” https://t.co/GqzTNCsVta Dr de Sousa tells us “there is a lot of sick leave caused by #asthma which can be avoided by improving treatment” https://t.co/GqzTNCsVta "06.06.2016 07:10:05" [{"text":"ASCO16", "indices":[69, 76]}] Boehringer .@Boehringer keeps up the pace to be second in the 3rd gen TKI race #ASCO16 https://t.co/qHihbK9Pvs .@Boehringer keeps up the pace to be second in the 3rd gen TKI race #ASCO16 https://t.co/qHihbK9Pvs "05.06.2016 16:20:04" [{"text":"Cancer", "indices":[45, 52]}, {"text":"ASCO16", "indices":[97, 104]}] Boehringer Committed to raise awareness for 23rd Annual #Cancer Survivors´ Celebration Walk & 5k Run at #ASCO16 https://t.co/O4RQCBs5zl Committed to raise awareness for 23rd Annual #Cancer Survivors´ Celebration Walk & 5k Run at #ASCO16 https://t.co/O4RQCBs5zl "05.06.2016 16:01:40" [{"text":"ASCO16", "indices":[34, 41]}] Boehringer HCPs: Have you found our booth at #ASCO16? #18063, Exhibition hall A! HCPs: Have you found our booth at #ASCO16? #18063, Exhibition hall A! "05.06.2016 15:01:32" [{"text":"lungcancer", "indices":[0, 11]}, {"text":"cancer", "indices":[31, 38]}] Boehringer #lungcancer is the most deadly #cancer in the world. Find out more from our infographic https://t.co/IdhmyI53dn https://t.co/CuuglVlItM #lungcancer is the most deadly #cancer in the world. Find out more from our infographic https://t.co/IdhmyI53dn https://t.co/CuuglVlItM "05.06.2016 14:01:33" [{"text":"ASCO16", "indices":[3, 10]}, {"text":"oncology", "indices":[65, 74]}] Boehringer As #ASCO16 is underway, you can find out more about our exciting #oncology pipeline here https://t.co/rCE6dp8xUQ As #ASCO16 is underway, you can find out more about our exciting #oncology pipeline here https://t.co/rCE6dp8xUQ "05.06.2016 13:30:41" [{"text":"lungcancer", "indices":[72, 83]}, {"text":"collaborativewisdom", "indices":[108, 128]}, {"text":"ASCO16", "indices":[131, 138]}] Boehringer .@CR_UK has developed a fab reading list for anyone looking for info on #lungcancer https://t.co/vecw8mCLCe #collaborativewisdom #ASCO16 .@CR_UK has developed a fab reading list for anyone looking for info on #lungcancer https://t.co/vecw8mCLCe #collaborativewisdom #ASCO16 "05.06.2016 12:35:13" [{"text":"ASCO16", "indices":[9, 16]}, {"text":"lungcancer", "indices":[105, 116]}] Boehringer HCPs: At #ASCO16? Go to Hall A 08:00-11:30 today to see our latest research into combination therapy for #lungcancer HCPs: At #ASCO16? Go to Hall A 08:00-11:30 today to see our latest research into combination therapy for #lungcancer "05.06.2016 12:01:14" [{"text":"ASCO16", "indices":[49, 56]}] Boehringer What has the biggest insight you have taken from #ASCO16 so far? What has the biggest insight you have taken from #ASCO16 so far? "05.06.2016 11:10:11" [{"text":"Head", "indices":[29, 34]}, {"text":"ASCO16", "indices":[81, 88]}] Boehringer HCPs: Our latest research in #Head&NeckCancer will be presented in Hall A at #ASCO16 today 13:00-16:30. See you there! POSTER #6049 HCPs: Our latest research in #Head&NeckCancer will be presented in Hall A at #ASCO16 today 13:00-16:30. See you there! POSTER #6049